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Abstract: 
 Cyanobacteria are one of the oldest forms of photosynthetic life 
and may have contributed significantly to the evolution of oxygen into 
the then anoxic environment. Cyanobacteria are also one of the best 
sources of natural secondary metabolites (cyanopeptides) some of 
which have harmful effects on the ecosystem, while others may be 
beneficial. It is known that these secondary metabolites are 
continuously produced during growth, however, it is not known 
whether the producing cyanobacteria actually benefit from these 
metabolites. The overarching aim of this study was to answer the 
question ‘Why do cyanobacteria produce secondary metabolites?’.  
 With this aim in mind, preliminary work focused on 
understanding the growth and secondary metabolite production 
characteristics of Microcystis aeruginosa PCC7806. The technique of 
labelling secondary metabolites with 15N was successfully employed in 
differentiation and quantification of ex-novo and de-novo metabolites. 
The effect of exogenous cyanopeptides such as microcystins, 
aerucyclamides, anabaenopeptins, aeruginosamide, cyanopeptolin and 
aeruginosin on M. aeruginosa PCC7806 was evaluated using a rapid 
bioassay approach along with an automated cell enumeration 
technique. The results indicate that at least some cyanopeptides 
(microcystins-LR, microcystin-LF, aeruginosamide, anabaenopeptin B 
and aerucyclamide A) induce significant changes to cell division and 
metabolite production rate. In an ecological scenario, the release of 
such secondary metabolites by lysing cells (such as when blooms 
collapse), may be perceived as an alarm signal by surrounding live 
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cells, which may in turn slow cell division and prepare for re-invasion. 
This may be a strategy for species survival and dominance.  
While the results from this study do not confirm a role for 
cyanopeptides, it is thought that the results are clearly indicative of 
the role played by cyanopeptides for the producing organism. In order 
to confirm a role, it is recommended that monitoring ribosomally 
synthesised metabolites (e.g. aerucyclamides) along with chlorophyll-a 
gene expression, with sophisticated techniques such as qPCR are used.  
 
Keywords – Cyanobacteria, Cyanopeptides, Secondary metabolites, 
Microcystis aeruginosa PCC7806, microcystin, demethyl microcystin-
LR, cyanopeptolin, aerucyclamide, anabaenopeptin, aeruginosamide, 
flowcytometry, de-novo production, ex-novo, UPLC, LC-MS/MS 
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1.1 Cyanobacteria – background 
 
Cyanobacteria are a group of photosynthetic organisms which 
are spread across varied ecosystems, including extreme ones [1]. 
Their range of habitats includes freshwater, brackish and marine 
environments. Some strains are known to grow in terrestrial 
ecosystems; however, moisture is an absolute requirement for their 
survival. This group of bacteria can be clearly differentiated from other 
forms owing to the presence of chlorophyll-a and phycocyanin [2]. As 
photosynthetic organisms, their nutrient requirement is relatively 
simple and consists of inorganic carbon, nitrogen, phosphates, traces 
of inorganic minerals, sunlight and water. This simple requirement and 
their ability to adapt to changing environments has enabled them to 
thrive in a wide range of ecosystems [3]. 
Cyanobacterial fossils have been dated back to 3.5 billion years 
confirming their presence even before the oxygenation of the earth’s 
atmosphere [4]. In those days, the atmosphere could not support 
oxygen enabled metabolism as its primary elements were mainly CH4 
and CO2 and H2O. It is thought that cyanobacteria predominated in this 
atmosphere evolving oxygen, ultimately leading to the oxygenation of 
the atmosphere [5]. In fact, it has been proven that the present day 
higher photosynthetic organisms evolved as a result of endosymbiosis 
of primitive cyanobacterial cells [6].  
Cyanobacteria are sometimes referred to as blue-green algae 
owing to the presence of the blue phycocyanin and the green 
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chlorophyll-a pigments. However, unlike algae which are eukaryotes, 
cyanobacteria are truly prokaryotes as they lack a well-defined 
nucleus, organised intracellular structures and reproduce asexually [7]. 
Presently, cyanobacteria are classified under prokaryotes as 
cyanophycaen members, which form a large monophyletic group 
(Figure 1.1). 
 
Figure 1.1: Phylogenetic tree of life depicting classification of 
cyanobacteria [8]. 
 
1.2 Blooms 
Cyanobacteria are capable of prolific growth under ambient 
atmospheric conditions. Factors such as low turbulence, warm 
temperature, high pH, optimal sunlight, low N:P ratio and low grazing 
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rates encourage bloom formation. Recently, it was reported that bloom 
frequencies have increased as a net result of global warming. Blooms 
can occur under wide ranging environmental conditions, although the 
tropical and subtropical climates seem to favour bloom formation [9]. 
Blooms may be widely classified as non-toxic and toxic based on the 
toxicity of the predominant organism that has formed the bloom. 
Overall, it has been estimated that up to 75% of blooms may be toxic 
i.e. the compounds secreted by the predominant organism may be 
toxic to humans or animals [10]. In 1996, 76 people were reported to 
have died due to Caruaru syndrome with symptoms such as 
hepatomegaly, jaundice, necrosis and apoptosis of hepatocytes. Later, 
it was confirmed that the symptoms were due to poisoning from 
microcystin contaminated water used for renal dialysis [11]. In 2003, a 
report suggested that the death of a large number of Lesser Flamingos 
in Kenya may be attributed to the presence of microcystin-LR and 
anatoxin-a in the Bogoria lake [12]. Recently, between 2007 and 
2011, the US department of health reported that 12 canines have 
succumbed to anatoxin poisoning, 3 to microcystin and 1 to brevetoxin 
[13].  
In UK, a number of dog deaths have been attributed to 
neurotoxin poisoning caused by consumption of cyanobacterial bloom 
contaminated water. It was confirmed that the cause of these deaths 
were due to anatoxin-a produced by Oscillatoria sp [46]. Bloom 
frequency have been reported to increase during warm dry summers in 
UK and Europe, causing the death of sheep, dogs and some cases of 
human illness [18]. Considering the implications of cyanotoxins, WHO 
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has set a provisional guideline value of 1 µg / L of total (free and cell 
bound) microcystin-LR for drinking water [14]. Even when the bloom 
type is non-toxic, it may still result in an adverse effect on the water 
body by depleting nutrient and oxygen levels and blocking sunlight 
penetration to the underwater photosynthetic organisms thereby 
inhibiting them. Also, when blooms collapse, they release excess 
ammonia into the ecosystem causing disease to fish [10].   
Recent research suggests that cyanobacterial blooms are 
promoted by higher temperatures as well as increased anthropogenic 
nutrient loads. It is also suggested that changing weather conditions 
will alter rainfall which may in turn contribute to further nutrient 
inflow. Further, climate change is predicted to be inevitable with 
increased temperatures, enhanced vertical stratification of aquatic 
ecosystems and alteration in annual weather patterns, all of which 
favour cyanobacterial growth [15 - 17]. Also, as toxic blooms have 
been reported in Australia, USA, UK, India, Africa and Europe it is 
imperative that toxic cyanobacteria are studied in depth to understand 
their growth and toxin production dynamics [18 - 20]. 
The predominant bloom forming cyanobacteria are the 
Microcystis, Anabaena, Nodularia, Cylindrospermopsis, Oscillatoria and 
Planktothrix. Blooms formed by toxic cyanobacteria such as 
Microcystis, Cylindrospermopsis, Nodularia release an array of their 
secondary metabolites into the aquatic ecosystem. Many of these 
secondary metabolites have been shown to exert a toxic effect against 
mice hepatocytes (hepatotoxin) or affect the nerve junctions 
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(neurotoxins) [10]. Along with the toxic effect, these blooms also have 
the additional negative effects of non-toxic blooms e.g. O2 depletion. 
These combined effects drastically affect water quality; kill fish and 
other aquatic life forms. Hence, cyanobacterial secondary metabolites 
have become a concern for healthcare as well as environmental 
sectors. Though cyanobacteria have been studied for several decades 
and several hundreds of secondary metabolites have been identified, 
their ecological significance and the benefit to the producing organism 
are yet to be fully understood. 
 
1.3 Secondary metabolites 
Cyanobacterial secondary metabolites have become a subject of 
intense research due to two main reasons. Firstly, some of the 
secondary metabolites have been reported as toxic to humans, animals 
as well as fish [10 - 13].  This has prompted the establishment of 
guideline values for some cyanotoxins. Secondly, cyanobacteria have 
become one of the best sources of new bioactive compounds. 
Terrestrial cyanobacteria have been reported to produce antiviral 
(cyanovirin N from Nostoc ellipsosporum and scytovirin from 
Scytonema varium) and anticancer (e.g. cryptophycins) compounds 
whereas marine cyanobacteria have been reported to produce 
compounds with activities ranging from antibacterial, (serine) protease 
inhibitors, cytotoxic and antineoplastic properties [21]. Cyanobacteria 
are known to produce nearly 800 different low molecular weight 
secondary metabolites some of which have been identified as toxins. 
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The toxins of cyanobacteria can still further be classified into 
hepatotoxins, neurotoxins and endotoxins based on their site of action. 
 
1.3.1 Hepatotoxins 
Hepatotoxins are compounds that affect liver cells (hepatocytes) 
in mammals. Cyanobacterial hepatotoxins are widely distributed 
among aquatic environments and have been attributed to some cases 
of livestock deaths [10]. Generally, these hepatotoxins are small cyclic 
peptide molecules ranging in size between 800 to 1100 Daltons, water 
soluble and released along with cell lysis [11].  Microcystins (MC) are 
one of the well-known hepatotoxins produced by species such as 
Microcystis, Anabaena, Planktothrix and Nostoc. Microcystins show 
considerable structural variance and to date more than 80 different 
structural variants have been reported. Microcystin-LR (microcystin-
LR) is the most commonly found variant (Figure 1.2). 
MCs are monocyclic heptapeptides with a conserved basic 
structure which consists of three D-amino acids at positions 1, 3, 6, 
the amino acid N-methyldehydroalanine (Mdha) at position 7, an 
unusual amino acid 3-amino-9-methoxy-2, 6, 8-trimethyl-10-
phenyldeca-4, 6-dienoic acid (adda) at position 5. The two amino acids 
at position 2 and 4 have always been reported as L-forms and are 
highly variable and MCs are named according to these amino acids 
(Table 1.1) [22]. 
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Figure 1.2 – General structure of Microcystins. The amino acids at 
position 2 and 4 are variable and always L-forms and gives rise to 
numerous variants (Table 1.1). 
 
Table 1.1 – Some common MC variants showing the amino acids at 
position 2, 4 
Variant Mol Wt Position 2 Position 4 
Microcystin-LA 910.1 Leu Ala 
Microcystin-LF 986.2 Leu Phe 
Microcystin-LR 995.2 Leu Arg 
Microcystin-LW 1025.2 Leu Trp 
Microcystin-LY 1002.2 Leu Tyr 
Microcystin-RR 1038.2 Arg Arg 
Microcystin-YR 1045.2 Tyr Arg 
Microcystin-WR 1068.3 Trp Arg 
 
Once ingested, microcystins are transported to the liver where 
they inhibit protein phosphatases Type 1 and type 2A enzymes. Protein 
phosphatases perform regulatory activities such as glycogen 
metabolism, cell division, apoptosis, and protein synthesis. When the 
Robert Gordon University 
- 16 - 
Thaslim Arif  April 2016 
enzymes are inhibited, the cells become more vulnerable towards 
tumor formation and in higher concentrations the cells die [22]. 
Another potent hepatotoxin is nodularin (NOD) (Figure 1.3). 
Though structurally similar to microcystin, nodularin is a pentapeptide, 
primarily produced by and identified in Nodularia spumigena. The 
general structure of NOD is cyclo-(D-MeAsp-L-arginine-Adda-D-
glutamate-Mdhb). Nodularia has been repeatedly isolated from blooms 
across the Baltic sea, coastal lagoons in Australia, German North Sea 
coast, New Zealand, North America and in River Murray, South 
Australia [23 – 27]. Like microcystin, NOD also inhibits protein 
phosphatase enzymes leading to functional disturbance within cells. 
However, nodularin is even more potent when compared to microcystin 
as nodularin penetrates cells better. It has been found that microcystin 
is a tumor promoter (a substance that has no carcinogenic potential 
but amplifies the cancer inducing effect of other carcinogens) whereas 
nodularin is a carcinogen [28, 29]. 
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Figure 1.3 – Chemical structure of nodularin (C41H60N8O10, Mol wt 
824.98). NOD is structurally different from MC in that two amino acids 
at position 1 and 2 of MC are missing and Mdha (N-
methyldehydroalanine) is replaced by Mdhb (N-
methyldehydrobutyrine) at position 5. 
 
NOD is of particular concern to the sea food industry as it is 
known to accumulate in mussels, fish, mysid shrimp and prawns at 
concentrations sufficient to induce hepatotoxicity to the consumers 
[30]. Though chemically similar to MC, NOD has fewer variants and 
thus far only 9 variants have been reported (Table 1.2) [31]. 
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         Table 1.2: A list of reported variants of NOD 
Variant [M+H]+ Ref 
NOD-R 825 
[31] 
Linear NOD 843 
[D-Asp]NOD 811 
[DMAdda]NOD 811 
[dhb]NOD 811 
[MeAdda]NOD 839 
Glu(OMe)]NOD 839 
[L-Har]NOD 839 [32] 
[L-Val]NOD 768 [33] 
 
Where, [M+H]+ stands for protonated molecule in positive ion mode 
of LC-MS 
Cylindrospermopsin (CYN) is yet another potent hepatotoxin, 
but varies in its mode of action. CYN is produced by freshwater 
cyanobacteria such as Cylindrospermopsis, Anabaena, Aphanizomenon, 
Lyngbya and Planktothrix [34] Chemically, CYN is a tricyclic sulphated 
uracil (Figure 1.4) derived alkaloid and is highly polar in nature. The 
toxicity of CYN is primarily attributed to its pyrimidine (Uracil) ring 
which binds to cytochrome P450 [35]. CYN inhibits protein synthesis, 
inhibits glutathione and cytochrome P450 which in severe cases leads 
to liver and kidney malfunctions. It has been reported that CYN inhibits 
protein synthesis irreversibly, induces membrane proliferation, 
detaches ribosomes from rough endoplasmic reticulum and promotes 
accumulation of lipids within cells. There are also reports that CYN may 
covalently bind and modify DNA [36 – 39].  
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Figure 1.4 – Chemical structure of Cylindrospermopsin (CYN). 
Chemical formula C15H21N5O7S, Mol wt 416.12 
 
1.3.2 Neurotoxins 
Neurotoxins are a class of compound that acts on neurons, and 
either inhibit nerve impulse transmission or stimulate neurotransmitter 
release. Cyanobacteria produce a number of cyanotoxins such as 
anatoxin, antillatoxins, saxitoxin and L-β-N-methylamino-L-alanine (L-
BMAA). Based on their chemical components, cyanobacterial 
neurotoxins can be classified as neurotoxic alkaloids, lipopeptides and 
neurotoxic amino acids. 
The alkaloid anatoxin-a (MW = 165 Da) and its closely related 
methylene homolog homoanatoxin-a (MW = 179 Da) are low molecular 
weight bicyclic cyanotoxins. Some of the organisms known to produce 
anatoxin-a are Oscillatoria, Anabaena [40] and Aphanizomenon [41] 
while homoanatoxin-a is produced by Oscillatoria, Anabaena and 
Phormidium [42, 43]. The organism Raphidiopsis mediterranea 
produces both the toxins [44]. In the past, there have been several 
incidences of animal poisoning where these toxins have been fatal for 
cows [45], dogs [46] and flamingos [12]. Anatoxin-a (Fig 5) was first 
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described as ‘very fast death factor’ as it kills mice within a short 
period at an intraperitoneal dose of LD50 of 250 µg/kg [47]. It is 
reported that the death of the animal is due to neuromuscular 
blockage followed by membrane depolarization which leads to 
respiratory arrest, hypoxia, acidosis and death [48]. The homolog 
homoanatoxin-a (Figure 1.5) was shown to be a potent agonist of 
muscular and neuronal nicotinic acetylcholine receptors [49]. 
 
Figure 1.5 – Anatoxin-a (165 Da) and Homoanatoxin-a (179 Da) 
 The neurotoxin produced by Anabaena flos-aquae strain NRC 
525–17, anatoxin-a(s) (Figure 1.6) has been shown to have 
exceptional anticholinesterase activity (LD50 (i.p) of 20 to 50 µg/kg 
mice). The letter ‘s’ in anatoxin-a(s) represents the characteristic 
symptom salivation induced by the toxin in vertebrates [50, 51]. 
Chemically, it is a guanidine methyl phosphate ester and irreversibly 
binds to acetylcholinesterase. Intoxication with anatoxin-a(s) is 
characterised by cholinergic symptoms such as reduced pulse and 
arterial blood pressure, salivation, convulsion and respiratory arrest. 
Anatoxin-a(s) acts as an irreversible but potent inhibitor of 
acetylcholine esterase, preventing it from hydrolysing the 
neurotransmitter acetylcholine thus preventing termination of synaptic 
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transmission. This results in continuous muscle stimulation and when 
respiratory muscles are involved, death occurs due to respiratory 
failure and brain hypoxia. It is reported that death due to anatoxin-
a(s) poisoning occurs typically within 30 mins of intoxication [52].     
 
Figure 1.6: Chemical structure of Anatoxin-a(s). Mol Wt 252 Da.  
 Another group of alkaloids, called saxitoxins (STX) is best known 
for their potent lethality in shellfish. Originally identified from 
dinoflagellates such as Alexandrium, Gymnodinium and Pyrodinium, it 
was later found that cyanobacterium such as Anabaena circinalis, 
Planktothrix, Aphanizomenon gracile, Cylindrospermopsis raciborskii 
and Lyngbya wollei also produce the toxin [53 – 57]. The term 
saxitoxins refers to a group of related analogs including saxitoxin, 
neosaxitoxin, gonyautoxins, C-toxins and decarbamylosaxitoxin. STX 
are trialkyl tetrahydropurine precursor molecules giving rise to about 
30 naturally different derivatives. The variable positions may be 
hydroxylated, sulphated or carbamoylated and most of the variants 
have been detected in both cyanobacteria and dinoflagellates [58]. 
However, one analog of STX, the zetekitoxin, isolated from the frog 
Atelopus zeteki has been found to be 580-fold more potent than STX 
[59]. Intoxication with STX results in symptoms such as vomiting, 
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diarrhoea, loss of motor control and paralysis. STX acts as a potent 
blocker of voltage gated sodium channel. Recently, it has also been 
reported as a calcium channel blocker and to prolong the gating of 
potassium channels [60, 61]. STX are responsible for a lethal human 
illness called paralytic shellfish poisoning (PSP). PSP poisoning occurs 
mainly due to the consumption of bivalve molluscs which are filter 
feeders and tend to accumulate STX producing dinoflagellates or 
marine eukaryotic alga. The LD50 for humans has been determined to 
be 5.7 µg/kg and hence this toxin is considered as highly toxic to 
humans. In fact, it was observed that these toxins were about 1000 
times more potent that the nerve gas sarin [62, 63]. 
 
Figure 1.7: General structure of Saxitoxin.  
   Cyanobacteria produce neurotoxic lipopeptides such as 
antillatoxins, kalkitoxins and Jamaicamides. Antillatoxin a (Figure 1.8) 
is a cyclic tripeptide that forms linkages with methylated lipid sections 
thus forming a lipopeptide. A N-methyl homophenylalanine homolog 
has also been reported (antillatoxin B) [64, 65]. Both antillatoxin A 
and B have been reported to cause neuronal death by inducing Na+ 
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influx. Hence these groups of toxins are also named as sodium channel 
activators [66, 67]. 
 
Figure 1.8 – General Structure of Antillatoxin 
 
1.3.3 Other bioactive compounds from cyanobacteria 
Anticancer compounds 
Cancer may be described as uncontrolled cell division leading to 
the formation of tumors, which may migrate to distant sites and 
establish new growth centres. Marine cyanobacteria, especially benthic 
strains have become an immense source of interesting bioactive 
compounds. Cyanobacterial strains Lyngbya, LeptoLyngbya, Symploca, 
Prochloron, Nostoc and Oscillatoria have been reported to produce 
compounds with antineoplastic properties. In 2001, a survey of 424 
cyanobacterial secondary metabolites revealed that about 15 % of the 
compounds could have anticancer properties (Figure 1.9) [67]. 
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Figure 1.9: The reported range of activity of marine cyanobacterial 
secondary metabolites 
 One of the ways by which some cyanopeptides arrest tumor 
growth is by inhibiting microtubules and actin proteins. The 
cyanopeptides cryptophycin 52, calothrixin A, dolastatin 10, 15 and 
symplostatin 1, hectochlorin and Lyngbyabellins are reported to inhibit 
tumor growth by arresting cell cycle at the G2/M phase.  Certain 
cyanopeptides such as aurilides A & B, cryptophycin 1, swinholide A 
are known to induce tumor cytotoxicity by inducing damage to 
mitochondrial DNA. An important pathway to induce tumor cell 
apoptosis is by the induction of caspase pathway. It should be noted 
that, unlike necrosis, apoptosis does not give rise to inflammation and 
hence induction of this pathway is considered an ideal pathway to use 
for cancer treatments. The cyanotoxins symplostatin 1, cryptophycin 1, 
52, somocystinamide A are some of the examples of caspase pathway 
stimulators (Table 1.3). 
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Table 1.3: Anticancer compounds produced by cyanobacteria 
Organism Compound Type Potency Ref 
Scytonema sp Scytonemin Alkaloid 
IC50 = 
7.8 µM 
[67] 
Lyngbya  
 majuscula 
Apratoxin A Lipopeptide 
IC50 < 
0.5 nM 
[68] 
L. majuscula Hectochlorin Lipopeptide 
GI50 < 
5.2 µM 
[69] 
L. majuscula 
Lyngbyabellin E - 
I 
Lipopeptide 
LC50 < 5 
µM 
[70] 
L. majuscula Curacin A Lipopeptide 
IC50 < 
ng/ml 
[71] 
Nostoc sp Cryptophycin Lipopeptide 
IC50 = 5 
pg/ml 
[72] 
Symploca  
 hydnoides 
Dolastatin 10 Lipopeptide 
IC50 < 
ng/ml 
[73] 
Symploca sp Symplostatin 1 Lipopeptide 
IC50 =  
3.9 - 
10.3 nM 
[74] 
Symploca sp Belamide A Lipopeptide 
IC50 = 
0.74 µM 
[75] 
Symploca sp Largazole  Lipopeptide 
IC50 = 
7.6 nM 
[76] 
L. majuscula Microcolin A Lipopeptide 
TC50 = 
22.6 nM 
[77] 
Prochloron sp Patellamide D Octapeptide 
IC50 = 
50 µM 
[78] 
Lyngbya  
 confervoides  
Obyanamide Lipopeptide 
IC 50 =  
0.58 
lg/ml  
[79] 
L. majuscula Jamaicamides A Lipopeptide  
IC 50 =  
15 
µmol/L  
[80] 
L. majuscula Aurilides B Lipopeptide  
LC50 =  
0.01 to 
0.13 µM 
[81] 
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Organism Compound Type Potency Ref 
Lyngbya  
 semiplena 
Wewakpeptins A 
- D 
Lipopeptide  
LC50 0.4 
µM 
[82] 
L. majuscula 
Somocystinamide 
A 
Lipopeptide  
IC 50 =  
1.4 
µg/ml  
[82, 83] 
Lyngbya sp Palauimide Lipopeptide  
IC 50 = 
13 nM 
[84] 
Lyngbya sp Ulongapeptin Lipopeptide  
IC 50 = 
0.63 µM 
[85] 
Oscillatoria sp 
Largamide A, G, 
H 
Lipopeptide  
IC 50 =  
4 - 25 
µM 
[85] 
 
 
1.4 Anti-Infective Compounds 
 Cyanobacteria produce a good range of antibacterial as well as 
antiviral compounds. The cyanobacterium Nostoc sp. ATCC 53789 
produces cryptophycins, antifungal agents. Cryptophycins (Figure 
1.10a) were also later found to have broad spectrum of activities 
against drug sensitive and drug resistant murine and human tumors. 
However, owing to their toxicity to non-tumor cells, clinical trials have 
been discontinued [86]. The compound cyanovirin-N (from Nostoc) has 
received much attention due to its HIV inactivation properties. 
Cyanovirin-N irreversibly inactivates diverse strains of HIV, including 
the sexually transmitted variant. As cyanovirin-N is stable under 
denaturating conditions, detergents, organic solvents and multiple heat 
thaw cycles, it is being considered for development as an anti-HIV 
agent [87].  The organism Oscillatoria nigroviridis has been reported to 
produce compounds that are antibiotic against Plasmodium falciparum, 
Leishmania donovani and Trypanosoma cruzi. The compound was 
Robert Gordon University 
- 27 - 
Thaslim Arif  April 2016 
termed as viridamide (Figure 1.10b) [88].  In addition, the alkaloid 
Nostocarboline (Figure 1.10c) from Nostoc sp. 78-12A was also found 
to be active against Trypanosoma brucei, Trypanosoma cruzi, 
Leishmania donovani and Plasmodium falciparum with IC50 values 
ranging from 0.5 to 0.194mM [89]. Aerucyclamide C isolated from 
Microcystis aeruginosa PCC7806 was also found to be active against T. 
brucei, while aerucyclamide B (Figure 1.10d) against P. falciparum with 
submicromolar IC50 values [90].  
 
 
Figure 1.10a – Cryptophycin 1 and 52 
 
 
Figure 1.10b – Viridamide A 
 
 
Figure 1.10c – Nostocarboline 
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Figure 1.10d – Aerucyclamide B and Aerucyclamide C 
 
1.5 Environmental conditions that affect secondary metabolite 
production 
 Cyanobacteria are prolific producers of secondary metabolites. 
In recent reports, it was mentioned that eutrophication and global 
warming could be one of the reasons for the increase in bloom 
frequencies thus leading to an increased secretion of toxins into the 
ecosystem [91]. Cyanobacterial growth requires optimal physical and 
environmental conditions like temperature, light, pH, phosphates, 
nitrates and trace metals [92]. In general, it is accepted that factors 
that enable enhanced growth enhances toxin synthesis [93].   
In the case of Microcystis, factors such as light [94], 
temperature [95], pH [96], high nitrogen [97], low phosphorous [98] 
and low iron [99] invariably affect cell growth and indirectly influence 
microcystin production. Further, it has also been suggested that 
growth rate directly influences microcystin production rate [95, 100]. 
However, some recent reports suggest that toxin production is a 
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complicated process and involves many more extrinsic and intrinsic 
factors and hence needs to be evaluated further [101].  
 In the case of Nodularia, low nitrogen to phosphorous ratio was 
observed to increase cell division which led to increased toxin levels 
[102]. In contrast to this finding, some researchers also report that 
chemostat cultures of N. spumigena grown in phosphate starved 
condition did not significantly decrease toxin levels [103]. These 
findings suggest that there may be more than one factor responsible 
for enhanced toxin synthesis and that a combination of optimal growth 
conditions such as light, nutrients, CO2 content play a complex role in 
enhancing the growth rate of an organism. This enhanced growth 
might lead to increased toxin levels in the environment. This is further 
confirmed in the case of Cylindrospermopsis where low levels of fixed 
nitrogen were observed to enhance toxin production [104].  In the 
case of C. raciborskii T3 which produces saxitoxin, the presence of 
extracellular NaCl played a significant role in the toxin production and 
a linear concentration dependent response was observed [105].  
 Most cyanobacterial blooms are comprised of toxic as well as 
non-toxic strains of one or more species. Thus, toxic and non-toxic 
strains coexist in the field [106, 107]. Surprisingly, a study on bloom 
succession concluded that bloom dynamics in lakes mainly result from 
the succession of a large number of genotypes and that non-toxic 
strains dominated at the end of bloom while in other lakes the toxic 
strains dominated. The authors conclude that while the growth 
parameters were similar, succession by certain genotypes followed a 
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seasonal pattern or it may be that other intrinsic factors may be 
influencing bloom types [94].  
Although cyanobacteria produce a wide range of secondary 
metabolites, it is still a matter of debate as to why they produce them. 
To date, no clear evidence has been reported regarding the usefulness 
of these secondary metabolites to the parent organism. Apart from 
reasons such as heavy metal chelation [109], anti-grazing [110], 
nitrogen storage [111], Photo/UV protection [112], quorum sensing 
[113], one possible reason could be that cyanobacteria communicate 
with each other using these metabolites (Allelopathy). During bloom 
formation, numerous biotic and abiotic factors play a role [114] and 
allelopathy may be one of the reasons [115].  Allelopathy has also 
been known to shape microbial communities in aquatic ecosystems 
[114, 116, 117].  
 
1.6 Allelopathy 
 The term allelopathy is derived from the Greek word ‘allelos’ 
meaning mutual and ‘pathos’ meaning suffering. Allelopathy was first 
used by Prof Molisch H, 1937, while reporting the effect of some plants 
on others [118].  Though this concept was initially thought of as a 
negative feedback phenomenon within higher plants, later it was 
broadened to define the direct or indirect and harmful or beneficial 
effect of organisms on one another by the release of chemical 
compounds. The compounds that induce this effect are called 
allelochemicals.  
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1.6.1 Allelopathy in bacteria  
 Initially, allelopathic interactions were thought to be present 
only among higher plants, however, in recent times, allelopathy has 
been reported among insects, animals and microbes [119]. The 
actinomycetes group of bacteria has been reported to produce 
compounds with interesting qualities. The soil bacterium Streptomyces 
saganonensis has been reported to produce herbicidin which inhibits 
the growth of several monocot and dicot plants [120]. The compound 
blasticidin from this genus was specifically shown to inhibit only dicots 
without any effect on monocots [121]. It should also be noted that 
compounds like cycloheximide, nystatin, streptomycin, bleomycin are 
all produced by this genus and are well known antibiotics (negative 
allelopathy to other bacteria). 
 Within the cyanobacterial community, the first report of 
allelopathy was in the organism Scytonema hofmanii which produced 
the compound cyanobacterin (a natural herbicide) [121 - 123] and a 
later report on hapalindole A (antimicrobial and antimycotic) from 
Hapalosiphon fontinalis [124]. Allelopathy has been documented in 
many species such as Microcystis, Nodularia, Aphanizomenon, Nostoc, 
Oscillatoria, Phormidium and Scytonema [125]. 
 
1.6.2 Cyanobacterial allelopathy 
Cyanobacteria form massive outbreaks of growth (blooms) when 
optimal conditions for growth occur. Adding to this, it has also been 
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thought that allelochemicals secreted by the growing cells may signal 
bloom formation [115]. In a study with C. raciborskii, it was observed 
that an allelochemical inhibited the surrounding phytoplankton hence 
reducing competition for nutrients [126]. In a recent study, it was 
noticed that the presence of exogenous microcystin toxin increased the 
intracellular toxin levels of the host organism. Hence, it was thought 
that the toxin may act as an infochemical (i.e., radar) for the host 
organism [127]. Further, it was reported that a compound (yet to be 
fully characterised) secreted by Planktothrix agardhii doubled the toxin 
production of microcystin and nodularin [128].  
 Though allelopathy has been studied for some time, there is still 
no convincing evidence why cyanobacteria secrete allelochemicals into 
the ecosystem. It is thought that allelochemicals are used to increase 
cellular fitness [129], to compete for resources or to signal blooming 
[130]. Several biotic and abiotic factors have been thought to trigger 
allelopathic secretions. Some of the biotic factors include competition 
among species [131 – 133] and allelochemical degrading heterotrophs 
[134]. The abiotic factors include light, temperature, pH and nutrient 
levels [135]. 
 Cyanobacteria are known to produce a large variety of 
secondary metabolites (Table 1.4). Unlike other organisms, their mode 
of synthesis is mainly by using the non-ribosomal peptide synthetase 
(NRPS) and the polyketide synthase (PKS) biosynthetic pathways. This 
process enables them to produce diverse peptides with unique 
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bioactive functions, although, very few have shown to have a growth 
inhibitory or stimulatory effect. 
 
Cyanobacterin 
 The first report of cyanobacterin (Figure 1.11) was in 1982 when 
it was isolated from Scytonema hofmanii. It was initially thought of as 
an antibiotic, however, an allelopathic role was later identified. 
Cyanobacterin specifically inhibited the growth of photosynthetic 
organisms, but had no effect on bacteria or protozoans. Cyanobacterin 
has been shown to inhibit the growth of Bracteacoccus sp. and 
Anabaena sp. at a concentration of 300 µg/ml [122]. However, a 
purified form of the toxin has been shown to have some inhibition even 
at a dose of about 2 µg/ml [136].    
 The compound is hydrophobic with a molecular weight of 430 Da 
and empirical formula C23H23O6Cl. Cyanobacterin inhibits the growth of 
photosynthetic bacteria by disrupting the thylakoids structure. It also 
is known to inhibit the oxygen evolution pathway and hence this 
compound is only active against photosynthetic organisms, mostly 
cyanobacteria [136]. It was also discovered that this compound could 
have a negative effect on angiosperms as well.  In these plants, the 
compound specifically inhibits Hill reaction centres and hence confirms 
that cyanobacterin inhibits oxygen evolving photosynthetic electron 
transport. Since cyanobacterin does not have any effect on 
photosystem I, the most probable site of action is supposed to be 
photosystem II [143]. 
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Figure 1.11 - Structure of the allelochemical Cyanobacterin 
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Table 1.4 – Summary of some known allelochemicals and their mode of action 
Organism Allelochemical 
Target 
organism 
Mode of Action Ref 
Fischerella sp 
Hapalindoles , 
Fischerellins 
Other 
Cyanobacteria, 
bacteria, fungi, 
protozoa, algae 
RNA synthesis/ 
polymerase 
inhibition 
[137] 
[138] 
[139] 
Microcystis sp 
Microcin, 
microcystin-LR, 
microcarborin 
Versicularia 
dubyana, 
Peridinium 
gatunense 
Photosynthesis 
inhibition, 
growth inhibition 
[142] 
[140] 
[141] 
Nodularia sp Norharmane 
Other 
Cyanobacteria 
Cytotoxicity,  
growth inhibition 
[123] 
Nostoc insulare 
Norharmane, 4,4-
dihydroxybiphenyl 
Other 
Cyanobacteria 
Cytotoxicity [117] 
Calothrix sp Calothrixin 
Other 
cyanobacteria, 
bacteria and 
mammalian cells 
RNA synthesis/ 
polymerase 
inhibition,  
growth inhibition 
[137] 
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Fischerellin 
 Fischerellin was identified in 1991 from the organism Fischerella 
muscicola. It is a hydrophobic compound which exists in nature as two 
isoforms. Fischerellin A (Figure 1.12a) is known to be a potent cytotoxin, 
whereas the less cytotoxic form is named as Fischerellin B (Figure 1.12b). 
It has been reported that this compound may also be produced by other 
species such as Fischerella ambigua and Fischerella tisserantii.  
 
 
Figure 1.12a: Structure of 
fischerellin a 
 
Figure 1.12b: Structure of 
fischerellin b 
 
 This compound showed growth inhibitory activity against Anabaena 
sp, Phormidium sp. Synechococcus sp. and Synechocystis sp. However, 
this compound did not have any effect on non-photosynthetic bacteria 
such as Bacillus sp. or Pseudomonas sp. Comparatively, this compound is 
more potent than cyanobacterin and is capable of inhibitory activity at the 
nanogram level [144].  Fischerellin inhibits cyanobacterial growth by 
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inactivation of PSII reaction centres and disturbing oxygen evolution 
[145].  
 
Calothrixin 
 The first report of Calothrixin (Figure 1.13) was in 1999 [146]. It is 
a pentacyclic bioactive secondary metabolite produced by Calothrix sp. In 
nature, Calothrix exists in two forms A (C19H10N2O3) and B (C19H10N2O2).  
 
Figure 1.13 – Structure of Calothrixin A 
Calothrixin is one of the compounds that show inhibitory activity 
against Hela cell lines and Jurkat cancer cell lines by inducing intracellular 
DNA damage [147]. Calothrixin A functions by inhibiting RNA synthesis 
and DNA replication of other cyanobacteria and algae and RNA 
polymerase of E. coli [148, 137]. This compound has received much 
attention from the medical community, as the compound is capable of 
inhibiting the chloroquine resistant malarial parasite Plasmodium 
falciparum at a concentration of 58 nanomoles [146].  
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Microcin SF608 
 Microcin, as the name indicates, is produced by Microcystis 
aeruginosa. The empirical formula of Microcin is C32H45N6O6 (Figure 1.14). 
When tested against the water moss Versicularia dubyana, it was found 
that Microcin significantly inhibited microsomal glutathione-S-transferase. 
In Daphnia magna, the peroxidase was inhibited. In the photosynthetic 
organisms V. dubyana, the oxygen production rate as well as the ration of 
chlorophyll a / b showed stress. In general, microcin is regarded as a 
serine protease inhibitor. Although, microcin has not been studied 
extensively, its inhibitory activity against unrelated aquatic organisms 
suggests that it might play an allelopathic role in combination with 
microcystin-LR [142].  
 
Figure 1.14  – Structure of Microcin (SF608) 
 
It could be concluded that at least some cyanobacterial secondary 
metabolites do play a part in allelopathy. Even the hepatotoxin 
microcystin has been thought of as an allelochemical. Initially, 
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microcystins were thought of as a defense chemical [149, 150]. However, 
a phylogenetic study concluded that microcystins were being synthesised 
even before the occurrence of grazers. This strongly suggests that 
microcystins could not be a defence chemical [151]. A recent study 
provided some evidence that the presence of extracellular microcystin 
increased their intracellular concentration, indicating that the cells 
detected the death of other cells and increased their cellular fitness [127].  
Another study indicated that microcystins could have metal 
chelation properties [152, 99]. These types of allelochemicals may bind to 
metals such as iron, copper, cadmium, zinc and act as siderophores to the 
parent organism. Indirectly, this could negatively affect the survival of 
competitors [130]. Also, the concentrations of key nutrients play an 
important role in allelochemical secretion. It is thought that low nutrient 
conditions stimulate allelochemical production, thereby decreasing 
competitor concentrations and increasing the chances of survival of a 
species [131]. Though conditions like light, temperature, nutrient 
shortage and the presence of competitors are thought to be conditions 
that induce allelopathic interactions, it is still not very clear as to how 
important allelochemicals are to the parent organism. 
 It could be generalized that of the hundreds of metabolites 
produced by cyanobacteria, only some have been characterised and even 
less have been fully studied. Of these few compounds, some of the above 
mentioned compounds have been suggested to have allelopathic 
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ecological roles and this may justify their production. However, within 
cyanobacterial ecology, there are many more unique compounds which 
are still poorly defined and their ecological role is still unclear. Hence a 
study of these compounds may enhance our understanding about the 
biological role of these secondary metabolites. Further, an understanding 
of these compounds may lead to the discovery of unique compounds with 
potential applications such as bloom mitigation, biomedical research tools 
and commercial benefits. Since only a fraction of the diverse pool of these 
compounds have been characterised, the chance of identifying a new role 
for a compound is greater. Therefore, a study into this field guarantees 
novelty will be challenging and may be commercially beneficial. In order 
to study allelopathy in cyanobacteria, a model organism needs to be 
chosen. The organism Microcystis aeruginosa PCC7806 seemed to be an 
ideal candidate as it has several features required for this type of study. 
 
1.7 Introduction to Microcystis aeruginosa PCC7806 
 M. aeruginosa (order Chroococcales) is a freshwater cyanobacteria 
distributed worldwide. The cells are spherical and about 3 to 6 µm in 
diameter (Figure 1.15). Due to the presence of chlorophyll-a, the cells 
appear green. In ambient conditions, the cells aggregate to form large 
colonies of indefinite shapes. However, under laboratory conditions, the 
cells occur in singles, doubles or tetrads which are easily disassociated. It 
is one of the most common bloom forming organisms and is well known 
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as a predominant toxin producer. Its annual life cycle consists of 4 stages, 
which are pelagic (rising to the surface and bloom formation) during 
summer, sedimentation during autumn, benthic during winter and 
reinvasion of the water body during spring [153]. Microcystis sp. achieve 
buoyancy through the use of their gas vesicles. During autumn through 
winter, the water temperature reduces slowing their metabolism. This 
leads to decreased respiration and increased accumulation of 
carbohydrates intracellularly which increases cellular density causing 
sedimentation [154].  
 
Figure 1.15 – Light micrograph of 
M. aeruginosa at 1000x [180].  
 One of the main nutrient requirements for the growth of Microcystis 
sp. is Nitrogen (N). Sources of N in a water system may be from lake 
eutrophication, N fixers and ammonia released from anaerobic 
metabolism. When N is not the limiting factor, the doubling time of 
Microcystis sp. is between 1.24 to 1.39 days [155]. Some recent studies 
suggest that excess N can promote abundant growth as well as increase 
intracellular microcystin content [156] and N limitation reduces 
microcystin quota disproportionately [157].    
 M. aeruginosa is well adapted to fluctuating phosphate (P) 
concentrations. Although phosphate is an essential nutrient for its growth, 
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it has evolved mechanisms for P uptake and storage enabling it to thrive 
in P depleted ecosystems [158]. In a recent study it was reported that the 
production of microcystin was directly proportional to the concentration of 
P up to 5 mg/L, above which the microcystin production decreased 
significantly. However, the authors also note that P along with N play a 
role in growth and microcystin synthesis and that an N:P ratio of 50:1 
gave maximum microcystin concentration per cell [159]. It is also thought 
that Iron (Fe2+) may play some role in inducing toxin production [160]. 
Iron is known to induce oxidative stress and hence may decrease cell 
growth indirectly. Hence a decreased biomass could give a higher 
calculated value for microcystin content. Also, a relationship between the 
inorganic carbon availability and the total microcystin content (intra and 
extracellular) have also been reported. It was reported that under 
depleted inorganic carbon concentrations, the intracellular and 
extracellular microcystin concentration increased [161]. However, as 
carbon is one of the primary nutrients, it could also be that the cells may 
have been starved resulting in reduced growth rate or increased death 
rate thereby releasing the intracellular microcystins. 
 
1.7.1 Secondary Metabolites of M. aeruginosa PCC7806 
 The organism M. aeruginosa PCC7806 has been studied extensively 
for over 40 years. The strain was originally isolated from Braakman 
Reservoir, The Netherlands in 1972. It is one of the most common bloom 
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forming cyanobacteria occurring widely in fresh water ecosystems [8]. 
One of the key characteristics of M. aeruginosa PCC7806 is its ability to 
produce an array of secondary metabolites such as aerucyclamides, 
cyanopeptolins and microcystin-LR (Figure 1.16). Among its secondary 
metabolites, microcystins are the most frequently observed and well-
studied. 
 
Figure 1.16: HPLC chromatogram of M. aeruginosa PCC7806 extracted 
with 80% Methanol (MeOH). The peaks: 996 Dalton is microcystin-LR, 
958 Da is cyanopeptolin A and 535 Da is aerucyclamide. The organism 
also produces other secondary metabolites such as aerucyclamide D (587 
Da) and aerucyclamide C (517 Da).  
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Aerucyclamides 
 Cyanobacteria are prolific producers of secondary metabolites 
which include polyketides, peptides and cyclamides.  In 2008, Portmann 
et al., [162] reported that M. aeruginosa PCC7806 produces 
aerucyclamides A, B, C and D. Aerucyclamides are a rare example of 
cyclamides that feature oxazoline, thiazoline and thiazole moieties in one 
compound. The ecological relevance of aerucyclamides is under 
investigation; however, a study revealed that aerucyclamides are about 1 
order less toxic than microcystins [160, 90] which could be attributed to 
their hydrophobic nature (Figure 1.17).  A later study has revealed that 
Aerucyclamide B showed potent activity against the chloroquine resistant 
strain of Plasmodium falciparum K1 but showed little or no activity against 
Rat Myoblast L6 cell lines. The compound Aerucyclamide C showed 
moderate activity against Trypanosoma brucei rhodesiense STIB 900 
[90]. It may be that in the future some of these compounds could be 
evaluated for biomedical purposes.  
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Figure 1.17: Chemical structures of aerucyclamides from M. aeruginosa 
PCC7806. 
 
Cyanopeptolins 
  In 1993, Martin et al., [163] reported that the organism M. 
aeruginosa PCC7806 produces 4 depsipeptides i.e., Cyanopeptolins A, B, 
C and D. These are peptide lactones which possess a ring structure built 
up by condensation of the aldehyde of reduced L-glutamic acid with the 
amino group of L-leucine (Figure 1.18). They possess identical structures 
consisting of cyclic L-glutamic acid-y-aldehyde, L-leucine, 7-methyl-
phenylalanine, L-valine, L-threonine, L-aspartic acid, hexanoic acid and a 
variable basic amino acid. This variable amino acid can be L-arginine 
(cyanopeptolin A), L-lysine (cyanopeptolin B), N-methyl-L-lysine 
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(cyanopeptolin C) and N-N-dimethyl-L-lysine (cyanopeptolin D), 
respectively [176]. In 1995, a sulphur containing cyanopeptolin-S was 
reported by Jakobi et al, [164]. 
 
Figure 1.18: Chemical structure of cyanopeptolin A, Mol Wt 958 Da 
 Biologically, cyanopeptolins are known to be protease inhibitors. 
Although the function of cyanopeptolin A is as yet unknown, the 
congeners cyanopeptolin S inhibits plasmin and thrombin where as 
cyanopeptolin 963A (reported in 2004 [164]) inhibits chymotrypsin. Apart 
from these functions, other cyanopeptolins have been found to be toxic to 
zebra fish embryos affecting their DNA damage recognition and repair, 
circadian rhythm, response to light, and to some extent metabolic 
activities [165]. They report that cyanopeptolins should be considered as 
neurotoxins which may have human health consequences. 
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Microcystin-LR (microcystin-LR) 
 Microcystins are produced by several genera such as Anabaena sp, 
Aphanizomenon sp., Planktothrix sp. and Microcystis sp. and different 
variants of microcystins have been reported. M. aeruginosa PCC7806 
produces only the leucine-arginine variant Microcystin-LR in abundance 
and its demethylated congener in relatively small quantities. Microcystin-
LR is a small (996 Da) monocyclic heptapeptide with a conserved 
structure of D-Ala-L-leu-D-MeAsp-L-Arg-Adda-D-Glu-Mdha (Figure 1.19). 
The unique amino acid Adda (3-amino-9-methoxy-2, 6, 8-trimethyl-10-
phenyldeca-4, 6-dienoic acid) is present ubiquitously within 
cyanobacterial species only.  
 
Figure 1.19 - Chemical structure of Microcystin-LR. In position 2 is leucine 
(L) and position 4 is arginine (R) both of which are variable regions 
 Within microcystin-LR, about 22 variants occur and the variation 
could be due to demethylation, variations at the 6th or 7th amino acid or 
 - 48 - 
 
modification of the amino acid Adda. The majority of the microcystin 
variants are produced by Microcystis sp, however, some strains of 
Anabaena sp and Planktothrix sp have been reported to produce 
microcystins. One of the characteristics of microcystin-LR is its ability to 
bind irreversibly to protein phosphatase 1 (PP1). The binding is brought 
about by the adda fitting into the hydrophobic grove of PP1, the 
carboxylate group and the carbonyl oxygen bond with the metal binding 
site and L-Leu binds to a tyrosine at the C terminal of PP1 [166]. PP1 
(and PP2) perform regulatory activities such as glycogen metabolism, cell 
division, apoptosis, and protein synthesis. When the enzymes are 
inhibited, the cells become more vulnerable towards tumor formation and 
in higher concentrations the cells die. It is thought that the presence of 
the adda amino acid along with hydrophobic amino acids is required for 
microcystin-LR toxicity and a substitution with hydrophilic amino acid 
such as arginine (at sites 2 or 4) significantly reduces its binding 
properties and hence reduces toxicity [167]. 
 The microcystin-LR toxin, by its property of binding to PP1 and PP2 
are predominantly localised within hepatocytes. Hence, microcystin-LR 
can be classified as a hepatotoxin. However, microcystin-LR by its nature 
cannot penetrate cell membranes, but require the multispecific bile acid 
transport systems for its uptake into hepatocytes [168]. Within the 
hepatocytes, microcystin-LR inhibits PP1 and PP2 and disrupts the critical 
phosphorylation / dephosphorylation balance disrupting cellular functions 
such as carbohydrate and lipid metabolism, gene expression, protein 
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synthesis, cell division [169]. At the cell membrane level, microcystins 
alter cytoskeleton components resulting in bleb formation, invagination 
and loss of microvilli [170] and ultimately resulting in formation of tumor 
cells [171, 172].  
 The property of microcystin-LR as a hepatotoxin and its widespread 
occurrence has interested many researchers to study their biosynthetic 
pathway. The knowledge of such a biosynthetic pathway may lead to the 
development of technologies to minimize toxin secretions into the 
ecosystem. The biosynthesis of microcystin-LR (and other microcystins) is 
unique as it does not follow the central dogma of protein synthesis but 
uses enzyme complexes to add amino acids without the employment of 
ribosomes. Such a pathway was later designated as non-ribosomal 
peptide synthesis and the enzyme complex was named as NRP synthetase 
[173]. In addition to NRPS a polyketide synthetase system has also been 
reported to be partially involved in microcystin-LR biosynthesis [174]. In 
1997, Dittmann et al., [175] reported the presence of three genes i.e., 
mcy A, B and D to be involved in microcystin-LR synthesis. In 2000, Tillet 
et al., [176] reported the complete structure of the microcystin-LR 
biosynthetic pathway (Figure 1.20). They report the presence of two 
operons (mcy A to C in forward and mcy D to J in reverse orientation) to 
a common promoter [176].  Although, 10 genes comprise the microcystin 
synthetase cluster, the genes mcy A, B and D are thought to be the key 
genes as insertional mutation of any of these genes results in complete 
cessation of microcystin synthesis [173 – 176].  
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Figure 1.20. Structural organization of the microcystin synthetase gene 
complex (mcy A-J).     Green – genes encoding NRPS modules. Blue – 
genes encoding PKS modules and Yellow – genes encoding modifying 
enzymes [176].  
 
 Apart from the genes described, several factors have been known 
to influence toxin biosynthesis. As a general rule, it is thought that 
microcystin is synthesised and accumulated continuously during growth 
phase and released during the stationary or decline phase. It is reported 
that during stationary phase, Microcystis sp. may accumulate up to 0.53 
± 0.06 pg/cell of microcystins. Factors such as temperature as well as pH 
are important for microcystin synthesis, however, these factors influence 
the optimal growth of the organism rather than microcystin induction. 
Light intensity may be one important factor for toxin biosynthesis and 
subsequent release in the ecosystem. In 1992, it was reported that as 
light intensity increased from 20 to 40 µE/m2/s the intracellular 
microcystin-LR increased from 2 to 5 ng/µg total cellular protein and 
beyond 40 µE/m2/s light, the toxin content remained same [177]. 
However, the reported values are in toxin content per unit total cellular 
protein and may indicate only the intracellular toxin content. As the 
biosynthesis of microcystins are carried out by enzyme complexes, the 
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effect of heavy metals (as cofactors) have been thought to be important. 
Only the metals iron and zinc are known to affect toxin production. In the 
organism M. aeruginosa PCC7806, it has been reported that Zn 
concentration of 0.25 µM increased growth by 1.5 times and toxin yield 
by 30 percent; however, higher concentrations were lethal to the cells. 
Similarly, Iron has also been reported as an important cofactor and the 
concentration of microcystin was inversely proportional to the available 
iron (Fe2+) concentration. In this view, it was hypothesised that 
microcystins are heavy metal chelators required for optimal growth [160]. 
 Several functions have been reported for microcystin-LR. Initially it 
was thought that microcystins were produced to dissuade phytoplankton 
grazers, but in 2003 a phylogenetic study concluded that the genes for 
microcystin synthesis evolved much earlier to the occurrence of grazers 
and hence could not be assembled in response to grazer stress [151]. 
However, it is not clear if the oldest known cyanobacteria harboured the 
microcystin genes (in its functional form) even then.  In a recent study, it 
was reported that microcystin-LR may function to remove competitors 
from the immediate surroundings and ensure bloom formation [178].  
Some of the other functions attributed to microcystins are signalling and 
gene regulation. It was reported that microcystin-LR may be produced in 
response to high light signal and regulate essential gene. However this 
hypothesis has not been conclusively proved and the authors suggest that 
additional mechanisms may be needed to sense high light intensities 
along with microcystin-LR [135]. 
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 Although microcystins have been studied for over 30 years, their 
primary function has remained unclear. One of the aims of this study is to 
investigate the role of microcystin-LR on the producing organism i.e., M. 
aeruginosa PCC7806. It should be noted that M. aeruginosa PCC7806 
produces several other secondary metabolites (aerucyclamides and 
cyanopeptolins) along with microcystin-LR and it would be interesting to 
see the effect of microcystin-LR on the production of de-novo metabolites. 
Further, in order to evaluate possible allelopathic interactions, the 
secondary metabolites produced by other cyanobacteria (cyanopeptides) 
will also be tested on M. aeruginosa PCC7806 and its parameters such as 
growth rate and secondary metabolite production rate will be monitored. 
 In order to understand the role of secondary metabolites, several 
basic tools such as analytical methods to differentiate between de-novo 
and ex-novo metabolites and a small scale rapid bioassay protocol needs 
to be developed. To enhance the accuracy of the data, a methodology to 
enumerate cyanobacteria using flow cytometry will need to be developed. 
Also, most previous studies in this field lack information in areas such as 
secondary metabolite production rate, an accurate quantification of the 
metabolite within a single cell, accurate count of the cell numbers, the de-
novo production of these metabolites and the fate of the secondary 
metabolites already present in the surroundings.  In most studies, 
microcystin is quantified as a measure of the change in total microcystin 
concentration over time. This type of quantification yields only an overall 
picture of the quantity of microcystins, but does not reveal any 
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information regarding microcystins metabolism (synthesis vs catabolism). 
Further, while calculating the rate of production, the total biomass is 
represented only in terms of total protein or the total chlorophyll content 
[100]. This leads to errors like the total biomass may be a composition of 
live and dead cells, which do not contribute to microcystin synthesis. Even 
studies that report a linear correlation between mcy D (one of the genes 
in microcystin synthesis operon) expression and microcystin concentration 
[179] fails to quantify the microcystin production against live cell 
numbers. This study aims to bridge this knowledge gap by developing 
tools that accurately quantify the de-novo production rate of secondary 
metabolites by providing 15N enriched media, hence allowing the study of 
the turnover rates of secondary metabolites.  
 
 
1.8 Research Aims 
 Cyanobacteria produce an array of secondary metabolites 
employing complex NRPS/PKS enzyme systems at the expense of energy. 
Although, cyanobacterial secondary metabolites (cyanopeptides) have 
been studied for several decades, a functional role for them or a distinct 
advantage to the host cells have not been convincingly proven. The aim 
of this study was to evaluate the role of cyanopeptides on M. aeruginosa 
PCC7806 and possibly determine if allelopathy is a reason for the 
production of secondary metabolites.  
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Objectives 
1. To understand the chromatographic profile of the various 
secondary metabolites of M. aeruginosa PCC7806 
In order to quantify the de-novo secondary metabolites produced 
by M. aeruginosa PCC7806, the methodology of replacing the 14N in 
the growth media with a stable isotopic 15N would be used. Further, 
robust analytical methods to differentiate de-novo metabolites will 
be used.  
 
2. To evaluate the role of exogenous microcystin-LR on M. 
aeruginosa PCC7806 
Microcystin-LR is one of the well-studied secondary metabolites and 
its thought that it may function as an allelochemical. In order to 
evaluate this hypothesis, M. aeruginosa PCC7806 would be exposed 
to 3 different concentrations of exogenous microcystin-LR and its 
effects on the growth and secondary metabolite production will be 
evaluated. This study may give some insights into the role of 
microcystin-LR and since M. aeruginosa PCC7806 is also a producer 
of microcystin-LR, this might shed some light on the advantages 
conferred by microcystin-LR on its hosts 
 
 
 
 - 55 - 
 
3. To evaluate the effect of cyanopeptides on M. aeruginosa 
PCC7806 
A range of cyanopeptides would be chosen and their effect on the 
growth and secondary metabolite production of M. aeruginosa 
PCC7806 would be studied. The growth rate and secondary 
metabolites production rate would be compared to that of a control 
which would reflect the effect of cyanopeptides on M. aeruginosa 
PCC7806. Additionally, the expression of genes mcyA and mcyE 
(responsible for microcystin-LR biosynthesis) would also be 
investigated and compared against the control. 
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2.1 Cyanobacterial Culture 
 The cyanobacterium Microcystis aeruginosa PCC7806 (Pasteur 
Culture Collection, Paris) was selected as it had several features that 
made it an ideal candidate for this study. The strain was originally isolated 
from the Braakman Reservoir, The Netherlands, in 1972. One of the main 
features of this organism is that it produces several well characterised 
secondary metabolites such as microcystins (microcystin-LR & DM-LR), 
cyanopeptolins (A, B, C & D) and aerucyclamide (A, B, C & D).  It is a 
unicellular organism; hence enumeration would be straight forward using 
haemocytometry or flow cytometry. Furthermore, M. aeruginosa PCC7806 
has been extensively studied for its general physiology as well as its 
molecular characteristics.   
 
2.2 Media Preparation 
 M. aeruginosa PCC7806 is a freshwater strain, hence the growth 
medium of choice was BG11 [181,182]. The preparation of BG11 was 
done as prescribed by Stanier et al., 1971 [183] without any modification. 
The components listed in stock I (Table 2.1) were prepared as individual 
stock solutions in Milli-RO and the required volume representing the 
concentration mentioned in stock 1 were taken. The media was prepared 
in the order listed in Table 2.1 and finally 1 ml from the trace element 
stock solution was added.  The media was appropriately distributed into 
conical flasks and autoclaved at 121 °C at 15 psi for 15 mins. 
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Table 2.1. Composition of BG11 media for the culture of M. aeruginosa 
[183] 
Stock I Final 
 
Components Formula g/L mM 
1 Sodium Nitrate NaNO3 1.5 17.65 
2 
Dipotassium Hydrogen 
Phosphate 
K2HPO4 0.04 0.23 
3 
Magnesium Sulphate 
Heptahydrate 
MgSO4.7H2O 0.075 0.30 
4 Calcium Chloride Dihydrate CaCl2.2H2O 0.036 0.24 
5 Citric Acid C6H8O7 0.006 0.03 
6 
Ammonium Ferric Citrate – 
Green 
FeSO4.7H2O 0.006 0.02 
7 EDTA - Disodium Salt C10H16N2O8.2Na 0.001 0.003 
8 Sodium Carbonate Na2CO3 0.02 0.19 
  Trace elements stock Formula g/L µM 
9 Boric Acid H3BO3 2.86 46.26 
10 
Manganese Chloride 
Tetrahydrate 
MnCl2.4H2O 1.81 9.15 
11 
Zinc Sulphate 
Heptahydrate 
ZnSO4.7H2O 0.22 0.77 
12 
Sodium Molybdate 
Dihydrate 
Na2MoO4.2H2O 0.39 1.61 
13 
Copper Sulphate 
Pentahydrate 
CuSO4.5H2O 0.08 0.32 
14 Cobalt Nitrate Hexahydrate Co(NO3)2.6H2O 0.05 0.17 
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2.2.1 Determination of de-novo secondary metabolite production 
As the production of secondary metabolites by M. aeruginosa 
PCC7806 is a continuous process, the need to quantify/differentiate 
between de-novo and ex-novo secondary metabolites arises. Also, most 
publications report only the quantity of intracellular or extracellular 
secondary metabolites at a particular sampling time point rather than 
actual de-novo production (fg/cell/day). To determine actual production, 
the methodology of growing M. aeruginosa PCC7806 in a media 
containing 15N nitrogen was employed [184, 185]. The BG11 media 
prepared with sodium nitrate (Na15NO3) would be termed as BG11-15N. In 
the case of preparation of BG11–15N media, all other preparation 
procedures remained the same as that of preparation of BG11-14N. 
Sodium nitrate (Na15NO3) was purchased from Cambridge Isotope 
Laboratories, Inc., USA. M. aeruginosa PCC7806 grown in (Na15NO3) 
media will have isotopic nitrogen as the only source of nitrogen and 
synthesis its metabolites incorporating only 15N. The atomic composition 
of each of the secondary metabolites of M. aeruginosa PCC7806 is well 
known and hence this knowledge could be used to differentiate between 
de-novo and ex-novo metabolites. For example, microcystin-LR (Chemical 
formula C49H74N10O12) is a heptapeptide containing 10 nitrogen atoms in a 
molecule (Figure 2.1). The atomic mass difference between 14N and 15N is 
1 and hence the total mass of the de-novo microcystin-LR would differ by 
10 i.e., microcystin-LR which has an average mass of 996, will have an 
overall increase of 10 mass units when all the nitrogen is 15N, thus 1006 
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mass units (Figure 2.2). This mass difference can be differentiated by LC-
MS allowing an accurate measure of the de-novo synthesised microcystin-
LR.  
 
Figure 2.1: Structure of microcystin-LR highlighting the position of 
nitrogen atoms
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Figure 2.2: HPLC-MS chromatogram of the methanol extracts of M. aeruginosa PCC7806 showing the 
mass shifts of its secondary metabolites when grown in BG11-14N or BG11-15N media.  
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2.3 Growth conditions  
For routine culture maintenance, sterile BG11-14N was used. M. 
aeruginosa PCC7806 was grown under continuous light of about 10 
µmols/m2/s and temperature 21 ± 1 °C and sub-cultured once in 15 days 
so that an actively growing inoculum would be readily available. However, 
for experimental assays, the light intensity was maintained at ~20 
µmols/m2/s (continuous) and temperature was maintained at 21 ± 1 °C. 
Lighting was provided by Philips cool white fluorescent lamps (58 watts). 
Light intensity was monitored daily using LI-COR LI-250A light meter by 
moving the flasks aside and placing the probe in its place. The flasks 
would be mixed once a day and the sampling was timed roughly at the 
same time each day. The flasks were incubated for the duration required 
by the experiment and samples were withdrawn after mixing the flasks 
thoroughly.  
 
2.4 Experimental setup  
2.4.1 Evaluation of microcystin as a signalling molecule 
 To determine if microcystins function as a signalling molecule, M. 
aeruginosa PCC7806 cells were grown in media containing exogenously 
added microcystin. The presence of exogenous microcystin may alter the 
growth and/or metabolism of PCC7806 which can be detected as 
differences in cell counts or the differences in production of secondary 
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metabolites. The growth media was BG11-15N i.e., BG11 media prepared 
with Na15NO3.  Three treatment conditions were used i.e., 0.1, 1 and 10 
µg/ml microcystin-LR (m/z 996) was added exogenously. A control was 
maintained to which no exogenous microcystin was added. For each 
treatment, 4 replicates were maintained. 
 A 10% inoculum of M. aeruginosa PCC7806 was added to sterile 
BG11 – 14N and allowed to grow for 15 days at 21 ± 1 °C at continuous 
illumination of 10 µmol/m2/s to reach active growth phase. This was used 
as the starting inoculum for the experiment. To remove traces of 
unlabelled nitrogen, the cells were centrifuged at 2000 g for 20 mins and 
the supernatant was discarded. The pelleted cells were washed once with 
nitrate free BG11 and centrifuged again. The pellet was then resuspended 
in sterile BG11-15N. This procedure allowed the removal of any unlabelled 
nitrogen present in the media and provided only labelled nitrogen as the 
sole nitrogen source. An aliquot from this suspension was taken for cell 
enumeration. Sterile BG11 – 15N (100 ml) was placed in conical flasks 
(250 ml) and M. aeruginosa PCC7806 was inoculated at a final cell density 
of 2.5 x 106 cells/ml of culture. Purified microcystin-LR (m/z 996), 1 mg 
was dissolved in Milli-Q by vortexing vigorously for several minutes. This 
preparation was filter sterilized (0.22 µm) using a syringe filter unit. 
Sterile microcystin-LR (m/z 996) was added to the treatments to a final 
concentration of 0.1, 1 and 10 µg/ml. The flasks were incubated under 
continuous light of 20 µmol/m2/s and temperature of 22 ± 1 °C for a 
period of 35 days. Sampling was carried out in 7 day intervals starting 
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from day 0 until day 35 and samples processed as described in Figure 
2.3. 
 
Figure 2.3: Overall sample processing flowchart for evaluating the role of 
exogenously added microcystin-LR (m/z 996). 
  
2.4.2 Evaluating the effect of exogenously added cyanopeptides 
 The culture and growth conditions were as described in section 2.1, 
2.2 and 2.3. As a general laboratory practice, an actively growing 
inoculum was readily made available by routine subculture of the 
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organism every 15 days. Where an older inoculum was required, a few 
culture flasks were left to incubate for 50 days.  
  In the previous assay, the cultures were grown in 250 ml conical 
flasks as they required multiple sample withdrawal. However, in order to 
evaluate the effect of several cyanopeptides, a faster approach was 
required. A number of publications have reported that samplings between 
5 - 10 days were sufficient to determine the effect of exogenously added 
compounds [185 - 190] on Microcystis sp. Hence, it was decided that a 
single sample would be withdrawn at day 10 and that a 20 ml culture be 
taken in 50 ml conical flasks would provide similar culture conditions and 
an appropriate volume of culture for analysis. The choice of lower culture 
volume is advantageous when considering the use of expensive resources 
such as purified compound (e.g. cyanopeptides), labelled nitrate and the 
relatively smaller space occupied by the culture vessels and hence more 
test conditions could be carried out at one time.  
 The inoculum (cells grown in BG11-14N) was centrifuged at 2000 g 
for 20 min and washed with sterile nitrate free BG11. The pellet was 
resuspended in 10 ml of BG11-15N and the volume required for 2.5 million 
cells per ml was added in to 3 L of sterile BG11-15N. From this, aliquots of 
60 ml were distributed into sterile 100 ml conical flasks and labelled 
appropriately. To these aliquots, sterile peptides solution was added. The 
flasks were mixed thoroughly and 20 ml aliquots were withdrawn and 
distributed into sterile 3 x 50 ml conical flasks. The preparation of the 
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peptide solutions is described in section 2.5. A control was maintained 
with equal quantity of Milli-Q water added instead of a peptide solution. 
 
 
Figure 2.4: Overview of culture preparation and sample processing 
flowchart to evaluate the effect of different cyanopeptides on M. 
aeruginosa PCC7806. 
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2.5 Preparation of peptides solutions 
 The cyanopeptides microcystin-LR, microcystin-LF, MC-RR, 
cyanopeptolin A, aerucyclamide A and D, aeruginosin, aeruginosamide, 
anabaenopeptin A and B were chosen. The intended peptide dosage was 
10 µg/ml, however due to difference in solubility, the concentration of the 
peptides in the final peptides solution varied. The purified peptides were 
kindly provided by Dr Christine Edwards, School of Pharmacy and Life 
Sciences, Robert Gordon University, Aberdeen, UK. 
 To 700 µg (100 µg x 7 vials) of each of the dried peptide, 1 ml of 
Milli-Q water was added to the first vial. This was vortexed vigorously and 
its contents transferred to the next vial and vortexed. This was repeated 
until the 7th vial. A further 1 ml of Milli-Q water was added to the first vial 
and vortexed and the steps repeated until the 7th vial had 2 ml of the 
peptide in solution. The concentration of this peptide solution was 
quantified against a purified peptide standard on the LC-MS. It was 
noticed that except for aeruginosamide, all the other peptides had 
dissolved reasonably well in Milli-Q water. Hence, only for 
aeruginosamide, the vials were sonicated (amplitude 50%, for 30 
seconds, pulse mode) using a probe sonicator. Finally, the 2 ml peptide 
solution of each of the peptides was filter sterilized (0.22µm) using a 
Millex® 13 mm dia PVDF syringe filter assembly and added to the 60 ml 
culture taken in 100 ml conical flask. From this 20 ml x 3 aliquots were 
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transferred to 50 ml conical flasks, which were then incubated as 
described in section 2.4.2   
 
2.6 Cell counting  
 The organism chosen for this study was unicellular in nature, 
moreover it also has been reported to contain intracellular pigments such 
as chlorophyll-a and phycocyanin [181, 191]. Hence, the choice of 
different cell counting methods such as Neubauer haemocytometer, 
Beckmann Coulter® EPIC XL-MCL flow cytometer and the Beckman’s 
MultisizerTM-3 were available. In order to make the best use of time, a 
protocol was optimized for all the cell counting instruments such that the 
counts obtained from any automated instrument are comparable to that 
of the basic haemocytometric cell counts. The Sedgewick rafter or the 
Utermohl counting chamber were not considered as the culture being 
investigated is a pure culture, relatively small in size (~ 3 µm in dia) and 
that the cell numbers were in the order of million cells per ml. 
 
2.6.1 Cell counting using Neubauer haemocytometer 
In order to accurately measure cyanobacterial growth, M. 
aeruginosa PCC7806 was counted using improved Neubauer 
haemocytometer. This method of cell counting was preferred to 
Sedgewick rafter or an Utermohl counting chamber as the cell size of M. 
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aeruginosa PCC7806 is between 3 to 4 µm and would take a longer time 
to settle (1 to 2 hours). The Sedgewick rafter or an Utermohl counting 
chamber is the preferred counting method for larger and low 
concentrations of phytoplanktons whereas the Neubauer haemocytometer 
has been used extensively for counting Microcystis cells [97, 156]. 
Moreover, the cell numbers used for our experiments would in the range 
of million cells per ml and hence getting sufficient numbers of cells to 
count would not be a problem. The cell culture was diluted appropriately 
using sterile nitrate free BG11 and no additional staining methods were 
employed as the cells naturally appear green in colour. The slide and 
cover slip was cleaned with ethanol using a lens paper prior to cell 
counting. The coverslip was pressed on the slide until the coverslip is 
firmly held by the haemocytometer. A small volume of the sample was 
taken in a Pasteur pipette and allowed to be drawn by the capillary action 
into the haemocytometer. The slide was placed under a microscope and 
observed at 400x magnification. One of the four corner squares was 
focused and cells were counted starting from the top left corner and 
moving towards the bottom right corner square. If cells fall on the triple 
grid lines, only the cells that appear on the top and left grid lines were 
counted and the cells on the bottom and right gridlines are ignored. 
Dilution of the culture was adjusted so that around 20 to 250 cells can be 
counted within one corner square. For every sample, four of the corner 
squares were counted and the average value taken. Each corner square is 
1 mm2 and a depth of 0.1 mm and hence the volume occupied would be 
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0.1 mm3, which would contain a liquid volume of 0.1 µl. Hence, in order 
to convert to per ml, the cell numbers are multiplied by 104.  
 
Cell number per millilitre was calculated using the below formula. 
 
Cells per ml = Number of cells per corner square x 10000 x Dilution factor 
 
Table 2.2: Example of cell counts of M. aeruginosa PCC7806 on 
haemocytometer 
  Cell per square     x 10000     
Conc A B C D Dilution Average 
Cells/ml 
in 
Million 
STDEV %RSD 
100 111 115 99 124 1:10 1122 11.2 1037224 9.2 
80 91 85 83 106 1:10 912 9.1 1040433 11.4 
60 75 88 72 69 1:10 760 7.6 838744 11.0 
40 57 35 43 39 1:10 433 4.3 960152 22.1 
20 250 219 230 222 0 230 2.3 139613 6.1 
10 130 180 127 138 0 143 1.4 246086 17.1 
5 40 70 49 55 0 53 0.5 126095 23.6 
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2.6.1.1 Cell counting using ImageJ 
 The cells were counted by haemocytometer as per the protocol as 
described previously (section 2.6.1). Cell counting using microscopy is 
preferred when the sample numbers are low and time is not a constraint. 
However, where a large number of samples need to be quantified, it 
becomes difficult to process all the samples in a suitable time; hence a 
semi-automated approach was explored. Most modern microscopes are 
equipped with image capture options and have software that can assist in 
counting cells. The ImageJ software is a freeware developed and 
maintained by ‘The National Institute of Health, USA’ and is capable of 
automated cell counting. The overall process of using the 
haemocytometer remained the same, except that the manual counting 
part was replaced by taking a monochrome image of the microscopic view 
of cells (Figure 2.5). The image thus taken was opened in the ImageJ 
application and processed as follows 
1) File>Open 
2) Image>Type>8-bit 
3) Image>Adjust>Threshold (move slider to highlight cells) 
4) Analyze>Analyze Particles. On the pop-up window select 
summarize and click Ok. Cell counts will be displayed on a new 
pop-up window. 
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A sample demonstration is shown. 
 
 
      
Raw image from           cells identified by            Cell count given by  
light microscope                 ImageJ                            ImageJ 
 
Figure 2.5: Screenshots of cell counting using the Image-J software. 
 
2.6.2 Cell counting using flow cytometry 
 Flow cytometry is a rapid particle counting technique and has been 
suitably adapted for the enumeration of phytoplankton including 
cyanobacteria. The technique is very effective in particle detections hence 
some researchers are using it for the identification and enumeration of 
cyanobacteria, new species of bacteria and sometimes even viruses [192, 
193].  The basic principle behind flow cytometry is that cells are aligned 
into single file by pressurized sheath fluid and passed through a narrow 
tube. An argon laser (488 nm) beam passes perpendicular to the stream 
of cells. Each time a cell passes through the beam, the light is deflected 
and this is counted as an event (Figure 2.6). The deflection is dependent 
on the density, size and the presence of pigments within the cell. In the 
case of cyanobacteria, the fluorescence emitted by pigments such as 
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chlorophyll-a can be measured as an event (Figure 2.7). The cell counts 
were obtained from the flow cytometer using the Expo32 ADC© software 
and using MS-Excel software the final cell numbers were calculated 
considering the dilution factor.  
 
 
Figure 2.6 – Flow cytometer schematics. Detectors range FL1 – 525 nm, 
FL2 – 575 nm, FL3 – 620 nm and FL4 – 675 nm. 
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Figure 2.7: Screen shots of flow cytometer showing dot plots. The gates 
were manually applied to distinguish between live and dead cells. Live 
cells were directly sampled from a culture of M. aeruginosa PCC7806 and 
dead cells were prepared by heat treating (45 °C for 10 min) an aliquot of 
the same culture.  
 
The organism M. aeruginosa PCC7806 is reported to possess 
chlorophyll–a (chl-a) and phycocyanin, which have an excitation 
wavelength of 430 nm and 625 nm respectively. The Coulter® EPICS-XL-
MCL™ flow cytometer is equipped with the 488 nm argon laser which 
makes it an ideal instrument owing to its capability to excite the 
chlorophyll-a pigment and detect its autofluorescence. The excited chl-a 
fluoresce at a higher wavelength of 669 nm which is detected by the FL4 
detector. Due to their single celled nature of M. aeruginosa PCC7806, cells 
can be counted and differentiated based on their fluorescence wavelength 
or lack of emission and classified as live or dead cells.  
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Table 2.3: Flow cytometer settings for enumeration of M. aeruginosa 
PCC7806. The dot plot was chosen taking FL4 on Y axis and FL1 on X 
axis. 
Excitation   488 nm  
  
Detectors Voltage (V) Gain 
FL1 (Green) - 525 nm 836 1.0 
FL4 (Red) - 675 nm 800 1.0 
   
Flow rate 15 µl/min (Low) 
Time/sample 60 Sec 
  
The flow cytometer was switched on and allowed to warm up for 15 
minutes. M. aeruginosa PCC7806 culture was diluted in 0.2 µm filtered 
BG11 and analysed in setup mode at a fixed flow rate of 15 µl/min. On 
the x axis FL1 (Log) was selected and on the y axis FL4 (log) was 
selected. The parameters such as voltage and gain were adjusted so that 
the event oriented towards the central region of the plot (Table 2.3). 
Once the cells (detected as events) appear within central region, gates 
were applied to enumerate and differentiate live and dead cells.  
 In order to differentiate between live and dead cells, an aliquot of 
the mid-log culture was taken in a thin walled vial and immersed for 10 
min in a water bath heated to 45 °C. The resultant cell suspension was 
considered as ‘dead cells’ of M. aeruginosa PCC7806 and used only for the 
purpose of differentiating the live cells from the population of a culture. It 
should be noted that the cells (events) occurring within the dead cell 
gates may be whole cells with little or no fluorescence, cellular debris or 
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empty cell walls. Also, the gate applied to differentiate live and dead cells 
serves only the function of differentiating live actively growing cells and 
does not serve to quantify the dead cell population from the suspension.  
A mixture of 50% live cells and 50% dead cells was prepared and 
diluted in filtered (0.2 µm filtered) BG11. This preparation was analysed 
in the flow cytometer in setup mode (which continually analyzes the 
sample allowing parameters to be optimized) and the required plots were 
chosen. The dot plot was chosen as it provides the number of events 
occurring within a gate. The logic behind this setup is that when the 
cyanobacterial pigments (chl-a) are excited by the argon laser, fully 
functional and intact chl-a would fluoresce red with a higher wavelength 
which would be detected by the FL4 detector. However, when the 
cyanobacterial cells are unhealthy, one of the characteristics is that the 
cultures appear pale green, an indication that the pigments are bleached, 
and hence the cells are compromised. It may also be that chl-a are 
unable to absorb any light and let the light pass through with minimal 
interference. This light would be detected by the FL1 detector and would 
give an indication of the count of unhealthy cells. The mixture of 50 % 
live and dead cells gave two distinct events population clearly separated 
from each other. By analyzing a mid-log cell suspension, one of the dense 
plots were identified as indicative of live cells and the same procedure 
was repeated with the heat treated cell suspension and two gates were 
drawn to differentiate live and dead cells.  The setting was saved and a 
sample of known cell density (previously determined by haemocytometer) 
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was analysed after making an appropriate dilution. The voltage and gain 
was again adjusted such that the number of events, correspond to the 
known cells per ml (after appropriate calculation).   
Cell numbers were calculated using the below formula. 
 
Where F represent the flow rate (µl/min), and it was set at 15 µl/min  
 While preparing dilutions, it should be noted that the maximum 
number of events the flow cytometer can count in one second is 
approximately 200. Higher number of events may lead to poor detection 
resulting in underestimation of cell counts. Any suspension with a higher 
cell density was further diluted so as to stay within the detection limits for 
the instrument.  
 In order to accurately measure cyanobacterial growth using a flow 
cytometer, the cells of M. aeruginosa PCC7806 were first counted in the 
haemocytometer and then the flow cytometer was calibrated against the 
haemocytometer cell counts. In this way the cell counts would be 
comparable to traditional cell counting methods. The count of live and 
dead cells was obtained as described previously. Appropriate dilutions 
were made in filtered BG11 prior to analysis on flow cytometer (Table 
2.4). 
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Table 2.4: Cell counts of M. aeruginosa PCC7806 on flow cytometer 
  Events per gate     
=(x/15) 
* 
1000 
    
Conc A B C Dilution Average Cells/ml STDEV %RSD 
100 854 846 743 200 162833 10.9 829045 7.6 
80 654 541 666 200 124083 8.27 917928 11.1 
60 530 431 530 200 99417 6.63 760178 11.5 
40 276 265 273 200 54250 3.62 76376 2.1 
20 155 160 153 200 31167 2.08 50918 2.5 
10 6282 6208 6268 1 6253 0.41 2621 0.6 
5 2908 3022 3063 1 2998 0.20 5354 2.7 
 
 The values of cell numbers obtained through the flow cytometer 
were comparable to that of those observed by the haemocytometer 
(Table 2.2) at higher concentrations. However, at lower concentrations 
the difference was significant. The relative standard deviation while using 
haemocytometer was between 6 to 24% while in flow cytometer it was 
between 0.6 to 12% and the error seemed to be higher in higher cell 
densities. The counts obtained from flow cytometer analysis represent 
only the live cell count. Since the culture used was mid-log, a small 
number of cells (events) appeared in the dead cell gate (5 %) and were 
excluded from the counting. Although some researchers have used flow 
cytometer to quantify Microcystis sp. their methods were complex and 
required additional dyes. The described method here is straightforward 
and gave consistent cell counts and could be modified further when 
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additional analysis is required. Further, the methodology could be adopted 
for other unicellular cyanobacteria by way of utilizing the emission 
properties of their intracellular pigments. However, for routine cell 
counting, the method described above is sufficiently accurate and robust. 
There are several advantages of using flow cytometry for counting 
unicellular cyanobacterial cells. The technique is straight forward and does 
not require sample fixing procedure. When accurate growth rates and 
production rates are to be calculated, the need to differentiate between 
live or dead cells arises. It could be concluded that flow cytometry can be 
used as effectively as a haemocytometer to enumerate unicellular 
cyanobacteria, but with a high degree of accuracy.  
 
2.7 Growth Rate and doubling time determination 
  The specific growth rate per day (µ) and doubling time (G) of 
M. aeruginosa PCC7806 was calculated using the formula given below 
[220].  
Growth rate (µ) per day = [log(X) – log(X0)] / [log(2) * Δt] 
Where, X0 is the initial cell count, X is the obtained cell count and Δt is the 
time interval taken between initial and obtained cell counts. 
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The doubling time in days (G) was calculated as: 
G = 1/µ 
where µ = growth rate. 
 
2.7.1 – Calculation of production rate (per cell per day) of 
secondary metabolites 
 In order to calculate the production rate of secondary metabolites, 
the cell numbers and the concentration of de-novo intracellular secondary 
metabolite (e.g. cyanopeptolin A) per ml was obtained. From this data, 
the production rate (per cell per day) was calculated as shown below. 
 
Steps 
W – The ‘new cell numbers’ were obtained by subtracting latest weeks cell 
numbers from the corresponding flasks previous weeks cell number. 
X – The concentration of ‘new’ secondary metabolite (e.g Cyano A) was 
obtained by subtracting latest weeks de-novo intracellular secondary 
metabolites concentration (per ml) from the corresponding flasks previous 
weeks de-novo secondary metabolite concentration (per ml). 
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Y – The ‘new’ concentration of secondary metabolites (X) was divided by 
‘new cell numbers’ (W) and the answer multiplied by 1 x 109 to convert 
µg/ml to femtograms per ml.  
Z – In order to obtain the concentration per cell per week, Y was divided 
by duration between two sampling points i.e. 7 days.  
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Sample 
Cyanopeptolin 
A 
(µg/ml) 
Cells/ml 
New Cells 
(W) 
New  
Cyano 
A (X) 
Cyanopeptolin 
A  
per cell per 
week(Y) 
Cyanopeptolin 
A  
per cell per 
day (Z) 
Average STDEV 
C1 0.0000 2597867             
C2 0.0000 2604000             
C3 0.0000 2626667             
C4 0.0000 2635333             
C1 0.2079 8994667 6396800 0.208 32.502 4.643     
C2 0.3787 8877333 6273333 0.379 60.368 8.624     
C3 0.4517 9177333 6550666 0.452 68.955 9.851     
C4 0.2801 8828000 6192667 0.280 45.229 6.461 7.395 2.308 
C1 1.0626 42652000 33657333 0.855 25.394 3.628     
C2 1.0247 48592000 39714667 0.646 16.266 2.324     
C3 0.9911 43112000 33934667 0.539 15.895 2.271     
C4 1.0242 47652000 38824000 0.744 19.165 2.738 2.740 0.628 
C1 1.5353 76334400 33682400 0.473 14.035 2.005     
C2 1.4541 84855600 36263600 0.429 11.842 1.692     
C3 1.4004 76042800 32930800 0.409 12.430 1.776     
C4 1.3737 73364400 25712400 0.350 13.595 1.942 1.854 0.145 
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2.8 Analytical methods (LC-MS analysis) 
 The analysis of the secondary metabolites of M. aeruginosa 
PCC7806 was performed using Waters ACQUITY UPLC® system 
equipped with a QTOF/MS (Quadrupole Time of flight Mass 
spectrometer) and a PDA detector (Photodiode array) [185, 198, 199]. 
All solvents such as methanol, acetonitrile, formic acid used were of 
HPLC grade. Samples for HPLC analysis were prepared as described in 
section 2.3 or 2.4 as per the experimental design. Briefly, the cell 
culture was centrifuged and the pellet and the supernatant separated. 
The pellet and supernatant were freeze dried and extracted with 80% 
methanol. The methanolic extract was centrifuged to remove debris 
and the supernatant was taken in HPLC vials for analysis. The BEH 
(Bridged Ethylene hybrid) C18 column (2.1 mm diameter, 130Å pore 
size, 100 mm length, 1.7 µm particle size, Waters®, Elstree, UK) was 
used to achieve separation of the metabolites. The mobile phase used 
was Milli-Q water and acetonitrile containing 0.1% formic acid. The 
flow rate was maintained at 0.2 ml per minute. The solvent gradient of 
acetonitrile was initially 20% and was gradually increased to 80% over 
a period of 10 minutes. This was followed by a washing step with 
100% acetonitrile and column equilibration. The capillary voltage was 
3.0 kV and cone voltage was set to 25 V. The source and desolvation 
temperatures were 80 °C and 300 °C respectively. Mass spectrometry 
analysis was performed in positive ion electrospray mode, scanning 
from m/z 50 to 2000 Da with a scan time of 1 second. 
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Table 2.5: The MS and UV values used for extraction of peak areas 
using MassLynx™ software for the different secondary metabolites 
 
Ex-novo De-novo 
 
MS UV MS UV 
microcystin-LR 996 238 1006 238 
Cyanopeptolin A 958 N/A 968 N/A 
Cyanopeptolin B 930 N/A 939 N/A 
Aerucyclamide A 535 N/A 541 N/A 
Aerucyclamide C 517 N/A 523 N/A 
Aerucyclamide D 587 N/A 593 N/A 
 
Peak areas for the corresponding ex-novo and de-novo 
secondary metabolites were obtained using the MassLynx™™ 
application (Table 2.5). Quantification of microcystin-LR was performed 
by comparing the peak area of the unknown sample against the peak 
area of a known standard. Previously purified and quantified 
microcystin-LR (m/z 996 of >99% purity by HPLC) standard was used 
to prepare a dilution series. The limit of detection of this method is 
reported to be about 0.5 pg/µl. The standard was prepared in 80% 
methanol to final concentration of 50, 10, 5 and 1 µg/ml in triplicate 
and analysed in HPLC-MS. The MS peak areas were obtained from the 
data using the proprietary MassLynx™™ data analysis software. 
Plotting peak area on the Y-axis and the concentration on the X-axis a 
simple linear regression curve was plotted and correlation co-efficient 
was obtained. Also, a line equation was obtained for the linear 
regression curve (y = mx + c) and concentration of the unknown 
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sample was obtained by solving for x (Figure 2.11, 2.12 and Table 2.6, 
2.7). 
 
Figure 2.11 – Standard curve of microcystin-LR (m/z 996) by the ESI-
MS, quantified using peak area at m/z 996. Error bars = 1 SD, n=3. 
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Table 2.6: An example showing calculations for finding the unknown 
concentration of microcystin-LR considering ESI peak area at m/z 996 
Peak area of Sample y = 271.44x - 112.61 
microcystin-LR 
in µg/ml 
249 =(249+112.61)/271.44 1.33 
228 =(228+112.61)/271.44 1.25 
261 =(261+112.61)/271.44 1.38 
 
Average 1.32 
 
STDEV 0.06 
 
 
Figure 2.12 – Standard curve of microcystin-LR by the UV quantified at 
238 nm. Error bar = 1 SD, n=3. 
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Table 2.7: An example showing calculations for finding the unknown 
concentration of microcystin-LR considering UV peak area at 238 nm. 
Peak area of Sample y = 1260.5x - 691.65 
microcystin-LR in 
µg/ml 
1219 =(1968+691.55)/1260.5 1.52 
976 =(1850+691.55)/1260.5 1.32 
1309 =(2117+691.55)/1260.5 1.59 
 
Average 1.48 
 
STDEV 0.14 
 
 
 
2.9 RNA extraction and purification 
 In order to study the gene expression profile of M. aeruginosa 
PCC7806, mRNA was extracted and the mRNA of 16s rRNA, the 
microcystin synthetase genes mcyA and mcyE were amplified. At day 0 
of the experiment, prior to the addition of peptides, 40 ml of cells in 
triplicate (2.5 million cell/ml) was taken in ice cold Falcon tubes. This 
would be considered as day 0 (baseline) and serve to compare with 
gene expression. At day 10, the culture was centrifuged at 4000 g for 
20 min at 4 °C and the supernatant discarded.  The RNA extraction 
procedure was performed using the TRIZOL™ Max™ Bacterial RNA 
Isolation Kit (Invitrogen, UK) with some modifications.  
 To the pellet, 200 µL of Max™ Bacterial Solution was added and 
mixed by pipetting. The samples were incubated in water bath 
maintained at 95°C for 4 min. To this, 1 mL of TRIzol® Reagent was 
added and mixed, 200 µl of cold chloroform was added and mixed 
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thoroughly. The tubes were centrifuged at 4000 g for 45 min at 4 °C. 
The upper aqueous layer was transferred to fresh tubes and 300 µl of 
cold isopropyl alcohol was added to precipitate RNA. The tubes were 
mixed and allowed to incubate at room temperature for 10 mins.  The 
tubes were centrifuged at 4,000 g for 30 min at 4°C. The supernatant 
was discarded and the pellet was resuspended in 500 µL of chilled 75% 
aqueous ethanol. The samples were vortexed thoroughly and then 
centrifuged at 4,000 g for 15 min at 4°C. This step was repeated twice. 
The pellets were air dried and to this 100 µL of RNase-free water was 
added. The samples were stored at -80°C in a freezer until purification.  
 
2.9.1 RNA purification 
 RNA purification was performed using RNeasy Mini Kit (Qiagen, 
UK) and DNase treatment using RNase-free DNase set (Qiagen, UK). 
To 100 µL of the extracted RNA, 350 µL of RLT buffer and 200 µL of 
chilled absolute alcohol was added. The samples were mixed and 
immediately transferred to Qiagen RNeasy columns. The columns were 
centrifuged at 12,000 g for 1 min at room temperature. The flow 
through was discarded and 350 µL of buffer RW1 was added and 
centrifuged for 12,000 g for 1 min. Then, 80 µl of DNase I mix (10 µl 
of DNase I stock with 70 µl of RDD buffer) was added to the column 
and allowed to incubate at room temperature for 15 mins. After 
incubation, 350 μl Buffer RW1 was added and centrifuged for 12,000 g 
for 1 min. Subsequently, 500 μl Buffer RPE was added to the column 
and centrifuged at 12,000 g for 2 min. The column was placed in new 
 - 89 - 
 
1.5 ml collection tube and 30 μl RNase-free water was directly added 
to the column membrane. The columns were centrifuged for 1 min at 
12,000 g to elute the RNA. The concentration and purity of RNA 
samples were determined by 260/280 nm ratio using Genova 
NanoSpectrometer (Jenway). It is generally accepted that a 260/280 
ratio of ~ 2 is acceptable for RNA. The RNA samples were stored at -
80°C in a freezer until use.  
 
 
 
Where, standard coefficient for RNA is 40 µg/ml. 
2.10 Semi-quantitative RT-PCR 
 The Qiagen® OneStep RT PCR kit was used for amplification of 
specific mRNA sequences. The primers were designed and purchased 
from Eurofins MWG, UK. 
16s rRNA Gene - Accession no - U03402 
Base 
pairs 
Tm 
(°C) 
% 
GC 
Product 
size 
Forward 5’-CTAAAGGCGGTGGAAACTGGC-3’ 21 61.8 57.1 214 bp 
Reverse 5’-ACAAGCCACGCCTAGTATCC-3’ 20 59.4 55.0 214 bp 
      mcyE Gene         
Forward 5’-CGAGAAATCTTGGGGCTACTTGAAC-3’ 25 63 48.0 535 bp 
Reverse 5’-CAATGGGAGCATAACGAGTC-3’ 20 57.3 50.0 535 bp 
      mcyA Gene         
Forward 5’-GCTGCCCAGATGCGAGAATG-3’  20 61.0 60 334 bp 
Reverse  5’-CCTCTAAAACCCGCAGTAAGTAATC-3’ 25 61.0 44 334 bp 
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The reaction mixture for RT-PCR was as follows: 
Qiagen RT-PCR Buffer, 5x 2.50 µL 
dNTP mix (10 mM each) 0.50 µL 
Primer (Forward) (0.6 µM) 0.75 µL 
Primer (Reverse) (0.6 µM) 0.75 µL 
RT Enzyme  0.50 µL 
RNase-free Water  5.00 µL 
RNA Template (100 ng)  2.50 µL 
Total  12.5 µL 
 
The PCR conditions were as follows:  
No of 
cycles 
Step 
Temp 
(°C) 
Time (min) 
1 Reverse Transcription 50 30.0 
1 Activates Taq DNA polymerase 95 15.0 
23 
Denaturation 94 0.5 
Annealing 55 0.5 
Extension 72 0.5 
1 Final extension 72 10.0 
 
 The PCR products were run in 1% Agarose gel prepared in 1x 
Tris-Boric Acid-EDTA (TBE) Buffer containing GelRed™ nucleic acid 
stain. The gels were viewed using Gel Documentation System: UVITEC, 
Cambridge and images were captured using UVIDoc HDS software. The 
gel bands were quantified using Quantity One® 1-D analysis software 
(BioRad). 
 
2.11 Statistical analysis 
 The one-way ANOVA statistical method was used to determine 
statistical significance. The mean of two groups e.g. the average cells 
numbers of ‘control’ at Day 10 to that of average cell numbers of 
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‘treatment’ was statistically compared and the resultant P-value gives 
an indication of the statistical significance between the groups. A P-
value of less than 0.05 was considered statistically significant while a 
P-value greater than 0.05 is statistically insignificant. A web based 
version of the Anova statistical software was used for the calculations 
[30]. Post data analysis, the Tukey’s HSD post-hoc test was performed 
with a confidence interval set to 95 %.  
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3.1 Introduction 
 The production of secondary metabolites by cyanobacteria has 
recently received much attention as many of these metabolites are 
either toxic to higher organism or have interesting biochemical 
characteristics [200]. The organism Microcystis aeruginosa PCC7806 
produces several interesting molecules such as the hepatotoxin 
microcystin-LR, the protease inhibiting cyanopeptolins and the 
antimalarial aerucyclamides [90, 175, 201]. Although this organism 
has been studied extensively for decades, questions such as 
production dynamics, accurate quantification, production per cell per 
day and excretion rate of these compounds remain largely 
unanswered.  
 The production of cyanobacterial secondary metabolites may be 
governed by extrinsic factors such as light, temperature, nutrient 
availability and intrinsic factors like growth rate, metabolite 
concentrations and gene regulations [97, 202 - 206].  While earlier 
reports indicated that growth limiting factors such as nitrogen 
depletion indirectly controlled microcystin production, by limiting 
growth rate [100], later reports add that microcystin production is a 
complicated process and factors such as nitrogen as well as light play a 
combined role [94]. In fact, it was reported that photon irradiance acts 
directly on the transcription and/or transcript stability of microcystin 
synthetase genes [207]. Further, the production of different 
microcystin variants may respond to environmental factors in different 
ways [208]. It has been reported that in Planktothrix agardhii, the 
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production of microcystin-RR decreased two fold, while the production 
of microcystin-LR increased three fold when photon intensity increased 
from 60 to 100 µmols/m2/s [101].  
 The reason for the complexity of peptide production could be 
explained by the fact that most of the secondary metabolites produced 
by cyanobacteria are a product of multifunctional enzyme complexes 
formed from non-ribosomal peptide synthetase and polyketide 
synthase (NRPS/PKS) [207, 183]. The NRPS/PKS system in M. 
aeruginosa PCC7806 was elucidated In 2000 and the authors suggest 
that microcystin-LR synthesis is achieved by a bidirectional operonic 
cluster consisting of 10 genes (mcyA - J) in which the genes mcyA - C 
code for NRPS while the genes mcyD – J code for PKS [176]. Further, 
In 2008 the gene sequence for aerucyclamides was identified and 
designated as mca (A - G) and in 2009 the gene sequence for 
cyanopeptolin was identified and designated as mcn (A - E) [209, 
210]. Although the genes for most of the secondary metabolites of M. 
aeruginosa PCC7806 have been identified, their inter gene 
relationships are largely unknown and it is thought that they operate 
independent of each other [211]. This was demonstrated when certain 
genes necessary for microcystin biosynthesis were inactivated which in 
turn abrogated microcystin production but the production of other 
metabolites were unaffected [175, 181]. Hence, if it were argued that 
environmental factors affected gene expression, then it is possible that 
the production of different cyanopeptides will be affected differently by 
the same culture conditions.  
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 Under typical laboratory batch growth conditions, cyanobacteria 
grow exponentially, then transition to a light-limited stage of linear 
growth before finally reaching a non-growth stationary phase. In 
cyanobacteria, cultures can be limited in their growth by self-shading 
that prevents light penetration into deep culture layers. The macro and 
microelement limitations and limitation by high content of dissolved O2 
and/or by low content of dissolved CO2 or of HCO3 are often 
superimposed on the light limitation. At the gene level, the 
transcription of approximately 10% of the genes in the wild type was 
differently expressed between the exponential and linear phase. It has 
been reported that the expression of photosynthetic and regulatory 
genes are under expressed while genes for DNA photolyase (DNA 
repair enzyme) and Chl-binding protein are strongly induced [108]. In 
a study on the unicellular cyanobacterium Cyanothece sp, it was 
reported that the specific growth rate in exponential growth phase was 
less dependent on the incident irradiance than the photosynthetic 
activity. They also comment that the transition from exponential to 
linear phase is caused by a light limitation and the transition from 
linear to stationary phase by nitrogen limitation [102].  
In terms of cell growth and microcystin biosynthesis, a 
consistent culture system or a set of growth condition have not been 
reported for the study of M. aeruginosa PCC 7806. While some 
researchers have monitored the growth for up to 60 days [94], some 
have monitored growth for 20 days [161, 214] and others report 
monitoring growth for 6 days or less [127, 215]. Nitrate seems to be 
an important requirement and in terms of NO3 concentration used, 
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authors have reported using between 2 mM to 24 mM [217, 218]. In 
an earlier work on M. aeruginosa PCC7806, it has been reported that 
the when light intensity is 5 ± 1 µmol/m2/s and nitrogen concentration 
is 9 mM of NaNO3 and starting cell density is 1 x 105 cells /ml, the lag 
phase growth is up to 5 days while the exponential phase could last up 
to 40 days.  However, at the same NaNO3 concentration and cell 
densities, light intensity of 39 ± 4 µmol/m2/s the exponential growth 
phase lasted only up to 10 days [216].  Another report has added that 
light intensities above 32 µmols/m2/s inhibits mcyB transcription, 
meaning microcystin production is inhibited [220] while others report 
that high light intensities induce passive release of intracellular 
metabolites [94, 127]. Enumeration of cells was also widely different 
and several cell counting methods such as microscopy [108], 
flowcytometry, measuring optical density, Chl fluorescence [102] and 
dry weight have been used. Hence, a direct comparison between 
growth parameters and the response of the organism to these 
parameters was not possible. In the case of Microcystis sp, a statistical 
report concludes that NaNO3 > 1.27 mM, K2HPO4 > 0.1 mM, iron > 
0.01 mM and temperature > 18.8 °C stimulates growth and 
microcystin production [219]. As the synthesis of secondary 
metabolites is achieved through NRPS/PKS complex, it could be argued 
that these secondary metabolites would be synthesised continuously. 
In fact, it has been reported that about 67 % variability in toxin 
production (as determined my mcyB transcripts) may be attributable 
to growth phase and temperature [220]. Combining published data 
and drawing on the experience of previous lab members [185], it was 
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decided that a culture grown for 15 days would provide the cells 
sufficient time to acclimatise and start multiplying. Such a culture 
would be an ideal starting inoculum for experimental purposes. Also, 
the starting inoculum cell density was decided to be kept consistent at 
around 2.5 million cells per ml. While light intensity is an important 
factor, in the case of M. aeruginosa PCC7806, light intensity above 32 
µmol/m2/s is detrimental to microcystin production [220] while light 
intensity between 10 to 20 µmols/m2/s has been reported to have no 
effect on cell productivity (as determined by protein content, 4.93 ± 
0.66 pg/cell) [94]. Hence it was decided that the inoculum would be 
grown at 10 µmols/m2/s but the experiments would be conducted at 
20 µmols/m2/s so as to provide ample lighting to the culture, when cell 
shading occurs as a net result of increased cell numbers. Such an 
approach adds consistency to experimental procedures while providing 
optimal growth conditions for the culture.  
 In this study, the production of de-novo cyanopeptides was 
monitored by growing the culture in BG11 media containing a stable 
isotopic nitrate (15N) salt i.e. (Na15NO3). As the exact number of 
nitrogen in each of the cyanopeptide is known, mass differences 
between de-novo and ex-novo cyanopeptides could be differentiated 
by LC-MS, and hence accurate measure of day to day production could 
be achieved. The combination of 15N labelling and TOF (time of flight) 
technology has been used previously and has been proven to be a 
robust, accurate and straight forward tool in the study of 
cyanopeptides [212]. The technique could be invaluable when studying 
the turnover rates of multiple metabolites of a single strain, its 
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intracellular and extracellular fate, how production rate and growth 
rate correlates. Also, owing to the slow growth, the cyanopeptide’s 
intermediates and their order of synthesis may also be deduced. In 
future, this study might be useful to compare the effect of 
environmental factors, allelopathic interactions and when coupled with 
15N labelling of primary metabolites could aid in understanding 
complex interactions between growth and intracellular metabolism 
[213]. 
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3.2 Aims 
 To study the incorporation of 15N into the secondary metabolites 
of M. aeruginosa PCC7806 
 
Objectives 
- To determine the chromatographic and ion profile of the 
secondary metabolites of M. aeruginosa PCC7806 
- To observe the fragmentation pattern of the secondary 
metabolites viz microcystin-LR, cyanopeptolin and 
aerucyclamides and to study the partial incorporation of 15N into 
secondary metabolites of M. aeruginosa PCC7806 
- To establish a protocol for the use of 15N in BG11 media to study 
the de-novo synthesis of secondary metabolites of M. 
aeruginosa PCC7806. 
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3.3 Material and Methods 
3.3.1 Culture, media and growth conditions 
 The culture, media preparation and growth conditions were as 
described in section 2.1, 2.2 and 2.3. Cell counting was performed as 
described in section 2.6.1 and samples were analysed as described in 
section 2.8. 
 
3.3.2 Experimental setup 
 In order to evaluate the growth characteristics of M. aeruginosa 
PCC7806, a 15 day old inoculum of the culture was aseptically 
inoculated into 200 ml x 3 BG11-15N media taken in 500 ml conical 
flasks. The cultures were incubated for 21 days at conditions described 
in section 2.3 and samples were withdrawn every day, roughly at the 
same time of the day. Samples were only withdrawn after thorough 
mixing of the flasks to ensure homogenous cell densities. Once 
samples were withdrawn, they were processed as shown in Figure 2.3.  
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3.4 Results 
3.4.1 Growth curve of M. aeruginosa PCC7806 
The aim of this study was to monitor the growth of the organism 
for a period of 21 days, however due to unforeseen circumstances the 
growth of M. aeruginosa PCC7806 could only be monitored for a period 
of 19 days (Figure 3.1). To maintain consistency between experiments, 
the starting inoculum cell density was maintained around 2.5 to 3 
million cells per ml [185].  
 
From the cell numbers monitored for a period of 19 days, the 
specific growth rate (per day) was calculated using the formula 
described in section 2.7. Statistically, the growth rate between day 1 
to 5 & 5 to 15 was insignificant (p = 0.21), indicating that the cells are 
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growing at a similar rate between day 1 to 15, beyond which 
stationary phase begins (Table 3.0). The doubling time (G) i.e. time 
taken for a cell to divide also correlated with the growth rate i.e. as 
growth rate decreased, the time taken for cells to divide increased. In 
literature, it has been reported that the growth rate of M. aeruginosa 
PCC7806 ranges from 0.2 to 0.5 per day [160, 200 - 221] under 
various growth conditions. Hence, it could be stated that the observed 
growth rates correlates well within literature reported values. Further, 
the doubling time observed here is also well correlated with that of 
reported values of 1.8 to 4.8 days [220-221]. 
 
Table 3.0 – The growth rate and doubling time of M. aeruginosa 
PCC7806 monitored for a period of 19 days. 
Days 
Growth rate /day 
(µ) 
Doubling Time in 
Days (G) 
1 to 5 0.39 ± 0.07 1.84 ± 0.45 
5 to 15 0.32 ± 0.05 2.27 ± 0.40 
15 to 19 0.23 ± 0.02 3.08 ± 0.29 
 
 
 The organism M. aeruginosa PCC7806 cannot fix atmospheric 
nitrogen and hence an exogenous nitrogen source needs to be supplied 
for its growth. In BG11 media, if the nitrate (in the form of Na 14NO3) 
is replaced with a stable isotopic nitrate (in the form of Na 15NO3) salt, 
the cells would utilize this nitrogen to form its secondary metabolites. 
The mass of the de-novo secondary metabolite thus produced will be 
heavier by the number of nitrogen atoms making up the metabolite. 
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For example, microcystin-LR contains 10 14N nitrogens and has an 
average mass of 996, but when all the nitrogen is incorporated as 15N, 
the average mass of the molecule raises to 1006 Da.  The intracellular 
secondary metabolites of M. aeruginosa PCC7806 was also monitored 
for the period of 19 days. With the use of 15N stable nitrogen as the 
sole source of nitrogen, the de-novo (newly synthesised) as well as the 
ex-novo (previously synthesised when growing in 14N inoculum) 
intracellular metabolites could be distinguished. The organism 
produces several secondary metabolites such as microcystins (MC’s), 
aerucyclamides and cyanopeptolins (Figure 3.2 – 3.6). 
- 104 - 
 
 
Figure 3.2: The HPLC-MS chromatogram of M. aeruginosa PCC7806 grown in BG11(14N) extracted with 80% 
methanol and separated on BEH-C18 column (Waters®). The peak at time 5.8 min represents unlabelled (ex-novo) 
microcystin-LR (m/z 996), at 6.5 min represents cyanopeptolin A (m/z 958), at 8.8 mins represents aerucyclamide 
A (m/z 535). The smaller peak at time 6.4 mins is cyanopeptolin B (m/z 930), at 7.5 mins is aerucyclamide D (m/z 
587) and at 9.1 mins is aerucyclamide c (m/z 517). This organism also produces demethyl microcystin-LR (m/z 
982), but elutes a few seconds after microcystin-LR and could not be separated as a single peak. 
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Figure 3.3: The mass spectrum of microcystins of M. aeruginosa PCC7806 as seen in the positive ion mode. The 
peak at m/z 996 is microcystin-LR (microcystin-LR) and the peak at m/z 982 is demethylated microcystin-LR. 
Microcystin-LR chemical formula C49H74N10O12, average mass = 995.18 Da. The position of nitrogen atoms are 
highlighted in red. 
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Figure 3.4: The mass spectrum of cyanopeptolins of M. aeruginosa PCC7806 as seen in the positive ion mode. The 
peak at m/z 958 is cyanopeptolin A, the peak at m/z 930 is cyanopeptolin B and the peak m/z 944 is cyanopeptolin 
C. Cyanopeptolin A chemical formula C46H72N10O12, average mass = 957.13 Da. The position of nitrogen atoms are 
highlighted in red. 
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Figure 3.5: The mass spectrum of aerucyclamides of M. aeruginosa PCC7806 as seen in the positive ion mode. The 
peak at m/z 535 is aerucyclamide A, the peak at m/z 517 is aerucyclamide C. Aerucyclamide A chemical formula 
C24H34N6O4S2, average mass = 535.21 Da. The position of nitrogen atoms are highlighted in red. 
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Figure 3.6: Comparison of HPLC-MS chromatogram of M. aeruginosa PCC7806 grown in 14N and 15N and extracted 
with 80% methanol. The peak at time 5.8 min represents microcystin-LR (m/z 996, unlabelled and m/z 1006, 
labelled), at 6.5 min epresents cyanopeptolin A (m/z 958, unlabelled and m/z 968 labelled), at 8.8 mins represents 
aerucyclamide A (m/z 535, unlabelled and m/z 541, labelled).  
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3.4.2 ESI-MS fragments of the secondary metabolites of M. 
aeruginosa PCC7806 
 In recent years, the combination of liquid chromatography (LC) 
with electron spray ionization mass spectrometry (ESI-MS) has become a 
robust tool for the detection of natural compounds [222].  ESI can either 
be positive or negative, but in this case the positive ion mode was used 
i.e. the spraying nozzle was kept at a positive potential. In positive ion 
mode, ion generation is achieved via transfer of protons and hence the 
ions thus generated are protonated molecules [223] and is represented 
by the general notation [M + H]+. As a result, the molecule of interest is 
detected with 1 mass unit increase e.g. microcystin-LR of average mass 
995.18 Da is detected on the mass detector as [995.18 + 1] = 996.18. 
An interesting feature of ESI-MS is the generation of multiple charged 
ions of large molecules, which yields additional information aiding in 
structure determination of an unknown molecule. In the case of 
microcystins, the formation of [M + H]+ and [M + 2H]2+ are widely 
reported [224].     
 Next, the generated ions collide against an inert gaseous target 
resulting in fragmentation of the molecule into product ions [225]. ESI-
MS of microcystins results in the formation of multiple charged ions and 
the ratio of [M + H]+ : [M + 2H]2+ is reported to be dependent on the 
presence of arginine residues within the molecule. In the case of 
microcystin-LR, which contains 1 arginine, the ratio is reported to be 
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around 100:11, whereas, in the case of microcystin-RR (containing 2 
arginine) the ratio is 21:100 and in the case of microcystin-LA (containing 
0 arginine) the ratio is 31:0 [224]. The ionic spectrum of a compound is 
thought to vary according to the CID-ESI-MS/MS conditions, yet certain 
characteristic ions present within a sample is indicative of the presence of 
a compound of interest. For example, the presence of the fragment ion 
m/z 135 indicates the presence of adda ([PhCH2CHOMe]+) which indicates 
that the sample may contain microcystins or nodularin while the presence 
of the ion m/z 498 indicates the presence of microcystin-LR [226, 227]. A 
list of the published fragment ions of microcystin-LR and demethyl-
microcystin-LR is provided in Table 3.1, however, it should be noted that 
the m/z values shown for 15N containing MC’s are calculated values 
derived from the published data.  
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Table 3.1:  Some of the published ion fragments of microcystin-LR and 
demethyl-microcystin-LR 
 
m/z-14N  m/z-15N  m/z-14N  m/z-15N  Ref 
Ion Structure microcystin-LR 
demethyl-
microcystin-LR 
  
[M+H]+ 996 1006 982 992 
224, 
228 
[PhCH2CHOMe]+ 135 135 - - 
224, 
228, 
229 
[Glu-Mdha+H]+ 213 215 198 200 
229, 
230, 
231 
[Arg-MeAsp+H]+ 286 291 271 276 
230, 
231 
[C11H15O-Glu-
Mdha+H]+ or Adda + 
(Glu or MeAsp) + Mdha 
+ H+ (–NH3–134 
Adda)] 
375 377 360 362 
226, 
229, 
230 
[M + 2H]2+ 498 503 491 496 
232, 
229, 
231 
[Mdha-Ala-Leu-MeAsp-
Arg+H]+ or Ala + Arg 
+ (Glu or MeAsp) + 
Leu + Mdha + H] 
553 561 538 546 
226, 
232, 
231 
[Mdha + Ala + Leu + 
MeAsp - Arg - NH2] 
570 578 555 563 
232, 
230, 
231 
[MeAsp-Arg-Adda+H]+ 
or Adda + Arg + (Glu 
or MeAsp) + H+] 
599 605 584 590 
226, 
230 
[M+2H-135]+ 861 871 847 857 
228, 
226, 
231 
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  The chromatographic peak representing microcystin-LR of M. 
aeruginosa PCC7806 (Figure 3.3, 3.7) actually consists of two major ions 
i.e. microcystin-LR (m/z 996) and its demethylated (Asp-3) congener 
demethyl-microcystin-LR (m/z 982). As a congener, both the microcystins 
showed similar fragmentation patterns. The mass spectrum also reveals 
that demethyl-microcystin-LR amounts to > 50 % of microcystin-LR, 
which is unusually high for M. aeruginosa PCC7806. It is thought that this 
might be an acquired characteristic of a culture being maintained for 
prolonged duration under light limiting conditions, however, this remains 
to be confirmed.  
 
 
Figure 3.7: The mass spectra of the MC peak of M. aeruginosa PCC7806. 
A) Day 0,  mass spectra when the organism was grown in 14N replete 
media and B) Day 10, when grown in 15N replete media. The ions at m/z 
996 is unlabelled microcystin-LR and m/z 982 is unlabelled demethyl-
microcystin-LR. The ion at m/z 1006 is fully labelled microcystin-LR and 
m/z 992 is labelled demethyl-microcystin-LR. The ions m/z 847, 861 and 
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857, 871 represent the adda cleaved products of their respective major 
ions.   
 
 Apart from the base peak at m/z 995.6, the peaks m/z 996.6, 
997.6 and 998.6 represent microcystin-LR formed from the naturally 
occurring isotopes of C, H, N and O. Such isotopomers were observed for 
all the metabolites studied. Table 3.2 shows the relative abundance of 
fully 15N labelled microcystin-LR isotopomers. 
Table 3.2: Relative abundance of labelled 
microcystin-LR isotopomers arising from naturally 
occurring isotopes 
m/z  Peak Area Relative % 
1005 1655 12.77 
1006 12962 Base Peak 
1007 5724 44.16 
1008 1986 15.32 
1009 608 4.69 
 
 Within the microcystin peak, the ion characteristic for microcystins 
i.e. m/z 135 could be detected. Relative to the major ions, the m/z 135 
ion was present only at about 1%. It should be noted that the adda 
fragment does not contain any nitrogen atoms and hence could not be 
differentiated between ex-novo and de-novo. This characteristic ion was 
present in all of the samples.  
 The next major ion within the ESI-MS ion spectra was the ion with 
m/z 498 which is reported to be representative of [M + 2H]2+, the doubly 
charged ion of microcystin-LR [224]. The relative abundance of [M + 
2H]2+ of each of the ions were calculated with regards to the protonated 
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ion [M + H]+ and it revealed that for the de-novo produced microcystins it 
amounted to 7 to 20 %, which correlated with literature values  of 11 to 
45% (Table 3.3) [224, 226, 231]. 
 
Table 3.3: The relative abundance of [M + H]+ and [M + 2H]2+ ions in the 
ESI mass spectra of microcystin. The ion abundance (%) was normalized 
to the base peak (100%) ion. Sample = Day 10, intracellular extracted 
with 80% MeOH 
Ion 
14N 
microcystin-
LR 
14N 
demethyl-
microcystin-
LR 
15N 
microcystin-
LR 
15N demethyl-
microcystin-LR 
[M + H]+ 342 (100%) 383 (100%) 5437 (100%) 3763 (100%) 
[M + 2H]2+ 92 (27%) 52 (14%) 1141 (20%) 278 (7%) 
Values outside the brackets represent peak area and values within the 
brackets are relative abundance in percentage 
 
 Along with the doubly charged ions, three other ions could be seen 
in relative high abundance to that of the doubly charged ions. Figure 3.8 
shows the respective ions comparison between day 0 and day 10. It 
should be noted that at day 0, no de-novo MC’s would be present whereas 
at day 10, the intracellular pool would predominantly be de-novo MC’s 
and this would reflect in the m/z ratio of the respective ions. The ions 
with m/z 491 are reported to be the doubly charged [M + 2H]2+ ion of 
demethyl-microcystin-LR ion  while the ion m/z 498 corresponds to its 
microcystin-LR congener (Figure 3.8, 3.9). The ions with m/z 475 are 
reported to be the doubly charged demethyl-microcystin-LR ion of [M + 
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2H – MeOH]2+ while the ion m/z 482 corresponds to its microcystin-LR 
congener [231].  
 
Figure 3.8: ESI-MS ion spectrum comparison between double charged 
ions between day 0 (unlabelled) vs day 10 (labelled). Ions m/z 498 and 
491 represent [M + 2H]2+ ex-novo microcystin-LR and demethyl-
microcystin-LR, m/z 503 and 496 are de-novo microcystin-LR and 
demethyl-microcystin-LR. The ion m/z 482 is ex-novo [M + 2H - MeOH]2+ 
of microcystin-LR and 475 is of demethyl-microcystin-LR. Its de-novo 
counterparts are m/z 487 and 480 respectively.  
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 The next sets of major ions were the m/z 861 and 847, which are 
proposed to be the cleavage of adda fragment (m/z 135) from the 
respective doubly charged MC congeners [228]. The relative abundance of 
these cleavage products with respect to the parent ions are given in Table 
3.4. It should be noted that the cleavage products are resultant of the 
CID of ESI-MS/MS process and do not occur naturally and hence, 
quantification of de-novo microcystins should accommodate these ions as 
well (Figure 3.10, 3.11). 
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Table 3.4: The relative abundance of [M + H]+ and [M + 2H -135]2+ ions 
in the ESI mass spectra of microcystin LR. The ion abundance (%) was 
normalized to the base peak (100%) ion. Sample = Day 10, intracellular 
extracted with 80% MeOH 
Ion 
14N 
microcystin
-LR 
14N 
demethyl-
microcystin
-LR 
15N 
microcystin
-LR 
15N 
demethyl-
microcystin
-LR 
[M + H]+ 342 (100%) 383 (100%) 
5437 
(100%) 
3763 
(100%) 
[M + 2H - 
135]2+ 
68 (20%) 94 (25%) 871 (16%) 956 (25%) 
Values outside the brackets represent peak area and values within the 
brackets are relative abundance in percentage 
  
 
Figure 3.10: ESI-MS ion spectrum comparison between the adda 
fragment [M + H - 135]+ cleaved ions of MC’s between day 0 (unlabelled) 
vs day 10 (labelled). 
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3.4.3 Partial Incorporation of 15N into microcystins 
 
 The aim of this study was to evaluate the rate at which 15N is 
incorporated into de-novo microcystins. The experimental design was 
such that M. aeruginosa PCC7806 would be grown in BG11 media 
containing 14N until mid-log following which the cells would be 
centrifuged, washed with nitrate free BG11 to remove traces of 14N and 
resuspended in BG11 media containing 15N.   As microcystin-LR contains 
10 nitrogen atoms, the number of 15N that can go into the synthesis of 
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de-novo microcystin-LR can range between 0 and 10. At day 0, owing to 
the fact that the inoculum was grown in 14N, only unlabelled microcystin-
LR (m/z 995) could be detected with high relative abundance. The 
intracellular concentration of the unlabelled microcystin-LR remained 
mostly unchanged for the duration of the experiment (Figure 3.13). It 
could be stated that, microcystin-LR being an intracellular molecule is 
neither utilized nor is exported. In terms of daily biosynthesis, until day 2, 
no de-novo MC’s could be detected, however, at day 3 the completely 
formed demethyl-microcystin-LR could be detected and in comparison 60 
% less of microcystin-LR could also be detected. It is unclear if demethyl-
microcystin-LR is synthesised from microcystin-LR by a demethylation 
process or vice-versa.  
 Since the cells contain some amount of 14N (or partially synthesised 
14N containing aminoacids) and the media contains large quantities of 15N, 
the microcystin-LR thus synthesised may contain nitrogen from either of 
the isotopes i.e. partially 15N incorporated microcystin-LR. In order to 
study the abundance of partially 15N incorporated microcystin-LR to that 
of fully 15N incorporated microcystin-LR, the relative abundance of each of 
the possible 14N/15N combinations was quantified. As microcystin-LR 
contains 10 nitrogen, the peak areas between m/z 994 to m/z 1006 were 
considered (Figure 3.12), where m/z 996 would represent microcystin-LR 
formed with 10 14N and m/z 1006 would be all 15N. As the natural 
abundance of the 15N isotope is ~0.36%, the probability of synthesising a 
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microcystin-LR molecule containing one or more 15N atoms in cells 
growing in the unlabelled media is very low.  
 
 The relative abundance of m/z 996 at day 0 was the highest, which 
reduced to 14 % by day 5 and continued to decline further on (Figure 
3.12). At the same time, the relative abundance of m/z 1005 (containing 
1 14N nitrogen and 9 15N nitrogen) was 9 % by day 3 and reached 13 % 
by day 5. This amount of m/z 1005 was stable until day 8 after which its 
concentration decreased to 9 % and was stable from there on. The 
concentration of m/z 1006 (10 15N) was negligible at day 0, but increased 
to 32 % by day 5 and reached 50 % by day 9 and remained stable 
henceforth. A previous work reported that the major ion at day 0 was m/z 
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995, but by day 18 the major ions had transformed to m/z 1004 [230]. In 
comparison, this data suggests that the major ions at day 0 m/z 996 
while at day 19 it is m/z 1006. Although, the experimental and detection 
methodologies are very different, it may be stated that this data 
correlates well with published findings. The evidence presented here 
suggests that it takes at least 2 days for the formation of fully 15N labelled 
microcystin-LR and that nitrogen is assimilated into microcystin-LR in 
order of its abundance in the media (Figure 3.13).  
 
 
 The pool of all the ions between m/z 995 to m/z 1007 was analysed 
for the relative percentage of each of the individual ions. It revealed that 
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m/z 996 and m/z 997 were the predominant ions in the unlabelled pool 
whereas m/z 1006 and m/z 1007 were the predominant ions in the 
labelled pool. All of the other ions were present in low concentrations only 
i.e. less than 10 % only. It was also observed that it takes 2 days for 
complete 15N labelling of microcystin-LR (Figure 3.13). Although partial 
incorporation studies on microcystin-LR is rare, some studies have 
investigated incorporation of 15N into metabolites such as jamaicamides, 
curazole, carmabin A, apratoxin A and hectochlorin have reported that it 
takes 10 days for complete incorporation to occur [212]. Interestingly, a 
study on partial incorporation of 15N into chlorophyll determined that 
complete incorporation occurs in about 2.08 days [213]. It should be 
noted that unlike secondary metabolites, chlorophyll is innately related to 
the metabolism of the organism and hence may explain its faster turnover 
rate. Overall, it may be stated that complete labelling of secondary 
metabolites takes a longer time period than labelling of primary 
metabolites and in the case of microcystin-LR, it takes 2 days for 
complete labelling.   
 
3.4.4 Partial incorporation of 15N into Cyanopeptolin 
 M. aeruginosa PCC7806 is reported to produce several 
cyanopeptolins such as cyanopeptolin A, B, C and D and 963A [201, 163]. 
Compared to microcystins, literature on cyanopeptolins is rather limited, 
but their anti-protease activity may lead to extensive studies in the 
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future. Cyanopeptolins are cyclic peptides containing 7 to 9 amino acids, 
one of which is variable. The L-glutamic acid aldehyde and the amino 
group of L-leucine form an unusual 3-amino-6-hydroxy-2-oxo-l-piperidine 
system (Aph) (Table 3.5). 
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Table 3.5: Cyanopeptolins from M. aeruginosa PCC7806 
Amino acid 
Cyanopeptolin variants 
A B C D 963A 
L-Arginine +         
L-Lysine   +       
N-Methyl-L-lysine     +     
N,N-Dimethyl-L-lysine       +   
Tyrosine         + 
L- Leucine + + + + + 
N-Methyl-L-phenylalanine + + + + + 
L-Valine + + + + + 
L-Threonine + + + + + 
L-Aspartic acid + + + + + 
Hexanoic acid + + + + + 
Chemical Formula C46H72N10O12 C46H72N8O12 C47H74N8O12 C48H76N8O12 C49H69N7O13 
m/z [M + H]+ (14N) 958.14 930.13 944.15 958.18 965.13 
m/z [M + H]+ (15N) 968.14 938.13 952.15 966.18 972.13 
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Under the conditions of the UPLC-MS used, the chromatogram of M. 
aeruginosa PCC7806 revealed that cyanopeptolins eluted after 
microcystin-LR at about 6.3 mins, which may indicate that cyanopeptolins 
are comparatively less polar than microcystin-LR. Of the 5 cyanopeptolins 
reported, only cyanopeptolin A peak was predominant, however, the ion 
spectrum revealed that cyanopeptolin A and D co-eluted (Figure 3.14, 
3.15).  
 
 
Figure 3.14: The positive ESI ion spectra of the ions of cyanopeptolin 
peak at time 6.3 mins. The ion m/z 965.55 represents 15N labelled 
cyanopeptolin D (Ret time 6.33 min) while the ion m/z 967.52 represents 
cyanopeptolin A (Ret Time 6.31 mins). 
  
 As the mass spectra of both cyanopeptolin A and D overlapped, it 
was impossible to differentiate their corresponding peaks. Also, a 
literature search for the fragmentation pattern of cyanopeptolin A or D 
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was unfruitful. The low energy ion spectra of cyanopeptolin A and D 
revealed several major peaks at m/z 474, m/z 475, probably representing 
doubly charged ions [M – CH3 + H]2+ of both the molecules respectively 
(Figure 3.14). A more detailed analysis of the fragmentation pattern of 
cyanopeptolins may need to be undertaken in the future to predict the 
composition of the observed fragments.  
 For the above stated reasons, cyanopeptolin A and D were 
excluded for the 15N partial incorporation analysis, while cyanopeptolin B 
(m/z 929) seemed to be an ideal candidate. Cyanopeptolin B contains 8 
nitrogen atoms and hence the possibility of 15N incorporating within it 
range from 0 to 8. Hence, the peak areas between m/z 929 to 937 were 
obtained and the relative ions percentage was calculated (Figure 3.15). 
The peak at m/z 930 represented [M + H]+ of unlabelled molecule 
whereas the peak at m/z 938 represented [M + H]+ of fully labelled (15N) 
molecule.  At day 0, the unlabelled peak showed the highest intensity, but 
by day 3 had reduced to less than 20 % of the ion pool, which reduced to 
below 10 % by day 4 and continued to decline. At the same time, the 
relative abundance of m/z 937 (containing 1 14N nitrogen and 7 15N 
nitrogen) was 18 % by day 3 and remained steady henceforth. This 
concentration of m/z 938 (15N8) was 6% at day 2, rapidly increasing to 
25% by day 3 and reached 40% by day 5. Interestingly, the percentage 
of m/z 939, synthesised out of the naturally occurring stable isotopes of C 
or O, followed a similar trend to that of m/z 937. Overall, it may be stated 
that the partial 15N incorporation of cyanopeptolins and microcystin-LR are 
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similar, but like microcystin-LR it takes about 2 days for the complete 15N 
labelling of cyanopeptolin A. 
 
 
3.4.5 Partial incorporation of 15N into aerucyclamides  
 M. aeruginosa PCC7806 also produces aerucyclamides A to D, but 
unlike other secondary metabolites aerucyclamides are ribosomally 
synthesised [90, 162]. Here again, a literature search for the 
fragmentation pattern of aerucyclamides was unfruitful, however, the 
structure and amino acid composition of all the aerucyclamides of M. 
aeruginosa PCC7806 has been predicted (Table 3.6). Aerucyclamides 
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differ from the other secondary metabolites studied here, as they are 
sulphur containing secondary metabolites.  
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Table 3.6: Aerucyclamides from M. aeruginosa PCC7806 
Amino acid 
Aerucyclamide variants 
A B C D 
D-allo-Isoleucine + +     
Glycine + +   + 
L-Threonine O-acyl O-acyl + + 
L-Methyloxazoline   + + + 
Thiazoline +     + 
Thiazole + + + + 
L-Isoleucine + + +   
Oxazole     +   
L-Alanine     +   
L-Valine     +   
Phenylalanine       + 
Chemical Formula C24H34N6O4S2 C24H33N6O4S2  C24H32N6O5S C26H31N6O4S3 
m/z [M + H]+ (14N) 535.71 533.70 517.62 588.77 
m/z [M + H]+ (15N) 541.71 539.70 523.62 594.77 
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 The UPLC chromatogram of the methanolic extract of M. aeruginosa 
PCC7806 revealed that this organism produces about 50% more of 
aerucyclamide A when compared to microcystin-LR (Figure 3.16) and for 
this reason aerucyclamide A was chosen for partial incorporation of 
14N/15N analysis. The positive ion spectra of aerucyclamide A did not 
reveal any significant fragments except for the base peak (Figure 3.17).  
 
Figure 3.16: The BPI (base peak intensity) chromatogram of M. 
aeruginosa PCC7806 methanolic extracts. The aerucyclamides elute after 
microcystin-LR and hence can be regarded as more hydrophobic than 
microcystin-LR. The peak m/z 593 represents 15N labelled aerucyclamide 
D, m/z 541 is aerucyclamide A and m/z 523 is aerucyclamide C.  
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Figure 3.17: The positive ESI-MS of labelled aerucyclamide A m/z 541. 
  
Aerucyclamide A contains 6 nitrogen, and during growth, the 
probability of 15N incorporating within may range from 0 to 6. Hence, the 
peak areas between m/z 535 to 541 were obtained and the relative ions 
percentage was calculated (Figure 3.18). The peak at m/z 535 
represented [M + H]+ of unlabelled molecule whereas the peak at m/z 
541 represented [M + H]+ of fully labelled (15N) molecule.  At day 0, the 
unlabelled peak showed the highest intensity, but by day 3 had reduced 
to 30% of the ion pool, which further reduced to below 20% by day 4 and 
continued to decline further. At the same time, the relative abundance of 
m/z 536 (containing 1 14N nitrogen and 5 15N nitrogen) was 12% by day 3 
and steadily declined henceforth. This concentration of m/z 541 (15N6) 
was 9% at day 2, rapidly increasing to 30% by day 4 and reached 40% 
by day 5. By day 10, the fully labelled molecule concentration had 
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reached 50% of the ion pool and remained steady henceforth. 
Interestingly, the percentage of m/z 542, synthesised out of the naturally 
occurring stable isotopes of C or O, followed a similar trend to that of 
cyanopeptolin B, but only reached a maximum of 15%. Overall, it may be 
stated that the partial 15N incorporation of aerucyclamides and 
microcystin-LR are similar and that both the molecules take 2 days for 
complete 15N labelling. 
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3.5 Discussion 
 This study tried to understand the growth and secondary 
metabolite production characteristics of the freshwater toxic organism M. 
aeruginosa PCC7806. In the environment, elevated water temperature, 
low photon irradiance, high water-column stability, intense zooplankton 
grazing on competing species, high pH, and low nitrogen/phosphorus ratio 
are generally the most important factors stimulating the growth of 
harmful cyanobacteria [234]. It has been reported that nitrate (NO3) 
concentrations may vary between negligible amounts to 142.8 µM and 
total phosphorous may range between 1.61 to 2.91 µM. Light intensities 
typically would be in the range of 200 to 500 µmols/m2/s, however it is 
known that Microcystis sp may avoid high light intensities by decreasing 
its buoyancy. Temperatures are also largely variable, but it is reported 
that temperatures of about 21 ± 2 °C are favourable for bloom formation 
[235 - 240].  Compared to real life conditions, the parameters used in 
laboratory experiments are designed to provide ample nutrients and 
growth conditions for the growth of M. aeruginosa PCC7806. In the 
conditions used here, it appears that the organism multiplies at a rate 
comparable to literature reported values. The conditions used in this 
study would be considered as mild when compared to environmental 
conditions. However, it is well known that conditions such as water 
turbulence, UV exposure, grazer population, cyanophages, nutrients are 
largely variable in the environment and M. aeruginosa PCC7806, by virtue 
of its gas vesicles is well capable of adapting to changing environments 
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[241].  In terms of growth characteristics, a direct comparison could not 
be made with other published studies, firstly because a consistent culture 
method (inoculum age, duration, light cycles, nutrient concentration) 
were largely variable and secondly this is the first study where M. 
aeruginosa PCC 7806 has been grown with 15N as its sole source of 
nitrogen. Moreover, the aim of this study was only to elucidate partial 
incorporation patterns of 15N into its secondary metabolites.   
This study tried to elucidate the secondary metabolites produced by 
M. aeruginosa PCC7806 using LS-MS/MS. According to literature, this 
organism produces several secondary metabolites such as microcystin-LR, 
demethyl-microcystin-LR, cyanopeptolins A to D, 963A and 
aerucyclamides A to D. In the HPLC protocol used here, it was observed 
that microcystin-LR, cyanopeptolin D, aerucyclamides A, C and D were 
the predominant peaks. The BPI of the chromatogram reveals that 
aerucyclamide A was present in the highest concentration followed by 
microcystin-LR at about 50% of the BPI. Cyanopeptolin D, aerucyclamides 
C and D were present in less than 20% concentration in the BPI picture. 
It was also observed that microcystin-LR and demethyl-microcystin-LR 
peaks could not be resolved, as were cyanopeptolin A and D. The peaks 
for cyanopeptolins B, C and 963A were not observable in the BPI picture 
and neither was aerucyclamide B (Figure 3.16). 
 In terms of ion fragmentation, microcystin-LR and demethyl-
microcystin-LR showed several well documented ions such as [M + 2H]2+ 
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and [M + 2H -135]2+. Also, the adda fragment m/z 135 could be 
observed. As for cyanopeptolins, the ion fragments m/z 474 and m/z 475 
were observed, however, their composition could not be readily 
confirmed. In contrast none of the aerucyclamides showed any 
fragmentations.  
 In terms of partial incorporation, it seemed that irrespective of the 
isotopicity, M. aeruginosa PCC7806 seem to assimilate the available 
nitrogen into its molecules for the biosynthesis of its secondary 
metabolites. In fact, it was observed that the relative abundance of the 
unlabelled molecules decreased owing only to the lack of 14N in the media. 
In terms of the time taken for M. aeruginosa PCC7806 to assemble fully 
15N incorporated metabolites, this study indicates that it takes about two 
days for complete biosynthesis of microcystin-LR (probably demethyl-
microcystin-LR as well), aerucyclamides A and cyanopeptolin B.  
 It was observed that the growth rate of M. aeruginosa PCC7806 
ranges between 0.3 to 0.7 per day and the doubling time ranged between 
1.5 to 3.5 days even within the logarithmic growth phase. When the 
growth rate was compared to the secondary metabolite production rate, a 
linear correlation for all of the major secondary metabolites such as 
microcystin-LR, cyanopeptolin and aerucyclamide was observed. It was 
also noted that even when the growth rate was at its lowest, a small 
amount of all of the mentioned secondary metabolites was continuously 
produced.  
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 Overall, it could be stated that this study has highlighted some 
interesting features of secondary metabolite production of M. aeruginosa 
PCC7806. While studying cyanobacteria, it is also imperative to closely 
monitor cellular metabolic activity. In this view, it is also suggested that 
future studies monitor the secondary metabolites production as well as 
one other molecule that closely correlates cellular activity. Chlorophyll-a 
(or its breakdown product pheophytin-a, C55H74N4O5, m/z 871.2) seems to 
be an ideal candidate and has been successfully studied using the same 
15N (and HPLC-MS) methodology. As chlorophyll-a is a molecule that is 
actively synthesised and degraded continuously, it may serve as an 
indicator of cellular metabolic activity when coupled with labelling studies 
[213, 233]. 
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4.1 Introduction 
 Cyanobacteria produce a diverse range of secondary metabolites 
which include small peptides, polyketides and alkaloids [242]. When 
optimal conditions of sunlight, temperature, nutrients (nitrates, 
phosphates) and low turbulence occur, cyanobacteria rapidly multiply and 
form blooms [114]. Although factors such as nutrient concentrations and 
low grazing populations of zooplanktons are advantageous, no single 
factor has been directly attributed to bloom formation. It is thought that 
increased anthropogenic eutrophication of water bodies in recent years 
enhanced by global warming may be one of the leading causes to the 
increased occurrences of blooms [243 - 245]. During late exponential 
growth phase and bloom collapse, the intracellularly produced secondary 
metabolites are released into the ecosystem. It has been reported that up 
to 75% of the blooms could be secreting secondary metabolites that may 
be toxic to the environment [122]. 
 The range of secondary metabolites produced by cyanobacteria has 
drawn much scientific interest in recent years. It is reported that 
cyanobacteria produce about 800 different secondary metabolites, whose 
activities range from hepatotoxic to neurotoxic to antibacterial, antifungal 
and enzyme inhibitory activities [247]. Although cyanobacterial secondary 
metabolites have been widely studied for their potential applications in 
commercial as well as pharmaceutical applications, the key question as to 
why cyanobacteria produce such a wide array of metabolites remains 
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unanswered. Only in recent years, it is thought that interspecies 
communication i.e., allelopathy may be one of the reasons.  
  Allelopathy in cyanobacteria has been reported as early as 1948, 
however intensive research in this field began only in the 1980s [123]. 
Several cyanobacterial secondary metabolites have been classed as 
allelochemicals based on the properties these compounds exhibit on other 
cohabiting organisms.  One of the first allelochemicals to be studied was 
cyanobacterin from Scytonema hofmanii which was reported to be 
specifically active against algae but did not have any significant effect on 
non-photosynthetic organisms [122]. Later, Moore et al., [124] reported 
the isolation of 18 hapalindoles from Hapalosiphon fontinalis which were 
either antibacterial or antimycotic in nature. Following this discovery, the 
search for allelochemicals continues and the compounds calothrixin A and 
fisherellin are some well known allelochemicals [137, 138].  
 The organism Microcystis has been studied for several decades as it 
is one of the most common bloom forming cyanobacteria [248] as well as 
its characteristic hepatotoxin microcystins (MC’s) produced by some 
species. MC’s are a group of heptapeptides containing a unique amino 
acid Adda along with a conserved structure of D-Ala-L-X-D-MeAsp-L-Y-
Adda-D-Glu-Mdha. Most of the variants of MC’s arise from the variable L-
amino acids at position X and Y. MC’s are unusual in their biosynthetic 
pathway involving a mixed Non Ribosomal Peptide Synthesis (NRPS) 
/Polyketide Synthetase (PKS) enzyme complex [176]. In spite of the 
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complex nature of MC’s and its synthesis, MC’s do not seem to play a vital 
role in the host organism’s survival or play a significant role in the 
immediate habitat of the host. Some functions, such as heavy metal 
chelation [99] or dissuasion of grazers have been attributed to 
microcystins although none of these functions have been conclusively 
proven [151].  
As MC’s are secondary metabolites (which are not directly involved 
in the host organism’s metabolism), it is thought that MC’s may have an 
allelochemical role.  Recently, Schatz et al., [127] reported that the 
exposure of Microcystis cells to MC, micropeptin or microginin (from 
lysates of Microcystis cells) resulted in significant increase in the 
accumulation of McyB (gene product of mcyB of the microcystin operon) 
as well as MC. With this evidence, the authors claim that these 
metabolites may have a signalling role. However, the authors fail to 
convincingly explain how the overproduction of microcystin by the host 
organism benefits its fitness or its survival.  
 In 2005, Hu et al., [249] reported that the presence of exogenous 
microcystin inhibited the growth of Synechococcus elongates while 
significantly increasing its glutathione as well as glutathione peroxidase 
activities. They concluded that exogenous microcystin induced significant 
oxidative stress on target organisms which in turn responded by up 
regulating antioxidative measures. However, the concentration of 100 
ng/ml of exogenous microcystin used in the study would be considered 
 - 141 - 
 
high when compared to ecological scenarios and hence allelopathic 
interactions between the organisms may not be relevant in nature. Also, 
from the study it could not be concluded if the induction of oxidative 
stress is a direct effect of exogenous microcystin on the organism or a 
nonspecific effect of MC’s localising within the thylakoids of the target 
organism [249]. 
    A further study by Babica et al., on the effect of MC’s on five 
photoautotrophs namely Chlamydomonas reinhardtii, Chlorella kesslerii, 
Pediastrum duplex, Pseudokirchneriella subcapitata and Scenedesmus 
quadricauda found no allelopathic effect within ecologically relevant 
concentrations of MC. However, the researchers had considered only 
growth as a parameter and the maximum exposure duration was only 11 
days [250]. In aquatic ecosystems, it is unlikely that cyanobacteria and 
their cohabitors are only exposed for a short duration. Also, it should be 
noted that the authors have not reported any significant reduction in the 
growth of the chlorophytes.  
 Some molecular studies may suggest that there is indeed a role for 
MC’s or at least they might have been useful in the past. The presence of 
a transport protein McyH encoded by a sequence within the microcystin 
biosynthetic cluster, as well as the complete loss of microcystin 
biosynthesis with the deletion of the mcyH gene suggest that microcystin 
is produced with strong intention of extracellular export [181]. Further, 
the discovery of a transcription factor (NtcA) that up regulates 
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microcystin synthesis during nitrogen stress adds benefit to the 
hypothesis that microcystin serves some function to the host organism, at 
least under stress conditions such as nitrogen limitation [182]. Hence it 
may be inferred that in order to fully understand the allelopathic role of 
MC’s, further studies are required and factors such as longer exposure 
durations, growth parameters such as growth rate, photosynthesis rate, 
effect of exogenous MC’s on the secondary metabolites and other 
parameters which reflect the molecular state of the organism need to be 
evaluated.  
 The organism M. aeruginosa PCC7806, originally isolated from 
Braakman Reservoir (in 1972, Netherlands) has been studied extensively 
for several decades. It originates from one of the most common bloom 
forming cyanobacteria occurring widely in fresh water ecosystems [251]. 
One of the key characteristics of M. aeruginosa PCC7806 is its ability to 
produce an array of secondary metabolites such as aerucyclamides, 
cyanopeptolins and microcystins (Figure 4.1). Among its secondary 
metabolites, microcystins are the most frequently observed and well-
studied. 
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Figure 4.2 - Chemical structure of microcystin-LR. In position 2 is leucine 
and position 4 is arginine both of which are L forms and variable. 
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 Figure 4.1: HPLC-MS chromatogram of M. aeruginosa PCC7806 extracted with 80% methanol (MeOH). 
The peaks 996 Dalton is microcystin-LR, 958 Da is cyanopeptolin A and 535 Da is aerucyclamide. The 
organism also produces other secondary metabolites such as aerucyclamide D (587 Da) and 
aerucyclamide C (517 Da). 
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Microcystins are monocyclic heptapeptides with a conserved 
structure of D-Ala-L-leu-D-MeAsp-L-Arg-Adda-D-Glu-Mdha (Figure 4.2). 
The unique amino acid adda (3-amino-9-methoxy-2, 6, 8-trimethyl-10-
phenyldeca-4, 6-dienoic acid) is present ubiquitously within 
cyanobacterial species only [252]. One of the characteristics of 
microcystin-LR is its strong inhibition of protein phosphatases (type PP1 
and PP2A of plant and mammals), but 1000 fold less affinity to PP2B. The 
binding of microcystin-LR to PP1 is through the carboxyl group of MeAsp 
with Arg96 and Tyr134, followed by the linkage of Mdha side chain to 
Cys-273. The binding of microcystin-LR to PP2A is through the adda side 
chain binding with the amino acids (Trp200, His 191, Gln 122 and Ile123) 
of the binding pocket, followed by van der Waals interactions between the 
adda with the residues of the binding pocket and later the covalent 
linkage of Cys269 of the enzyme with Mdha side chain [253, 254]. Protein 
phosphatases perform regulatory activities such as glycogen metabolism, 
cell division, apoptosis, and protein synthesis. When the enzymes are 
inhibited, the organism becomes vulnerable towards tumor formation and 
in higher concentrations the cells die.   
 As stated, although microcystins have been studied for several 
decades, their primary function to the host organism has remained 
unclear. Besides ecological concerns, the effect of MC’s on human health 
has drawn significant attention towards the study of microcystins. One 
approach to study this molecule is to determine how microcystin affect 
the growth and secondary metabolite production of a known microcystin 
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producing organism such as M. aeruginosa PCC7806. An understanding of 
how the molecule interacts with the host organism may provide an 
explanation of why the organism is producing the molecule. The study by 
Schatz et al., provided some evidence that the presence of extracellular 
microcystin increased their intracellular concentration, indicating that the 
cells detected the death of other cells and increased their cellular 
microcystin content [127]. It is also worthwhile to note that very few 
studies have reported the effect of MC’s on its host organism. Since M. 
aeruginosa PCC7806 produces several other secondary metabolites along 
with microcystin, it would be interesting to see the effect of microcystin-
LR on its own production as well as on the other metabolites produced by 
the organism. To further enhance the accuracy of the data, a 
methodology to enumerate cyanobacteria using flow cytometry will be 
employed as this method enables one to differentiate between live cells 
and lysing cells. 
Also, previous studies in this field often lack information in areas 
such as production rate, an accurate quantification of the metabolite 
within a single cell, accurate count of the cell numbers, the de-novo 
production of these metabolites and what is the fate of the secondary 
metabolites already present in the surroundings.  In most studies, 
microcystin is quantified at time points i.e., measure of the change in 
total microcystin over time. This type of quantification yields only an 
overall picture of the quantity of microcystins, but does not reveal any 
information regarding microcystins metabolism (synthesis vs 
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degradation). Further, while calculating the rate of production, the total 
cell population is often only represented in terms of total protein or the 
total chlorophyll content [100]. This leads to errors such as over or 
underestimation of the cell density, which in turn leads to errors in 
microcystin quantification. Even studies that attempt to report a linear 
correlation between mcy D (one of the genes in microcystin synthesis 
operon) expression and microcystin concentration [255] do not quantify 
the microcystin production against live cell numbers. This study aims to 
bridge this knowledge gap by developing tools that accurately quantify 
cell numbers and differentiate between live and dead cyanobacterial cells, 
quantify the production of de-novo (newly synthesised) secondary 
metabolites and evaluate how the exogenous presence microcystin-LR 
affects the growth and the production of other peptides of the host 
organism. In order to accurately measure the daily production of new 
microcystin (de-novo), yet another novel methodology of replacing the 
nitrogen source in the growth media with a stable isotopic nitrogen (15N) 
containing sodium nitrate would be employed. While the organism grows 
in such a media, the metabolites thus synthesised will incorporate the 
isotopic nitrogen whereby increasing its mass equivalent to the number of 
nitrogen atoms in a molecule of MC. This mass difference is detectable on 
the HPLC-MS and serves to differentiate between the de-novo and native 
MC. 
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4.2 Aim 
To investigate the role of microcystins as signalling molecules in a 
microcystin producing cyanobacteria 
 
Objective 
1) To determine the effect of exogenously added microcystin-LR on 
the growth of M. aeruginosa PCC7806 
2) To determine if exogenously added microcystin-LR affects the 
production of secondary metabolites such as microcystin-LR, 
aerucyclamides and cyanopeptolins produced by M. aeruginosa 
PCC7806 
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4.3 Material and Methods 
4.3.1 Cultures  
 The cyanobacterium M. aeruginosa PCC7806 (Pasteur Culture 
Collection, Paris) was selected as it had several features that made it an 
ideal candidate for this study.  
 
4.3.2 Media and growth conditions 
 Media preparation and growth conditions were followed as 
described in section 2.2 and 2.3.  
 
 
4.3.3 Flow cytometry 
Cell counting in this study was performed using flowcytometer. The 
protocol used for cell counting was as described in section 2.6.2. 
 
4.3.4 Analytical methods (LC-MS analysis) 
 Analysis of secondary metabolites of M. aeruginosa PCC7806 was 
performed as described in section 2.8 
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4.3.5 Monitoring de-novo microcystin-LR production 
 Monitoring de-novo secondary metabolite production was carried 
out by providing 15N as the sole source of nitrogen. The principle behind 
this technique is described in section 2.2.1 
 
4.3.6 Experimental setup  
 The details of experimental setup were as described in section 
2.4.1. Briefly, M. aeruginosa PCC7806 was exposed to exogenously added 
purified microcystin-LR at concentrations of 0.1 µg/ml, 1 µg/ml and 10 
µg/ml. A control was also maintained without the addition of any 
exogenous microcystin-LR. The reason behind choosing high 
concentrations of microcystin was that during blooms collapse, high 
localised concentrations of microcystin-LR of up to 1500 µg/g dry weight 
of biomass has been reported [285]. It is thought that high 
concentrations of microcystins may trigger cellular survival mechanisms. 
Also, previous work in this field has used similar concentration of 
microcystins, to study its effects on other strains of Microcystis sp [185].  
 M. aeruginosa PCC7806 was grown in the presence of exogenously 
added microcystin-LR for a period of 35 days and samples were 
withdrawn once a week and analysed for cell numbers and de-novo 
secondary metabolites. As the doubling time for this organism is reported 
to be about 3 days, samples were withdrawn once per week in order to 
allow the cells to sufficiently multiply. Besides, many publications in this 
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field report samplings between 7 to 10 days [220, 221]. Also, 
withdrawing samples frequently would increase significant changes in the 
culture system while adding the risk of contamination.    
   
4.3.7 Data extraction and analysis of cell growth 
 The cells counts were obtained from the flow cytometer using the 
Expo32 ADC© software and MS-Excel software the final cell numbers 
were calculated considering the dilution factor. The protocol followed was 
as described in section 2.6.2 
 
4.3.8 UPLC Data extraction 
 Peak areas for the corresponding secondary metabolites were 
extracted using the MassLynx™™ application (Table 4.1) and the data 
entered into MS-Excel application. In MS-Excel, unknown concentration of 
the secondary metabolite was calculated by obtaining its peak area and 
comparing it to that of a known concentration of microcystin-LR in UV and 
MS mode. Statistical significance (P-values) was obtained using a one-
way Analysis of Variance (Anova) analysis. The Anova was chosen as it 
compares the mean of two groups and the resultant P-value gives an 
indication of the statistical significance between the groups. A P-value of 
less than 0.05 is considered statistically significant while a P-value greater 
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than 0.05 is statistically insignificant. A web based version of the Anova 
statistical software was used for the calculations [257].  
 
Table 4.1: The MS and UV values used for extraction of peak areas using 
MassLynx™ software for the different secondary metabolites 
 
Native De-novo 
 
MS UV MS UV 
microcystin-LR 996 238 1006 238 
Cyanopeptolin A 958 - 968 - 
Cyanopeptolin B 930 - 939 - 
Aerucyclamide A 535 - 541 - 
Aerucyclamide C 517 - 523 - 
Aerucyclamide D 587 - 593 - 
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4.4 Result  
 The hypothesis that microcystins may perform the role of a 
signalling molecule was proposed by Schatz et al. in 2007 [127]. Their 
research suggested that the presence of exogenous microcystin (and 
other secondary metabolites such as microginin or micropeptin) increased 
the intracellular concentrations of microcystin, indicating that the 
producing organism is also able to detect the presence of these 
metabolites and subsequently upregulate the production of intracellular 
microcystin. It has also been reported that the expression of NRPS/PKS 
genes involved in microcystin production occurred throughout the day-
night cycle [206] indicating that MC’s are produced continuously and may 
have an important purpose. A growth study between MC-producing and 
non-MC-producing strains revealed that the non-MC producing strain 
dominated the microcystin culture and it was thought that due to the high 
energy requirement of toxin production, the MC-producing strain could 
not compete with its mutant counterpart [258]. Hence it could be 
understood that a toxin producing organism diverts considerable amount 
of energy towards microcystin production. However, it also important to 
note that a biological or an allelochemical role for microcystin has not 
been convincingly proved [149].  
An experiment was designed in such a way that an organism that 
produces microcystin-LR would be exposed to 3 concentrations of 
microcystin-LR added exogenously. The growth of the organism would be 
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monitored for a period of 35 days with sampling once a week. Along with 
growth, the production of microcystin-LR would be monitored. The 
organism M. aeruginosa PCC7806 produces several other secondary 
metabolites (such as cyanopeptolins and aerucyclamides). Therefore, the 
production of these metabolites was also monitored. Hence a 
comprehensive picture of the effect of exogenous microcystin-LR on the 
growth and the secondary metabolite production of an organism would be 
explored against a control i.e., without addition of any exogenous 
microcystin-LR. All other experimental parameters such as temperature, 
light and nutrient concentration were comparable to that of the control. 
Exogenous microcystin-LR was added to the flasks at a final concentration 
of 0.1, 1 and 10 µg/ml 
 The fate of exogenously added microcystin-LR was also monitored 
throughout the duration of the experiment to determine if added 
microcystin-LR remained unaltered or if M. aeruginosa PCC7806 is able to 
assimilate it. The use of BG11-15N as the sole source of nitrogen enables 
us to differentiate the added microcystin-LR from the de-novo synthesised 
microcystin-LR. The mass spectrometric analysis of the exogenously 
added microcystin-LR revealed that the sample contained roughly 25% of 
demethylated microcystin-LR (Demethy-microcystin-LR, MW 982 Da) and 
75% methylated microcystin-LR (MW 996 Da). This would not affect the 
experimental setup but while determining the production of de-novo 
microcystin-LR, the sum of Demethy-microcystin-LR and microcystin was 
determined. Also, since a known concentration (50 µg/ml) of the same 
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microcystin-LR preparation was used to prepare standard dilution series, 
the peak area representing the concentration of the standard should also 
be obtained as m/z (982+996). The UV detector of the HPLC-MS detects 
microcystin-LR by its absorbance property at 238 nm and hence no 
adjustment is needed in order to quantify microcystin-LR by UV method. 
 
4.4.1 Analysis of the exogenously added microcystin-LR 
 It is generally accepted that microcystin-LR is a stable molecule 
and could persist in the environment for several days. It has been 
reported that microcystin-LR could withstand pH extremes and is stable at 
temperatures up to 300 °C [259]. In the environment, the half-life of 
microcystin-LR is thought to be about 10 weeks. However, in the absence 
of sunlight, microcystin-LR may remain stable for several months to years 
[260]. The use of labelled nitrogen (15N) in the media serves to accurately 
track the fate of exogenous added microcystin-LR as it is unlabelled while 
the de-novo produced microcystin-LR is labelled. Moreover, the 
intracellular as well as extracellular unlabelled microcystin-LR can be 
quantified independently to determine if there is any change in the 
distribution or location.   
The exogenous unlabelled microcystin-LR data (Figure 4.4) 
indicates that at lower concentrations, the concentration remained mostly 
unaltered for the duration of the assay (5 weeks).  Although the intended 
dosage was 0.1, 1 and 10 µg/ml the actual average concentration the 
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flasks had received were determined to be 0.1, 0.94 and 9.14 µg/ml. This 
could be due to the fact that purified microcystin-LR is poorly soluble in 
water and some loss may have occurred during the process of dissolving 
and filtration. The treatment that received 9.14 µg/ml microcystin-LR 
showed a 9.6% increase by week 2 and thereafter declined steadily with 
6.5 µg/ml (29% decrease) at week 5. Interestingly, this trend was not 
observed in the lower concentrations but the concentration seemed to be 
maintained although some variability could be seen. If it was assumed 
that the organism M. aeruginosa PCC7806 assimilated microcystin-LR or 
that the microcystin-LR has been degraded, then it would be expected the 
same trend would have been observed even in the lower concentration 
treatments as well. Further, with the help of the ex-novo i.e., unlabelled 
microcystin-LR data (Figure 4.5) it could be seen that the intracellular 
concentration of unlabelled microcystin-LR remains steady throughout the 
duration of the experiment. Hence it could be interpreted that the 
exogenously added microcystin-LR is not assimilated by M. aeruginosa 
PCC7806. The loss of microcystin-LR seen at higher exogenous 
concentration of microcystin-LR may be due to non-biological reasons 
such as aggregation or microcystin-LR binding to cell components and this 
going undetected. An interesting point to note here is that the quantity of 
intracellular ex-novo microcystin-LR remaining constant, even though the 
cells are actively dividing through week 1 to 3 then division is declining. It 
would be expected that the concentration of intracellular ex-novo 
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microcystin-LR decreases over time as it is known that microcystin-LR is 
produced during active growth and released during senescence. 
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Figure 4.4: The trend of exogenously added microcystin-LR (m/z 982+996) tracked for 5 weeks. Plot  A ) 
Control. B) 0.1 µg/ml exogenous microcystin-LR. C) 1 µg/ml exogenous microcystin-LR & D) 10 µg/ml 
exogenous microcystin-LR. Error bars=1SD, n=4. 
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4.4.2 Effect of exogenous microcystin on growth of M. aeruginosa 
PCC7806 
 The growth of M. aeruginosa PCC7806 was monitored using flow 
cytometry and in particular the cells appearing within the ‘live cells’ gate 
were considered for analysis purposes. As the experiment design had a 
control group that did not receive any exogenous microcystin-LR, the 
treatments were individually compared to the control at any given week, 
to determine the effect of exogenous microcystin-LR on the cell numbers.   
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 From the plot of live cells, it was evident that the log phase growth 
of M. aeruginosa PCC7806 was up to week 3 (Figure 4.6 and 4.6.1) and 
the stationary phase was between week 3 and week 4 after which cell 
numbers declined. In a recently published study, it has been reported that 
when a toxin producing Microcystis sp. was grown in BG11 containing 1.5 
g/L of sodium nitrate, the cell grow exponentially until day 9 and then 
remain stable until day 21 [261]. In a previous publication, it has been 
reported that the growth curve of M. aeruginosa PCC7806 showed 
logarithmic growth until day 10 followed by a stationary phase [262]. 
However, this data shows slower growth which could be a result of 
inoculum differences. An important observation here is that most 
publications denote the growth of the cells as either a quantification of 
 - 162 - 
 
Chl-a content, biomass (g/L) or haemocytometric method, while this 
method used flow cytometry and differentiated the live cells from the 
population. Estimation of chl-a requires multiple extraction steps and the 
measured optical density provides only a rough indication of the cell 
density and the health of the cells, while haemocytometry is a tedious 
process and cell counts may not be very accurate. Compared to the chl-a 
and haemocytometry, the protocol developed in the flow cytometer is 
rapid and cells are counted based on the principle of autoflourescence of 
chl-a. Hence only cells that emit a strong fluorescent signal will fall within 
the live cell gate and are enumerated as a live cell.  
Although the cells were exposed to exogenous microcystin-LR from 
day 0, an indication of the effect could only be observed at week 3. It is 
likely that during logarithmic growth, M. aeruginosa PCC7806 tolerates 
the presence of exogenous microcystin-LR. Between week 2 and week 3 
the treatments that received 1 and 10 µg/ml microcystin showed reduced 
growth (20% less) when compared to the control and the treatment that 
received 0.1 µg/ml microcystin. From week 4 onwards no active growth 
was seen and the cell numbers started to decline. In order to determine if 
the difference in cell numbers observed between the control and 
treatments was statistically significant, analysis was performed for 
individual weeks comparing the control to the treatments. The statistical 
analysis was performed excluding week 0 as all the flasks in this week 
received the same cell numbers during inoculation.  
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 At week 1, the P-value of the treatment 10 µg/ml indicated that 
their difference in cell numbers were significantly different from that of 
the control. However, an observation of the percentage variability of the 
cell number within the treatment showed that the difference was a mere 
6.8%. It should also be noted that the anova test compares the variability 
within the replicates of a sample set and compares that with the other. At 
week 1, the variability within the control was 1.7% only while the 
variability within treatments 0.1 µg/ml was 4.2%, 1 µg/ml was 9.7% and 
10 µg/ml was 6.8%. The treatment 10 µg/ml, although different from the 
control showed a small variability within the replicates and hence the 
statistical analysis indicates that the values are statistically significant 
from the control by virtue of its variability within the replicates. In the 
case of the treatment 1 µg/ml, the variability within the replicates was 
comparatively larger and hence the difference observed in respect to the 
control may not be significant. This fact is further confirmed by the P-
values seen at week 2 where none of the treatments were statistically 
different from the control. Hence it could be inferred that            M. 
aeruginosa PCC7806 tolerates exogenous microcystin-LR concentration of 
up to 10 µg/ml while actively growing. In an earlier report, it was found 
that a Microcystis bloom might secrete up to 5 ng/ml of microcystins into 
the water system [214] while other reports suggest that microcystin 
concentrations can vary between 5 to 43 ng/ml [39].  Higher 
concentrations reported were between 1.3 to 1.8 µg/ml [264] where the 
cells had been exposed to algicide treatment. In a broad sense, it could 
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be stated that MC-producing Microcystis cells are always exposed to some 
exogenous microcystins but in varying concentrations and seemed to 
survive and reinoculate the waters system when conditions turn 
favourable. From this study, it could be stated that M. aeruginosa 
PCC7806 are able to tolerate exogenous microcystin-LR up to 0.1 µg/ml 
(i.e., 100 µg/L) and higher concentrations may negatively affect cell 
division. It should also be noted that the cells need not be in an actively 
growing state in order to tolerate this concentration of microcystin-LR.   
 In an incubation period of 35 days, week 3 seems to be the peak of 
cell density following which the cell numbers begin to decline. However it 
should be noted that this observation may be applicable only when the M. 
aeruginosa PCC7806 is grown in BG11 media containing 1.5 g/L of sodium 
nitrate and a static culture system. From the growth curve plot, it could 
be seen that week 3 was also the end of log phase growth for all the 
treatments. Further, it is also observed that the presence of 0.1 µg/ml 
microcystin-LR is in fact mildly favourable to the growth of M. aeruginosa 
PCC7806 although not found to be statistically significant. This has been 
observed by a previous work which reported an 18% increase in cell 
numbers [265] in the presence of exogenous microcystin-LR. However, in 
the present study, only a 2 to 8% increase in cell numbers could be 
observed between the control and the 0.1 µg/ml treatment. The 
difference may be due to cell counting procedures which in this case used 
flow cytometer and live and dead cells could be differentiated. Taken 
together, it is clearly evident that presence of low concentrations of 
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exogenous microcystin-LR is mildly beneficial for the host and in 
ecological scenarios, this may confer an advantage towards species 
survival irrespective of the growth phase of the host organism [266].  
 Treatment with 1 µg/ml showed significant decrease in cell 
numbers when compared to the control at week 3. As this difference was 
not observed in week 2, it could be concluded that under certain 
conditions (such as nutrient limitation, accumulation of metabolic by-
products), microcystin-LR concentration of higher than 0.1 µg/ml 
negatively affects the growth of M. aeruginosa PCC7806. This trend was 
also observed at week 4 and 5, although not statistically significant. As 
evident from the growth curve plot, at week 4 and 5 there are factors 
which affect the growth of cells even in the control. This may also have 
introduced large variability within the control and hence when this is 
compared to the treatment, the difference is not statistically significant.  
 The treatment 10 µg/ml showed significant decrease in cell 
numbers from week 3 to week 5 when compared to the control. Unlike 
the 1 µg/ml treatment, the difference was not transient and hence it 
could be confirmed that under static culture conditions, microcystin-LR 
concentrations of above 1 µg/ml may affect cell division while a 
microcystin-LR concentration of above 10 µg/ml strongly inhibits cell 
division and or survival. It remains to be determined as to how 
microcystin-LR brings about this affect and if the same effects could be 
observed in a continuous culture system.  
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 The use of flow cytometer was primarily to enumerate cells and to 
some extent differentiate between live and dead cells (events that fall out 
of the live cells gate in the flow cytometer). When the growth curve of the 
live cells was interpreted along with the dead cells, it was observed that 
there was no significant difference between the control and the 
treatments in any given week (figure 4.6.2).  
 
 
A statistical analysis of the dead cells would be erroneous as the 
events appearing within the dead cell gate may represent anything 
between an empty cell wall, disintegrating cell debris or a whole cell with 
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little Chl-a fluorescence. It may be worthwhile to adjust the dead cell gate 
to capture only events with a higher signal strength and observe 
differences. However, with the present data, it could be concluded that 
the presence of even a high concentration of microcystin-LR (10 mg/L) 
does not significantly increase cells death of the host organism. Taken 
together, it appears that microcystin-LR does not induce cell death but 
inhibits cell division. Ecologically such a scenario might occur during 
bloom senescence; however the cells may never be exposed to such 
concentrations. The rapidly growing cells utilize the available nutrients 
and may reach a stationary phase of growth. The presence of the 
produced microcystin-LR in their immediate surrounding (assuming low 
turbulence) may signal the organism to further decrease cell division and 
prolong generation time. In this way, species survival might be 
guaranteed for long periods of stress.  
In order to confirm if exogenous microcystin-LR increases the 
generation time the live cell population alone was considered and 
generation time calculated. It revealed that during mid-log growth, the 
generation time of M. aeruginosa PCC7806 was about 3 days (Table 4.3). 
In some studies, it was reported that the generation time of Microcystis 
sp. is between 1.24 to 1.7 days [155, 267, 268]. However, other studies 
report a doubling time of 3.25 days [269]. Hence it could be stated that 
the generation time of M. aeruginosa may vary between 1.24 to 3.25 
days depending on conditions of light, temperature, aeration, irradiation 
and nutrients.  
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During late exponential growth, the generation time of M. 
aeruginosa PCC7806 had extended to 9 days (3 folds) and it is 
understood that nutrients limitation could have been one of the factors. 
This increase of generation time was further exacerbated with the 
presence of microcystin-LR where the extension of generation time was 
proportional to the microcystin-LR concentration. Interestingly, the 
presence of 0.1 µg/ml microcystin-LR seemed to mildly decrease the 
generation time, however, as the difference was a mere 3%, it’s not 
considered a significant effect. For the treatment that received 1 µg/ml 
microcystin-LR, the generation time had extended to 15.3 days while the 
highest concentration tested i.e., 10 µg/ml, the generation time was 
extended to 22.48 days (2.5 fold compared to the Wk 3 control). The 
generation time was extrapolated beyond 3 weeks and it was surprising 
to note that the generation time for the treatments that received 1 µg/ml 
and above microcystin-LR was beyond and considerably longer (around 
120 days). However, as the formula used to calculate the generation time 
requires that the cells be in their logarithmic growth phase, and hence the 
value obtained beyond week 3 may be an artefact.  
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Table 4.3: The calculated doubling time (in days) of M. aeruginosa 
PCC7806 
  Wk 1 Wk 2 Wk 3 Wk 4 Wk 5 
Control 3.94 2.99 9.08 - - 
0.1 µg/ml microcystin-LR 3.83 3.12 8.80 - - 
1 µg/ml microcystin-LR 3.76 3.14 15.33 - - 
10 µg/ml microcystin-LR 3.63 3.20 22.48 - - 
 
 The fact that the presence of microcystin-LR does not significantly 
induce cell death is interesting to note as it confirms that microcystin-LR 
is not toxic to the producing organism even at very high concentrations. 
In that case, the question remains as to how microcystin-LR extends 
generation time significantly. One possibility may be that microcystin-LR 
may bind to metal ions and make them unavailable for the host. Another 
possibility is that microcystin-LR is known to bind to intracellular proteins 
and localised within thylakoids. As thylakoids are centres of respiration, 
the overabundance of microcystin-LR might interfere with the cells 
respiration and hence slow cell growth. A recent report found that 
microcystin-LR is localised within the thylakoid membrane causing a 
decrease in photosystem II activity without any negative effects on the 
cell survival [270]. 
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4.4.3 Effect of exogenous microcystin-LR on production of 
Microcystin 
 The effect of exogenous microcystin-LR on M. aeruginosa PCC7806 
was studied with a view to understanding if there are any effect seen at 
the cellular as well as molecular level. The production of microcystin can 
be considered as a reflection of the metabolic state of the organism and if 
any changes are seen, it would indicate that exogenous microcystin has 
an effect on the producing organism at a molecular level. Also, as this 
organism produces several other secondary metabolites, a comprehensive 
analysis of the other metabolites such as aerucyclamides and 
cyanopeptolins would indicate if the effect occurs at multiple levels.  
 The de-novo microcystin was quantified by obtaining the peak 
areas for the mass m/z 1006+992 i.e., the methylated microcystin 
(microcystin-LR) as well as the demethylated-MC (Demethy-microcystin-
LR). It was thought that M. aeruginosa produced about 90% methylated 
microcystin-LR and 10% Demethy-microcystin-LR [271]. However, the 
PCC7806 culture used in this work was seen to produce significantly 
higher quantities of Demethy-microcystin-LR i.e., of the total amount of 
de-novo microcystin produced, Demethy-microcystin-LR ranged between 
45 to 55% (Figure 4.7, 4.8). It was also observed that the control and 0.1 
µg/ml treatment produced equal or slightly lower Demethy-microcystin-
LR (10% less) than microcystin-LR, whereas the treatments that received 
1 and 10 µg/ml microcystin-LR produced about 15% higher Demethy-
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microcystin-LR (Figure 4.8). It is unusual that PCC7806 produces more 
than 10% of demethylated microcystin and it may be explained by the 
culture being maintained under low light for several years. However, 
confirmatory evidence is not available at this time. 
 
Figure 4.7: Intracellular ESI-MS ions of m/z 992 (Demethy-microcystin-
LR) and 1006 (microcystin-LR) as seen in the control at week 3 
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Statistical analysis was performed between the two microcystin 
variants at week 3 and it appeared that the presence of exogenous 
microcystin-LR of 1 µg/ml or higher, the ratio of Demethy-microcystin-LR 
to microcystin-LR was significantly higher. It remains to be explored if the 
effect seen was indeed from the exogenous microcystin-LR. As the M. 
aeruginosa PCC7806 produces methylated as well demethylated 
microcystin in abundance, the quantification of microcystin was performed 
by adding the quantities of both the isomers to give an account of the 
total de-novo microcystin produced. At week 0, as one would expect no 
traces of de-novo microcystin were seen whereas by week 1, the 
intracellular microcystin content had reached to 0.33 ± 0.07 µg/ml. Even 
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at week 1, the effect of exogenous microcystin-LR was detectable and at 
concentrations higher than 0.1 µg/ml seemed to inhibit the synthesis of 
de-novo microcystin (Figure 4.9).  
 
 Statistical analysis of the intracellular de-novo microcystin content 
revealed a very interesting picture. The treatment with exogenous 
microcystin-LR at 0.1 µg/ml showed similar intracellular concentrations to 
that of the control throughout the experiment. The treatment with 
exogenous microcystin-LR at 1 µg/ml showed significant difference 
beginning week 2 and continuing until week 4. The treatment with 
exogenous microcystin-LR at 10 µg/ml showed significant difference with 
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respect to the control for the entire 5 weeks. Collectively, it appears that 
the presence of exogenous microcystin-LR beyond 0.1 µg/ml may inhibit 
microcystin biosynthesis. It should be noted that the cell numbers did not 
mirror this effect and until week 3, no significant differences could be 
noticed (Figure 4.9). This data contradicts the results of Schatz et al. 
(127) wherein they report that the presence of exogenous microcystin-LR 
enhances the intracellular microcystin production. The differences may be 
due to the concentrations of microcystin-LR they had used (10 - 50 
ng/ml), while in this study concentrations ranged from 100 ng/ml to 10 
µg/ml. Also, the method of quantification used here is very sensitive 
compared to using antimicrocystin-LR antibodies. Although the results 
presented here contradicts the published data, it should be noted that the 
treatment that received 0.1 µg/ml did show some positive effect on the 
microcystin content. They also state that exposing cells to greater than 10 
ng/ml of microcystin has no additional effect on microcystin production, 
however, the present data shows that at higher concentrations, cell 
numbers as well as intracellular microcystin content are reduced.  
However, a dose dependent correlation could not be established but 
overall, the treatment 1 µg/ml showed a 25% reduction (average for 5 
weeks) while the 10 µg/ml treatment showed a 37.7% reduction.  
 It has also been reported that presence of exogenous microcystin-
LR is known to induce morphological and physiological changes such as 
cell aggregation, cell volume increase as well as increase in cell 
pigmentation [272]. However, these parameters were not measured in 
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this assay, but it could be stated with some confidence that the flasks 
that received exogenous microcystin-LR did not show any changes in 
aggregation compared to the control. It may also have been because the 
flasks were mixed once a day to enable homogenous cell distribution and 
even light penetration.  
 In order to confirm that the intracellular microcystin synthesis had 
indeed reduced, the de-novo microcystin content was divided by the cell 
number (live) such that an indication of the production per cell could be 
obtained. Here, the calculations are done with the assumption that the 
live cells retain most of the microcystin produced whereas the aged cells 
would have leaked their intracellular content [273]. It was calculated that 
the average microcystin quota (for control) was 33.8 (± 2.2) femtograms 
(fg) of microcystin per cell and this rate remained constant for the 
duration of 5 weeks (Figure 4.10). In literature, it has been reported that 
the intracellular microcystin-LR quota for M. aeruginosa PCC7806 ranges 
between 35 to 51 fg per cell [221, 94]. It was encouraging to note that 
the values observed correlated well within the range of reported values.  
 - 176 - 
 
 
 At week 1, the effect of exogenous microcystin-LR was most 
pronounced compared to any other week followed by week 2. Comparing 
week 1, 2 and 3 it could be that the cells exposed to 1 and 10 µg/ml 
microcystin-LR were actively adapting themselves to the new 
environment and by week 3 their intracellular toxin level was comparable 
to that of the control. It should be noted that the cultures were exposed 
to the exogenous microcystin-LR throughout the assay and the question 
of how the cells are able to almost fully recover microcystin production at 
a later stage arises. It is well known that microcystin-LR biosynthesis is 
an enzymatic process involving a system of NRPS/PKS enzymes [176]. 
Hence, if even one of the enzymes in the biosynthetic pathway is inhibited 
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(or its production reduced), the production of microcystin-LR would suffer 
initially but should be able to recover with time, as characteristic of an 
enzymatic reaction.  As the experimental design did not accommodate to 
monitor this fact, at this stage it could only be hypothesised that an 
enzyme is being inhibited by the exogenous microcystin-LR and this is 
reflected in the production rate.  
Beyond week 3, the intracellular toxin production was affected, 
however, only the 10 µg/ml treatment showed a significant reduction 
compared to its control. The average intracellular toxin production was 
calculated in order to determine if there was any net reduction on the 
intracellular toxin production [Figure 4.11]. Comparing to the control, the 
treatment 0.1 µg/ml did not show much significant difference but it also 
revealed that the treatments 1 µg/ml (P=0.02) and 10 µg/ml (P=0.02) 
were significantly different from the control. As the cell numbers have 
also been accounted for in this calculation, it appears that the exogenous 
microcystin-LR has had some effect on the toxins production. This 
confirms that the presence of exogenous microcystin-LR inhibits the 
production of de-novo MC, however the effect is not concentration 
dependent i.e., lower concentrations (0.1 µg/ml) may mildly stimulate 
microcystin-LR synthesis whereas higher concentrations inhibit synthesis 
in a dose independent manner. Such a finding has also been reported 
previously [127] where they claim that exogenous microcystin-LR 
concentrations above 50 ng/ml had little effect on the toxin biosynthesis 
and as the culture aged, the response was diminished. 
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 An attempt was made to calculate the microcystin production rate 
i.e., intracellular production of de-novo microcystin-LR per cell per day 
(Figure 4.12). The weeks 0, 4 and 5 were not considered in the 
calculation as at week 0 no de-novo microcystin-LR was detected and at 
weeks 4 and 5, the net production was negative compared to the previous 
week. The reason that no net increase can be seen in the intracellular 
microcystin may be due to culture aging and causing the cells to leak 
their intracellular contents.  
 Between week 0 and 1, the control seemed to be producing 
microcystin at a rate of 7.4 ± 1.4 fg/cell/day. Compared to the control, 
the treatment 0.1 µg/ml showed about 8% increase whereas the 
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treatments 1 and 10 µg/ml showed a 36% and 68% decrease in 
production respectively. By week 2, the control and the 0.1 µg/ml 
treatment seemed to have reduced its production rate by about 40% 
when compared to week 1, and is maintained at the same rate by week 3. 
It is interesting to note during mid-log growth, the microcystin production 
rate has actually reduced while in literature it is reported that the 
production rate linearly correlates with specific growth rate [100, 97]. 
However, there are major differences in cell enumeration and 
microcystin-LR quantification between the published work and 
methodology applied here. In this work, cell numeration was using flow 
cytometry and microcystin quantification was highly sophisticated 
(considering only de-novo MC) whereas in the published work, cell 
counting was either by microscopy or by dry weight and microcystin 
detection was by the PDA detection system monitoring only the total 
microcystin pool at a given time point. Also, in terms of culture 
conditions, their work was in nitrogen deplete conditions (0.2 mM NaNO3) 
whereas this work was in nitrogen replete (17.65 mM NaNO3) conditions. 
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 Between week 1 and 2, the treatments 1 and 10 µg/ml were again 
seen to be reduced compared to the control while at week 3, their 
intracellular production was significantly higher than the control. 
However, when the sum of the de-novo production for the three weeks 
was calculated it revealed that the net production was about 16.8 fg with 
about 5% difference among the control and treatments. Hence, it may 
only be concluded that although the presence of exogenous microcystin-
LR may seem to have an influence on the microcystin-LR production 
initially, in the long run, the net production reaches levels comparable to 
the control. It may be speculated that as microcystin-LR biosynthesis is 
an enzymatic process, the observations made herein are only transient 
reflections of the intracellular molecular events and in order to 
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conclusively determine the effect of exogenous microcystin-LR (on 
intracellular microcystin-LR), further experiments which precisely monitor 
growth parameters are required.  
The organism M. aeruginosa PCC7806 is known to secrete 
microcystin into the ecosystem during late log and stationary phase of its 
growth cycle [274]. A graph of the extracellular microcystin (m/z 
992+1006) excluding the exogenously added microcystin-LR (m/z 
996+982) was plotted and it was evident that there was an unusually 
high amount of microcystin-LR present (Figure 4.13) compared to 
reported values. It has been reported that for PCC7806, the amount of 
extracellular microcystin-LR would range between 10 to 16% [221]. In 
another report, it has been reported that the extracellular microcystin-LR 
would amount to 7% of the total microcystin-LR produced at day 20 
[214]. However, in this case at day 21, the extracellular microcystin-LR 
amounted to 26% of the total microcystin-LR at that time point. The 
reason for unusually high amounts of extracellular microcystin-LR could 
not be explained, however, it is speculated that changes in light intensity 
from 5 to 20 µmol/m2/s as well as replete nitrogen conditions might have 
caused the cells to release higher microcystin into the extracellular. This 
could also serve as an indication that replete nitrogen conditions (such as 
in eutrophic lakes) may cause pronounced microcystin release into water 
bodies. Such a phenomenon has been previously reported by Weidner et 
al. [94] where they report a 20 fold increase in extracellular microcystin-
LR when the light intensity changed from 10 to 40 µmol/m2/s. However 
 - 182 - 
 
they still report that at any time point the extracellular microcystin-LR 
was only about 2.47% of the total microcystin-LR. 
 The percentage of extracellular microcystin to that of the total 
microcystin (Intra + Extra (m/z 992+1006)) was calculated and it was 
noticed that the extracellular microcystin content increased progressively 
with time. If it were suspected that the presence of exogenous 
microcystin-LR may have induced the release, it could be seen that the 
extracellular microcystin data for the control as well as the treatment did 
not show any pattern in relation to the concentration of exogenous 
microcystin-LR. As the methodology employed specifically differentiates 
between exogenously added and secreted de-novo microcystin-LR, it can 
be confirmed that exogenous microcystin-LR did not have a pronounced 
effect on the secretion of intracellular MC.  
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4.4.4 The effect of exogenous microcystin-LR on cyanopeptolin 
and aerucyclamides 
 The organism M. aeruginosa PCC7806 produces several variants of 
cyanopeptolins such as A, B, C and D (Table 4.4), however, not all of 
them have been chemically characterised (275, 201). Cyanopeptolins are 
depsipeptides, possessing structures consisting of cyclic L-glutamic acid- 
γ -aldehyde, L-leucine, N-methyl-phenylalanine, L-valine, L-threonine, L-
aspartic acid, hexanoic acid and a variable basic amino acid. This variable 
amino acid can be L-arginine (cyanopeptolin A), L-lysine (cyanopeptolin 
B), N-methyl-L-lysine (cyanopeptolin C) and N/N dimethyl-L-lysine 
(cyanopeptolin D), respectively. The L-glutamic acid- γ -aldehyde and the 
amino group of L-leucine form an unusual 3-amino-6-hydroxy-2-oxo-l-
piperidine system. With the use of HPLC-MS, these compounds were 
separated and their respective peak areas were obtained using the 
MassLynx™™ software. However, as only a cyanopeptolin A standard was 
available, the quantification of only cyanopeptolin A was performed while 
the peak area of cyanopeptolin B is shown as an example.  
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Table 4.4: The mass of compounds of M. aeruginosa PCC7806 when 
grown in BG11 (14N) and BG11 (15N) 
Compound 
m/z in BG11 
(14N) 
m/z in BG11 
(15N) 
cyanopeptolin A 958 968 
cyanopeptolin B 930 938 
cyanopeptolin C 944 952 
cyanopeptolin D 958 966 
cyanopeptolin 970 972 982 
cyanopeptolin 963 A 963 971 
Note – Cyanopeptolin A and D have the same molar mass but differ by 
one amino acid i.e, cyanopeptolin A has L-arginine while cyanopeptolin D 
has Nε,Nε-Dimethyl-L-lysine. 
The effect of exogenous microcystin-LR on the production of 
cyanopeptolin A was evaluated. In order to quantify cyanopeptolin A, a 
standard curve of the respective peptide was plotted taking known 
concentration of the purified peptide (Figure 4.14). From this standard 
curve, a line equation was obtained and using this equation, the unknown 
concentration of the sample was determined (Figure 4.15). 
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The intracellular de-novo cyanopeptolin A concentration increased 
until week 3, following which there was a decline (Figure 4.15). This 
superimposed with the cell number data seen during this period, could 
indicate that cyanopeptolin biosynthesis follows the growth curve. An 
exogenous microcystin-LR concentration of 0.1 µg/ml did not show any 
significant inhibition for the duration of the experiment except on week 3. 
However, an exogenous microcystin-LR concentration of 10 µg/ml showed 
significantly lower concentration of intracellular cyanopeptolin A 
throughout the duration of the experiment. The treatment that received 1 
µg/ml exogenous microcystin-LR showed significant differences at week 
2, 3 and 4. It was clearly evident that the presence of a high 
concentration of exogenous microcystin-LR negatively affected the 
intracellular concentration of the metabolite, however, it could not be 
concluded as to how this inhibition was brought about. It is also 
interesting to note that even though the cells continue to divide after 
three weeks, the intracellular cyanopeptolin content decreased similar to 
the ‘live cell’ numbers. This could indicate that the cells were becoming 
aged and leaking their intracellular contents. 
Statistical analysis revealed that the presence of exogenous 
microcystin-LR significantly reduces the cyanopeptolin-A content and this 
effect was non-linearly proportional to the concentration of exogenous 
microcystin-LR of above 0.1 µg/ml. The 0.1 µg/ml treatment showed 
comparable or slightly higher concentration of intracellular cyanopeptolin, 
however, not significant.  However, it should be noted that, as in the 
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earlier case, this reduction or increase seen could be due to the cell 
numbers and may not indicate actual reduction in total cyanopeptolin per 
cell. The higher treatments 1 and 10 µg/ml showed significant reductions 
and in particular the 10 µg/ml treatment showed significant reduction all 
through the five weeks of the assay. When compared to the intracellular 
de-novo microcystin-LR production, it was observed that both these 
metabolites followed a similar trend. This could be taken as an indication 
that exogenous microcystin-LR has no specific influence on any of these 
metabolites and may be affecting this change at a higher point in their 
biosynthetic pathway. It remains to be explored if the reduction seen is a 
result of microcystin-LR binding to a specific substrate or a particular 
enzyme or if it is a net non-specific effect of the high concentration of 
exogenous microcystin-LR.  
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The extracellular de-novo cyanopeptolin A was also tracked for 5 
weeks and it was evident that the extracellular concentration did not tally 
with the intracellular production/release which had occurred between 
week 3 to 5 (Figure 4.16). This may well indicate that cyanopeptolins are 
unstable molecules exogenously or it may well be that M. aeruginosa 
PCC7806 may be causing the degradation. This needs to be further 
investigated. Another observation was that the presence of exogenous 
microcystin-LR does not seem to trigger the release of intracellular 
cyanopeptolins when the cells are in log phase, but may have contributed 
to its release as the cells aged. 
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The extracellular cyanopeptolin concentration (Figure 4.16) was 
also analysed for statistical significance and it appeared that the 
treatment 0.1 µg/ml had no effect on the release of cyanopeptolin from 
within the cells. The 1 µg/ml treatment had significant effect on the 
release of intracellular cyanopeptolin starting from week 3 onwards, 
however at week 5 the variability of the replicates within the control was 
high and hence nothing significant could be seen. From the growth curve 
of M. aeruginosa PCC7806 (Figure 4.6), it could be deduced that week 3 
indicates the end of log phase growth followed by stationary growth until 
week 4 and cells death occurring thereafter. In treatment 10 µg/ml, the 
effect is seen to start as early as week 2 and continues throughout the 
duration of the experiment. The contradiction at week 4 could be due to 
high variability within the replicates of the 10 µg/ml treatment.  
 A comparison between the intracellular and the extracellular 
cyanopeptolin levels revealed that, unlike microcystin-LR, the percentage 
of the extracellular cyanopeptolin to the total content was only about 6% 
until week three after which the cells seemed to release higher amounts. 
Compared to microcystin-LR, it may be the differences in their relative 
structure or their hydrophobicity coupled with the activity of their 
respective transport proteins causing the differences in release (276).   
Considering the intracellular de-novo cyanopeptolin concentration 
and the live cell numbers, the production rate was calculated i.e., the 
production per cell per day was calculated (Figure 4.17). It was calculated 
 - 190 - 
 
that the M. aeruginosa PCC7806 produces cyanopeptolin A at the rate of 4 
± 2.98 fg/cell/day during its logarithmic growth phase. It is thought that 
this is the first report where production rate of cyanopeptolin A has been 
reported. One way Anova statistical analysis was performed on the 
production rate data and it revealed that although some significant 
differences were observed sporadically, a consistent pattern could not be 
observed. Hence it may be concluded that the presence of exogenous 
microcystin-LR inhibits the growth of M. aeruginosa PCC7806 which in 
turn inhibits intracellular metabolite synthesis. However, it is beyond the 
scope of this experiment to determine how microcystin-LR inhibits cell 
growth or any of its secondary metabolites. This should be investigated 
further and it may even reveal an intracellular binding site for 
microcystin-LR. 
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 M. aeruginosa PCC7806 also produces cyanopeptolin B, about 25% 
to that of cyanopeptolin A. Its intracellular de-novo cyanopeptolin B 
concentration could be detected using HPLC-MS, however, extracellular 
concentration was seen to be too low for detection using this system. A 
quantification of cyanopeptolin B could not be performed due to non-
availability of purified standards and hence only the peak areas have been 
reported so as to give an indication of its intracellular concentrations 
(Figure 4.18). 
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 In comparison to cyanopeptolin A, cyanopeptolin B also showed 
similar intracellular production ratios and hence its behaviour in response 
to exogenous microcystin-LR also closely resembled that of cyanopeptolin 
A. In a report by Tonk et al. [277], it is shown that at 20 °C, M. 
aeruginosa PCC7806 produced about 10% cyanopeptolin A when 
compared to microcystin-LR. However, in this study, it is seen that 
cyanopeptolin A is about 50% compared to that of microcystin-LR. This 
was also the case in the treatments 0.1, 1 and 10 µg/ml exogenous 
microcystin-LR and hence it is concluded that the presence of exogenous 
microcystin-LR does not significantly affect the production ratios of 
cyanopeptolins to microcystin-LR. It is thought that differences between 
the literature reported and observed values may be due to the different 
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media used. Although several publications have reported the isolation and 
characterization of cyanopeptolins [201, 164, 283], no literature on the 
production dynamics of cyanopeptolins by Microcystis sp. (or any other 
cyanobacteria) could be found. A report by Uwe et al., estimates that 
cyanopeptolins may amount to roughly 0.1% of the dry weight of a 
bloom. However, the authors declare that since a purified standard was 
not available, their estimates may be inaccurate. In fact, they also add 
that their estimation was based on comparison with a microcystin 
standard in the UV mode at 225 nm absorption [284].  
 The organism M. aeruginosa PCC7806 also produces 
aerucyclamides A – D [162, 90] which were first identified in 2008 (Table 
4.5). Unlike microcystins, aerucyclamides are thought to be synthesised 
ribosomally and usually contain at least one sulphur atom. Furthermore, 
all the aerucyclamides contains just 6 nitrogen atoms. The function of 
aerucyclamides is still being investigated, however, potential commercial 
uses for aerucyclamides as antiplasmodial as well as antitrypanosomal 
agents have been demonstrated [278].  
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Table 4.5: The mass of aerucyclamides of M. aeruginosa PCC7806 when 
grown in BG11 (14N) and BG11 (15N) 
Compound 
m/z in BG11 
(14N) 
m/z in BG11 
(15N) 
aerucyclamide A 535 541 
aerucyclamide B 533 539 
aerucyclamide C 517 523 
aerucyclamide D 587 593 
 
 In order to quantify aerucyclamides, a standard curve was drawn 
using known concentrations of purified aerucyclamide A taking the 
concentration on x axis and peak area on y axis (Figure 4.19).  
 
Figure 4.19: Standard curve of aerucyclamide A (m/z 535) as measured 
using HPLC-MS/MS. Purified aerucyclamide A was taken in 80 % methanol 
in concentrations of 0.1, 1 and 10 µg/ml. Error bars = 1 SD and n = 4 
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   The concentration of the intracellular and extracellular de-novo 
aerucyclamide-A was deduced using the line equation derived from the 
standard curve. The graph revealed that the intracellular aerucyclamide 
concentration was inhibited by exogenous microcystin-LR concentrations 
higher than 1 µg/ml while concentrations of up to 0.1 µg/ml had no 
observable effect (Figure 4.20). Here again, the pattern of synthesis 
closely followed the growth curve i.e., increased production until week 3, 
following which the net production reduced. Statistical analysis was 
performed on each week comparing the 3 treatments individually to the 
control. The analysis revealed that the presence of up to 0.1 µg/ml 
microcystin-LR did not have any significant effect on the intracellular 
aerucyclamide concentration while concentrations higher than 1 µg/ml 
demonstrated significant effect. A key observation here is that, although 
aerucyclamide biosynthesis is different i.e., ribosomal instead of non-
ribosomal, its pattern of biosynthesis as well as response to exogenous 
microcystin-LR remains similar to the other metabolites. 
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 Statistical analysis was also performed on the quantities of 
extracellular aerucyclamide-A and it appeared that the presence of up to 
1 µg/ml exogenous microcystin-LR did not have any significant effect on 
the release of intracellular aerucyclamide. Whereas, an exogenous 
microcystin-LR concentration of above 1 µg/ml may have a significant 
effect on the release of intracellular aerucyclamides and this effect could 
be seen as early as from week 2 onwards. However, when comparing the 
percentage extracellular to the total aerucyclamide, it revealed that the 
presence of exogenous microcystin-LR had no net effect on the release or 
intracellular aerucyclamides (Table 4.6).  
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Table 4.6: The percentage of extracellular aerucyclamide A to the total 
pool. Paired t-test was performed between the control and the three 
treatments for 5 weeks 
 % Extra Wk 1 Wk 2 Wk 3 Wk 4 Wk 5 P-value 
Control 12.89 21.21 31.21 57.58 73.04 ND 
0.1 µg/ml 14.19 25.10 34.62 57.24 72.29 0.188 
1 µg/ml 15.07 21.52 39.08 63.29 72.34 0.1314 
10 µg/ml 16.33 20.01 33.03 60.98 76.72 0.0723 
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 The production rate of intracellular aerucyclamide A was calculated 
(Figure 4.22) and the overall rate of aerucyclamide A was 2.24 ± 0.46 
fg/cell/day. It also revealed that the presence of exogenous microcystin-
LR may inhibit the intracellular aerucyclamide A production at least when 
the microcystin-LR concentration is as high as 10 µg/ml. The discrepancy 
seen at week 3 may be explained by the decrease in cell numbers at that 
week when compared to the control.  
Aerucyclamide B is an oxidative derivative of aerucyclamide A with 
a difference of just 2 hydrogen atoms [162] and amounting to just 8% of 
aerucyclamide A. However, aerucyclamide C and D were only 35% and 
28% to that of aerucyclamide A.  Even in the presence of exogenous 
microcystin-LR, the production ratios remained unchanged i.e., 
exogenous microcystin-LR had no specific effect on the production of any 
of these metabolites. It should be noted that the quantification of 
aerucyclamide B and C could not be performed, however, a purified 
standard for aerucyclamide D was available and this peptide was 
quantified. The intracellular de-novo aerucyclamide D profile revealed that 
exogenous microcystin-LR concentrations of above 1 µg/ml were 
inhibitory to the synthesis of intracellular aerucyclamide D (Figure 4.24). 
Again, the overall intracellular aerucyclamide D profile followed the 
growth curve of the organism. 
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Figure 4.23: Standard curve of aerucyclamide D (m/z 587) measured 
using HPLC-MS/MS. Purified aerucyclamide D was taken in 80 % 
methanol in concentrations of 0.1, 1 10 and 25 µg/ml. Error bars = 1 SD 
and n = 4 
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It was also noted that the concentrations of aerucyclamide D and A 
were similar to each other i.e 1.1 µg/ml at week 3 and hence it may be 
concluded that M. aeruginosa PCC7806 produces aerucyclamides A & D in 
similar concentrations. However, the extracellular aerucyclamide D profile 
was unlike that of aerucyclamide A but closely resembled the pattern of 
cyanopeptolins i.e it seemed that aerucyclamide D was stable 
intracellularly whereas unstable exogenously (Figure 4.25). 
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 Considering the intracellular de-novo aerucyclamide D and the live 
cell numbers, the production rate of aerucyclamide D was calculated. It 
was estimated that M. aeruginosa PCC7806 produces aerucyclamide D at 
the rate of 2.03 ± 0.77 fg/cell/day. The production also revealed that 
presence of exogenous microcystin-LR may significantly inhibit the 
biosynthesis of aerucyclamide D (Figure 4.26). The ambiguity observed at 
week 3 may merely be due to the effect of the decline in cell numbers of 
the treatments when compared to the control. 
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An interesting observation was made when the percentage of 
extracellular metabolite to that of the intracellular metabolite was 
calculated. At week 5, cyanopeptolin A and aerucyclamide D were the two 
metabolites whose extracellular concentrations were about 39% and 53% 
of their respective intracellular concentrations. The other metabolites such 
as microcystin-LR, aerucyclamide A, B and C were higher than their 
respective intracellular concentrations i.e., 176%, 272%, 158% and 
142% respectively.  From this, it could be concluded that microcystin-LR, 
aerucyclamides A, B and C are not assimilated or degraded by M. 
aeruginosa PCC7806, however, contrary to the belief that these are (at 
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least microcystin-LR) predominately intracellularly stored molecules a 
significant quantity of these metabolites are released to the extracellular 
environment. The cyanopeptolins A, B and aerucyclamide D, although 
their extracellular concentration is about 50% that of their intracellular 
content at week 5, the question arises as to what would have happened 
to the quantities produced during the previous weeks. It may be that 
these metabolites are stable when inside the cell, but once secreted are 
unstable or may have been degraded. 
 Aerucyclamides are relatively newly characterised 
compounds and very little data is available on their production dynamics. 
The interest in aerucyclamides is increasing as they have potential 
application (or at least their derivatives) as antimalarial compounds 
[278]. Also, as aerucyclamides are ribosomally synthesised compounds 
and their gene sequence recently elucidated, they may be useful in 
studying cyanobacteria at the transcriptional level [209]. In this view, the 
findings of this study may serve as a measure of aerucyclamide A and D 
production rate under optimal conditions, from which efficiency of 
genetically modified clones could be ascertained. 
 
 
 205 
 
Figure 4.27: The concentrations of extracellular de-novo aerucyclamides A (m/z 541), B 
(m/z 539), C (m/z 523) and D (m/z 593) of M. aeruginosa PCC7806 when exposed to 
exogenous microcystin. Error bars = 1 SD and n=4. Only the peak areas are shown as 
a means of comparison. 
A B 
C 
D 
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4.5 Discussion  
 The aim of this study was to evaluate if microcystin-LR functions as 
a signalling molecule to its host organism M. aeruginosa PCC7806. The 
effect of exogenous microcystin-LR on the growth of M. aeruginosa 
PCC7806 and its secondary metabolite production was studied. The 
growth curve of M. aeruginosa PCC7806 showed similar trends compared 
to literature values i.e., log phase growth was until day 21 in a static 
culture system, however, between reported results and the data observed 
here, there were differences such as media used, light intensity, 
temperature and aeration and hence data could not be readily compared 
[258, 94, 161].  
 The use of flow cytometry on M. aeruginosa PCC7806 has proved to 
be a reliable tool to enumerate and differentiate between healthy and 
unhealthy cells. Hence, it is recommended that this protocol be adapted 
for further studies on this organism. This protocol may also be 
extrapolated for the study of other pigmented unicellular cyanobacteria. 
With the aid of the flow cytometric technique, the effect of exogenous 
microcystin-LR on the growth of M. aeruginosa PCC7806 was studied with 
special interest on the live cell population. The results indicated that 
exogenous microcystin-LR concentrations of above 1 µg/ml may have a 
significant effect on the growth of M. aeruginosa PCC7806. It could also 
be stated that exogenous microcystin-LR does not cause cell death, but 
may serve to prolong the generation time significantly. Such an effect 
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may be brought by the interference of localised microcystin-LR within 
thylakoid membranes and around polyphosphate bodies [270], however 
this needs to be confirmed with further studies. It is recommended that, 
similar future studies be coupled with the analysis of one other parameter 
reflective of the cells metabolism i.e., photosynthetic activity, in order to 
precisely evaluate the effect of exogenous microcystin-LR. 
In respect to the intracellular microcystin content, literature values 
report a concentration of 1.5 µg/ml microcystin-LR at day 20 whereas 
about 2.6 µg/ml at day 21 was observed here. Further, the extracellular 
microcystin content is 10% compared with the intracellular content [214], 
whereas here it is 23% at day 21 and 176 % at day 35. These differences 
could again be attributed to the difference in culture conditions, inoculum 
age and nitrate content of the media, however, as the organism in 
comparison is M. aeruginosa PCC7806 it could be argued that the only 
comparable value could be the microcystin production rate which is 5.6 ± 
1.6 femtograms/cell/day which is broadly corroborated in several 
publications [221, 94, 279]. Another interesting feature of this organism 
was highlighted i.e. the organism seemed to produce 81% of Demethy-
microcystin-LR when compared to microcystin-LR, however, in literature it 
has been reported that Demethy-microcystin-LR is mostly about 6% of 
microcystin-LR produced [279]. Although some reports suggest that 
certain Microcystis aeruginosa blooms may contain Demethyl-microcystin-
LR ranging from 16 to 220% of the microcystin-LR in lower pH conditions 
[280], such a finding for M. aeruginosa PCC7806 has not been previously 
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reported. It remains to be explored if any of the culture conditions used, 
such as light, nitrate or continuous illumination may have caused the high 
production of Demethyl-microcystin-LR. It also is unknown if Demethyl-
microcystin-LR is an intermediate in the biosynthesis of microcystin-LR or 
vice versa. However, such investigations are beyond the scope of this 
experimental setup. 
 The use of stable labelled nitrogen as the only source of nitrogen 
enabled accurate quantification of de-novo production of all the secondary 
metabolites of M. aeruginosa PCC7806. This comes as an invaluable 
technique to differentiate between exogenously added microcystin-LR and 
the newly produced microcystin-LR i.e. the production dynamics of 
microcystin-LR could be monitored. By the use of this technique, it was 
clearly evident that the concentration exogenously added microcystin-LR 
remained almost unchanged throughout the duration of the experiment 
i.e. 35 days. This confirmed that M. aeruginosa PCC7806 does not 
catabolise the produced microcystin and that it was stable about at least 
one month in the conditions tested here. An intriguing question arises as 
to why an organism should produce a compound that it does not utilize. It 
also remains to be evaluated if this is the fate of the other secondary 
metabolites of M. aeruginosa PCC7806.  
 The production of de-novo microcystin-LR followed the growth and 
hence it could be stated that the presence of exogenous microcystin-LR 
does not significantly inhibit the biosynthesis of microcystin-LR, although 
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initial suppression of production could be seen. A recent metabolomics 
analysis has reported that wild type M. aeruginosa PCC7806 is able to 
quickly adapt to saturated light conditions owing to its ability to synthesis 
microcystin. Further they also conclude that a microcystin deficient 
mutant accumulates stress markers in a similar situation, indicating that 
microcystin may function as a stabilizing agent under stressful conditions 
[281]. This conclusion fits well within these findings where it is not 
possible to find a specific role for microcystin as the cultures were not 
stressed. Alternatively, it is not understood why high concentrations of 
exogenous microcystin-LR should significantly suppress growth. If this is 
argued as a direct effect of stress, it would mean that the high exogenous 
microcystin-LR had overwhelmed the cells and ultimately suppressed 
growth. The 0.1 µg/ml exogenous microcystin-LR consistently showed 
mildly beneficial effects on growth which may be an indication of 
microcystin-LR acting as a stabilizing molecule, however, as the effect 
was not significant, it may only be stated that this hypothesis needs to be 
evaluated further. It is thought that due to diminished intracellular 
activity, the production is delayed rather than inhibited. It is noted that 
microcystin-LR and the other secondary metabolites of M. aeruginosa 
PCC7806 are produced by and NRPS/PKS enzyme complex and hence 
quantification of these may not strictly reflect the intracellular metabolic 
state of the organism. Hence it would be a wise choice to include other 
parameters which are tightly bound to the metabolic process to evaluate 
the effect of microcystin-LR on the metabolic state of the organism.  
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 The quantification of intracellular secondary metabolites may reveal 
the effect of exogenous microcystin-LR on their production dynamics 
while, the quantification of the extracellular de-novo secondary 
metabolites may shed some light on the release of the secretion of these 
metabolites. This is thought to be the first study to report the production 
rates of several of the metabolites of M. aeruginosa PCC7806 (Table 4.7). 
As seen from this study, the presence of exogenous microcystin-LR does 
not have any net effect on the release of intracellular metabolites. It is 
also seen that the release of metabolites is directly related to its 
intracellular concentration. 
Table 4.7: The daily production rates of few of the metabolites of M. 
aeruginosa PCC7806 
Metabolite fg/cell/day 
microcystin-LR 5.6 ± 1.6 
Cyanopeptolin A 4.0 ± 2.9 
Aerucyclamide A 2.2 ± 0.5 
Aerucyclamide D 2.0 ± 0.7 
   
 All the secondary metabolites of M. aeruginosa PCC7806 i.e., 
microcystin-LR, cyanopeptolins and aerucyclamides behaved with similar 
production and release dynamics. Hence, it is concluded that the presence 
of only high exogenous microcystin-LR has a significant effect on the 
production of any of M. aeruginosa PCC7806 secondary metabolites. 
Interestingly, it was noted that while microcystin-LR, aerucyclamides A, B 
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and C are not assimilated or degraded by M. aeruginosa PCC7806, the 
cyanopeptolins A, B and aerucyclamide D, although appearing stable 
when inside the cell, are unstable, once secreted.  
 In conclusion, although this study was robust in it design to expose 
M. aeruginosa PCC7806 to very high concentrations of one of its 
secondary metabolites (microcystin-LR), the response of the organism 
was only mild and temporary. This observation does not confirm or 
negate the hypothesis that microcystins may have a signalling function. 
The fact that, unlike some secondary metabolites that are unstable once 
outside the cell, microcystin-LR is stable for prolonged period of time 
indicates that this molecule was synthesised with a specific function. 
Whether this molecule serves a functional role to M. aeruginosa PCC7806 
or another organism in its vicinity, needs to be investigated in future 
studies.  
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The effect of cyanopeptides on M. 
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5.1 Introduction 
 Cyanobacteria are prolific producers of secondary metabolites 
[286]. Due to the varied ecosystems these cyanobacteria inhabit, it is 
thought that challenging environmental conditions as well as competition 
pressures have influenced cyanobacteria to produce a wide variety of 
secondary metabolites [287, 288] ranging from small peptides to 
polyketides to alkaloids [289]. However, there is considerable debate as 
to the primary function of any of these metabolites. While several 
hypotheses such as colony survival, cellular fitness and dissuasion of 
predators exist, none of these have been convincingly proven. 
 One way of evaluating the functional role of cyanopeptides is by 
exposing these peptides to a cyanobacterium, which has been well 
characterised, and studying the effects of the peptides on its 
growth/metabolic characteristics [6, 290]. The organism M. aeruginosa 
PCC7806 fits the purpose as this is one of the most studied 
cyanobacterium owing to its capability to synthesis a wide variety of 
secondary metabolite synthesis capability. In this study, M. aeruginosa 
PCC7806 was exposed to an array of cyanopeptides and its growth, 
secondary metabolite production rate and gene expression patterns were 
studied. The range of peptides chosen for this study was microcystins 
(microcystin-LR, microcystin-LF and microcystin-RR), anabaenopeptins (A 
& B), aerucyclamides (A & D), aeruginosin, aeruginosamide and 
cyanopeptolin A. It should be noted that M. aeruginosa PCC7806 in itself 
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produces cyanopeptides such as microcystin-LR, cyanopeptolins, 
aeruginosin and aerucyclamides.  
 One of the most frequently encountered and widely studied 
cyanopeptides are the microcystins. These hepatotoxic heptapeptides are 
produced by several genera such as Microcystis, Nostoc, Oscilatoria, 
Planktothrix and Anabaena sp [291, 292]. To date, nearly 100 different 
variants have been reported, mostly arising from the substitution of 
different amino acids at position two and four of the molecule [293]. 
Recently, it was reported that a single species (Microcystis viridis NIES 
102) could produce up to 47 microcystin variants [294]. Although highly 
variable, all microcystins have a common unique β-amino acid Adda (3S-
amino-9S-methoxy-2S,6,8S-trimethyl-10-phenyldeca-4E,6E-dienoicacid), 
which is known to impart the molecules characteristic hepatotoxicity 
[295]. 
 The toxin microcystin-LR is one of the most commonly encountered 
cyanopeptides and along with microcystin-RR (microcystin-RR) accounts 
for nearly 45 to 99% of total microcystin concentration in certain natural 
blooms [296, 297]. Another isomer of microcystin-LR, Demethylated-
microcystin-LR (D-MeAsp at position 3 is demethylated to Asp), is also 
commonly encountered within strains that produce microcystin-LR [298]. 
Microcystin-RR (Figure5.1a), a variant of microcystin-LR, wherein the L-
amino acid at position 2 is replaced by arginine (R) is also sometimes 
encountered along with microcystin-LR [299].   
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      Figure 5.1a: Microcystin-RR                Figure 5.1b: Microcystin-LF 
 
 In terms of toxicity, microcystin-LR is one of the most toxic 
microcystin with an LD50 of 50 nmol/kg while that of microcystin-RR is 
580 – 630 nmol/kg when tested intraperitoneally on mice [300, 301]. 
Another microcystin variant, microcystin-LF (phenylalanine at position 4, 
Figure 5.1b) is one of the least studied and no in-vivo data is available to 
date, however, a recent in-vitro study reports its toxicity to be 7 times 
higher than microcystin-LR to primary human hepatocytes [302]. 
 Like microcystins, anabaenopeptins are also protein phosphatase 
inhibitors and were first reported by Harada et al In 1995 [303, 304]. In 
recent years, anabaenopeptins have also been reported in Planktothrix, 
Aphanizomenon, Nodularia and Microcystis. Anabaenopeptins are cyclic 
peptides with a conserved lysine at position 5 and a unique ureido bond 
between the amino acid and the ring (Figure 5.2) [305]. It has also been 
reported that certain anabaenopeptins have potent carboxypeptidase A 
inhibitory activities [306]. 
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Figure 5.2: Structure of Anabaenopeptin A, chemical formula C44H57N7O10. 
Mol wt – 843.96 
 Another class of compounds, the aerucyclamides (Figure 5.3) were 
only very recently isolated and characterised from M. aeruginosa 
PCC7806 [162]. Compared to microcystins, these were an order less 
toxic, but interestingly, they showed promising and selective activity 
against malarial parasite (aerucyclamide B, IC50 = 0.7 µM) and Human 
African Trypanosomiasis (HAT) (aerucyclamide C, IC50 = 9.2 µM) [307].  
Unlike most cyanopeptides, aerucyclamides are thought to synthesised 
ribosomally and hence may be used as tools to study the metabolic profile 
of certain cyanobacteria [90]. 
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Figure 5.3: Structure of Aerucyclamide A, C24H34N6O4S2, Mol wt – 534.69 
Da  
 The organism M. aeruginosa PCC7806 is also known to produce the 
linear peptide, aeruginosin (Figure 5.4), which has been shown to inhibit 
serine protease [217]. Although, aeruginosins were initially thought to be 
restricted to Microcystis, recent reports suggest that species such as 
Planktothrix and Nodularia, may also synthesize its congeners [308]. 
Chemically, aeruginosins are unique in that they contain a central Choi 
moiety (2-carboxy-6-hydroxyoctahydroindole) and Hpla ((4-hydroxy) 
phenyl lactic acid) moieties [309]. In terms of toxicity, aeruginosins are 
considered to be only slightly less toxic than microcystins but additionally 
show potent inhibitory activities against thrombin (IC50 = 21.8 nM) and 
trypsin (IC50 = 112 nM).  Currently aeruginosins are being investigated 
for their potential applications in life threatening conditions such as 
venous thrombosis.  
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Figure 5.4: General structure of aeruginosins. R1 – N-terminus, R2 – 
hydrophobic amino acid 
  
 Another unique linear peptide, aeruginosamide (Figure 5.5), has 
also been reported to be produced by Microcystis, although very little 
literature is available on the molecules functional properties. 
Aeruginosamides are characterised by the presence of diisoprenylamine 
and the carboxylated thiazole moieties which are not reported in other 
cyanobacterial metabolites [310]. However, like aerucyclamides, 
aeruginosamides are also ribosomally synthesised and hence may prove 
potentially useful in studying cyanobacterial metabolic phases [311]. 
 
C-terminal Guanidine 
2-carboxy-6-
hydroxyoctahydroindole (Choi) 
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Figure 5.5: Structure of Aeruginosamide, C30H48N4O4S, Mol wt – 560.79 
Da 
 The organism M. aeruginosa PCC7806 also produces several cyclic 
depsipeptides called cyanopeptolins (Figure 5.6) [163]. These are 
molecules that contain the structural element AHP (3-amino-6-hydroxy-2-
piperidone), and show potent serine protease activity at micromolar 
concentrations [201]. Apart from Microcystis, cyanopeptolins are also 
known to be produced by Planktothrix and Scytonema hofmanii [312]. 
Although initially cyanopeptolins were thought be to non-toxic, recent 
evidence suggest that cyanopeptolins are potent inhibitors of trypsin (IC50 
= 670 picomoles), human kallikerin (4.5nM) and factor Xia (3.9nM), while 
micromolar concentrations were required for inhibition of plasmin (0.49 
µM) and chymotrypsin (0.9 µM) [313].  
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Figure 5.6: Cyanopeptolin 963A, C49H69N7O13, Mol wt – 963.48  
 
 Although cyanobacteria are a rich source of unique metabolites, 
very little is known about their production dynamics, and even less about 
why they produce such unique compounds. A single organism such as M. 
aeruginosa PCC7806 is known to produce 4 classes of unique peptides 
i.e., microcystins (microcystin-LR, demethyl-microcystin-LR), 
aeruginosins, aeruginosamides (A-D) and cyanopeptolins (A-D, 963A) [6]. 
Considering the conserved nature of the corresponding genes as well as 
the energy expenditure diverted towards the production of these 
peptides, it is highly unlikely that these peptides are remnants of ancient 
genes. This study was aimed to evaluate the effect of several of these 
cyanopeptides on the growth and peptide production of dynamics of M. 
aeruginosa PCC7806. It is hoped that this study may reveal the subtle 
changes induced by these peptides on its host and may shed some light 
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on the principle reason of what cyanobacteria stand to benefit from these 
peptides. 
5.2 Aim 
 To evaluate the effect of cyanopeptides on M. aeruginosa PCC7806 
 
5.2.1 Objectives 
1) To determine the effect of exogenously added cyanopeptides 
namely, microcystin-LR, microcystin-RR, microcystin-LF, 
aeruginosin, aerucyclamide A and D, cyanopeptolin A, 
aeruginosamide, anabaenopeptin A and B, on the growth of M. 
aeruginosa PCC7806. 
2) To study the effect of these cyanopeptides on the secondary 
metabolites production of M. aeruginosa PCC7806. 
3) To evaluate the effect of these cyanopeptides on expression of 
genes mcy A and mcy E of microcystin-LR biosynthesis cassette.  
 
 
 
 
 
 - 222 - 
 
5.3 Materials and Methods 
5.3.1 Culture and growth conditions 
 The culture and growth conditions were as described in section 2.1 
and 2.3. The experimental setup was as described in section 2.4.2. The 
preparation of various peptides solution was as described in section 2.5 
  
5.3.2 Sampling and sample processing 
 Samples were withdrawn on day 0  and 10. On the sampling day, 
1.5 ml of the culture was aseptically withdrawn from each flask and 0.5 
ml used for cell counting and the remaining 1 ml was used for LC-MS 
analysis.  
 
5.3.3 Cell counting 
 Cell counting was performed using haemocytometer using the 
protocol described in section 2.6.1 
 
5.3.4 Sample preparation for HPLC-MS/MS 
 From 1 ml sample taken on day 0 and 10, the samples were 
processed for LC-MS. The cells were centrifuged at 13000 g for 20 
minutes and the supernatant and the pellet separated. The supernatant 
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was freeze dried. To the pellet and freeze dried supernatant, 1 ml of 
aqueous 80% methanol was added and allowed to extract for 1 hr. This 
was centrifuged again at 13000 g for 20 minutes and the supernatant was 
taken in HPLC vials for analysis. The analysis of the metabolites was 
performed as described previously [2.8] except that the column used was 
CORTECS™ UPLC® C18+, 90 Å pore size, 1.6 µm particle dia, 2.1 x 100 
mm solid core.  This column was chosen as it enabled separation of 
demethyl-microcystin-LR from microcystin-LR and hence quantification of 
the two microcystins could be performed independently.  
 
5.3.5 RNA extraction, purification and semi-quantitative PCR. 
 RNA extraction was carried out as described in section 2.9 and 
semi-quantitative PCR was performed as described in section 2.10 
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5.4 Results 
 In order to evaluate the effect of cyanopeptides on the growth of 
M. aeruginosa PCC7806, it was essential to determine the amount of 
cyanopeptide added exogenously at day 0 and their concentrations at Day 
10 (Figure 5.7).  
 
 The intended concentration was 10 µg/ml, however due to 
differences in solubility of the peptides, this could not always be achieved. 
The peptides aeruginosin (A’sin) and cyanopeptolin A (Cpep A) were the 
only peptides found to be readily soluble in water, however, all the other 
peptides required additional vortexing steps to dissolve. The peptide 
aeruginosamide (A’mide) was the least soluble in water and required 
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sonication. Even after sonication, it was observed that the maximum 
concentration that was added exogenously to the final culture was about 
0.47 ± 0.1 µg/ml. It could be either that the peptide was poorly soluble in 
water or that the additional sonication step may have destroyed the 
peptide. It would be advisable, in future, to initially dissolve 
aeruginosamide in DMSO.   
 In order to quantify the different peptides, a standard curve of each 
of the peptides was performed taking several dilutions of the purified 
peptide in 80% aqueous methanol. These were analysed in HPLC-MS and 
a linear standard curve was plotted. The peptides microcystin-LR, 
microcystin-LF, aeruginosin, anabaenopeptin A and cyanopeptolin A were 
present at approximately 10 µg/ml at day 0. Except cyanopeptolin A, the 
concentrations of all the peptides remained unchanged for the duration of 
the study i.e., until day 10. In fact, even the other peptides that showed 
poor solubility also remained stable over the duration of 10 days. It may 
be concluded that M. aeruginosa PCC7806 is unable to degrade these 
peptides except cyanopeptolin A, which may either have been degraded 
by the activity of the culture or is naturally unstable. The unstable nature 
of cyanopeptolin A has been previously noted in Chap IV, Figure 4.16, 
where it was seen that the release of intracellular de-novo cyanopeptolin 
A did not correlate with the amount present extracellularly.   
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5.4.1 Effect of cyanopeptides on the growth of M. aeruginosa 
PCC7806 
 The cell density measured at day 0 was 2.5 million cells and by day 
10 they had increased 50 fold (Figure 5.8).  At day 10, the cells density 
had reached 124 million cells/ml which was 1.5 fold higher than that 
observed previously (~80 million (Figure 3.1)). The reason for this may 
be due the difference in the inoculum cells preparation which were grown 
in BG11 containing 0.75 g/L of sodium nitrate. This may serve as an 
indication that, although this organism does not fix its own nitrogen, 
excessive amounts of nitrogen may have a growth suppressing effect.   
 At day 10, the cells grown in the presence of microcystin-LF, 
microcystin-RR, A’mide, Ana A & B, and Aeru A & D showed significant 
growth inhibition compared to the control. At this point, it was not known 
if this was due to growth inhibition or toxicity of these cyanopeptides to 
the cells of M. aeruginosa PCC7806. In the case of aeruginosin, it may be 
stated that this cyanopeptide does not have an effect on the growth of M. 
aeruginosa PCC7806. The fact that M. aeruginosa PCC7806’s genome 
contains a gene cluster for aeruginosin suggests that it should be 
producing its own aeruginosin, however, analysis of HPLC data did not 
provide any evidence for this. It is thought that M. aeruginosa PCC7806 
may be producing a variant of aeruginosin [6] thus far not characterised. 
From this study, it is also known that aeruginosin is readily soluble in 
water (easily diffusible into the surroundings), which is an ideal 
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characteristic for an allelochemical. A study on the effect of this 
cyanopeptide on other cyanobacteria/diatoms may provide some evidence 
of an ecological role.  
  
Likewise, the cells exposed to cyanopeptolin A also showed no 
effect on the growth of M. aeruginosa PCC7806. It is thought that the 
decrease in concentration of cyanopeptolin A (by 50% compared to day 
0) may be the reason. At the moment, it is not known if cyanopeptolin A 
has been degraded or has been modified in some way. It is suggested 
that the stability of cyanopeptolin A be further studied in order to 
establish its suitability in bioassays. It is interesting to note that 
aerucyclamide D and aeruginosamide, even though being in low 
concentrations showed significant growth inhibitory effects. It should be 
noted here that M. aeruginosa PCC7806 produces microcystin-LR and 
aerucyclamides (A & D) and hence the inhibition seen may be a combined 
effect of the respective ex-novo and de-novo cyanopeptides.  
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 From the cell numbers, the doubling time of the different 
treatments was calculated and compared to the control for statistical 
significance. The formula used to calculate doubling time is described in 
section 2.7. It was observed that the average doubling time of M. 
aeruginosa PCC7806 was 1.77 ± 0.08 by day 10 (Table 5.1). The 
doubling time of M. aeruginosa PCC7806 has been reported to be between 
2 to 4 days in some studies [269, 221] while others have reported it to be 
between 1.8 to 2.9 [220], although growth conditions were different in 
each study. In this study, the doubling time reported can be stated as the 
highest for M. aeruginosa PCC7806. The fast doubling time seen here may 
be attributed to the cumulative effect of growing the inoculum in BG11 
media containing 12 mM nitrate, optimal growth conditions provided by 
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growing the culture in 20 ml volume taken in 50 ml conical flask and 
approximately 20 µmols/m2/s light and 20 °C temperature.  
From the doubling times data, it appears that certain cyanopeptides 
such as microcystin-LR, microcystin-LF, aeruginosamide, aerucyclamide A 
and anabaenopeptin B seem to be significantly extending the doubling 
time, when compared to the control. The fact the exogenous microcystin-
LR extends the doubling time has been reported in a previous assay 
(Chapter IV, Table 4.3), which confirms that high concentrations of 
cyanopeptides in the surroundings significantly affect cell division rates. It 
would be an interesting exercise to evaluate the mechanism by which 
cyanopeptides bring about this change. Table 5.1: The mean doubling 
time (in days) of M. aeruginosa PCC7806 under the effect of 
cyanopeptides 
Treatment Day 0 – 10 
Control 1.77 ± 0.08 
Aeruginosin 1.79 ± 0.06 
Cyanopeptolin A 1.81 ± 0.02 
Aerucyclamide A 1.99 ± 0.03* 
Aerucyclamide D 1.89 ± 0.05 
microcystin-LR 1.98 ± 0.10* 
microcystin-RR 1.91 ± 0.06 
microcystin-LF 1.94 ± 0.05* 
Aeruginosamide 1.95 ± 0.07* 
Anabaenopeptin A 1.95 ± 0.12 
Anabaenopeptin B 1.92 ± 0.03* 
* - indicates statistically significant from that week’s control. p≤0.05 
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5.4.2 The effect of cyanopeptides on microcystin 
 The use of stable labelled nitrogen (15N) enabled differentiation 
between de-novo (newly synthesised) and ex-novo (already present) 
microcystins within cells. Further, the use of the CORTECS™ UPLC® C18+ 
column for HPLC-MS was useful in differentiating between the two forms 
of microcystins viz; demethyl-microcystin-LR and microcystin-LR 
produced by M. aeruginosa PCC7806. The amount of intracellular de-novo 
demethyl-microcystin-LR (m/z 992) was quantified against a standard of 
purified microcystin-LR, at day 0 and 10. The one-way Anova analysis 
was performed so as to determine statistical significance (Figure 5.9). 
 
 - 231 - 
 
 As expected, at day 0, no de-novo demethyl-microcystin-LR could 
be detected. However, by day 10 the detectable quantities of demethyl-
microcystin-LR had accumulated within cells. The cells that were exposed 
to microcystin-LR, microcystin-RR and aerucyclamide D (Aeru D) showed 
significantly reduced quantities of intracellular demethyl-microcystin-LR 
while none of the other treatments showed any significant change. 
Considering the age of the inoculum used (33 days old) and the doubling 
time, it could be suggested that the day 10 observations could represent 
the actual effect of the exogenous peptides on M. aeruginosa PCC7806. 
Although previous reports have quantified demethyl-microcystin-LR 
independently, most publications report the microcystin concentration as 
the sum of microcystin-LR and demethyl-microcystin-LR [314 - 316] and 
methodologies published [317], this is the first report where demethyl-
microcystin-LR separation has been adequately achieved and the de-novo 
production reported (Figure 5.10). 
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Time in minutes 
Figure 5.10: The chromatogram of microcystins of M. aeruginosa PCC7806 using the CORTECS® column. 
A is ESI-MS of 15-N labelled microcystin-LR (m/z 1006), B is ESI-MS of 15-N labelled demethyl-
microcystin-LR (m/z 992) and C is UV (238 nm) spectra of demethyl-microcystin-LR and microcystin-LR. 
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 In order to obtain a complete picture of the effect of cyanopeptides 
on the microcystin production of M. aeruginosa PCC7806, the 
quantification of de-novo microcystin-LR (m/z 1006) was also performed 
and it could be observed that at day 10, only aerucyclamide A and D 
showed significant sustained inhibition (Figure 5.11). From the growth 
curve of M. aeruginosa PCC7806 reported earlier (Chap IV, Figure 4.6) 
the logarithmic growth phase is between day 7 to day 14 and hence it 
could be stated that during active growth, the presence of certain 
exogenous peptides such as aerucyclamide A and D may have a 
significant effect on the biosynthesis of microcystin-LR, at a dose of 4 to 6 
µg/ml. It remains to be explored if cyanopeptolin A or aeruginosamide 
would also have a similar effect; however, in this study we observed that 
cyanopeptolin concentrations decreased with time while poor solubility of 
aeruginosamide limited its availability in the assay. 
 The intracellular de-novo microcystin-LR concentrations seen here 
was compared to values reported elsewhere and at day 10 the 
intracellular microcystin-LR concentrations were comparable i.e., 0.6 ± 
0.08 µg/ml. This is an interesting observation as the cell numbers were 
1.5 fold higher, yet the intracellular content remains almost similar. This 
could serve as an indication that microcystin biosynthesis and cell growth 
rate are independent processes, in fact a negative correlation between 
growth rate and microcystin biosynthesis can be observed.  
 - 234 - 
 
 
 Although the use of the Cortecs® columns enabled the separation of 
microcystin-LR from demethyl-microcystin-LR, studies report that both 
these congeners are equally potent toxins [318] and in the ecosystem 
these congeners are often co-produced [319 - 322]. The ratio of 
demethyl-microcystin-LR to microcystin-LR might vary between 9 to 50%, 
however, in most studies with Microcystis the microcystins are reported 
as the sum of the congeners [271].  In order to further understand the 
effect of cyanopeptides on total microcystin biosynthesis, the net de-novo 
microcystin content i.e. microcystin-LR + demethyl-microcystin-LR was 
calculated [Figure 5.12]. It should be noted that in this study, we 
observed that demethyl-microcystin-LR was present in equal 
concentrations to that of microcystin-LR.  
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 The total de-novo intracellular microcystin concentration at day 10 
was about 1.09 ± 0.09 µg/ml which correlated well with previous studies 
(Chap IV, Figure 4.9). In a typical ecosystem microcystin concentration 
are known to range widely (4 to 1500 µg/g dry weight of biomass) and 
several factors such as temperature and light availability have been 
known to affect this [323 - 324]. Hence it could only be interpreted that 
even in controlled laboratory studies, some microcystin variability should 
be expected and it is recommended that appropriate controls are 
maintained when a study such as this is performed.  
 In terms of the effect of cyanopeptides, only microcystin-LR, 
microcystin-RR, aerucyclamide A and D sustained the inhibition by day 
10. This data corroborates a previous observation (chap IV, Figure 4.9), 
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but contradicts the findings of Schatz et al. [127], wherein they report 
that the presence of exogenous microcystin-LR (and microginin and 
micropeptin) upregulated microcystin production. However, it should be 
noted that the concentration of microcystin-LR used in this study was 
much higher than may be found ecologically, except under localised 
conditions. Considering the fact that several other peptides used in this 
study were of equally high concentrations, yet M. aeruginosa PCC7806 did 
not show any significant inhibition, it may be concluded that even high 
concentrations of exogenous cyanopeptides is non-toxic to the host. 
Additionally, the inhibition shown by microcystin-RR may also be due to 
the same mechanism as microcystin-LR, however, this needs to be 
confirmed by further studies.  
 M. aeruginosa PCC7806 produces microcystins and aerucyclamides 
and it is an interesting observation that on exposure to aerucyclamides 
(or microcystin-LR), an inhibition in microcystin biosynthesis is seen 
although the organism seems to be insensitive to other peptides such as 
anabaenopeptins or aeruginosin. If it is argued that the seeming reduction 
in microcystin biosynthesis could be due to inhibited cell numbers, 
observation of the cell numbers (Figure 5.8) reveal that apart from 
microcystins and aerucyclamides, the anabaenopeptins and 
aeruginosamide also showed significantly inhibited cell numbers but this 
inhibition did not translate into microcystin biosynthesis (Figure 5.12). In 
order to further investigate this question, the production per cell per day 
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(production rate per day) of de-novo microcystin (m/z 992+1006) was 
calculated (Figure 5.13). 
  
Analysis of production rate revealed that between day 0 to 10, the 
net de-novo production rate was 9.67 ± 0.9 fg/cell/day. Previously, we 
have observed that the production rate between day 0 to 7 was 7.4 ± 1.5 
fg/cell/day and 4.4 ± 0.5 fg/cell/day between day 7 to 14 (Chap IV, 
Figure 4.12). The difference observed could be explained by the fact that 
the nitrate concentration was 50% less in this study but growth was at 
least 1.5 fold higher. Also, the inoculum used in this study was one month 
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old compared to the mid-log inoculum (15 days) used previously. This 
suggests that although M. aeruginosa PCC7806 requires nitrogen for its 
growth, nitrate at a final concentration of 12 mM (0.75 g/L of NaNO3) is 
sufficient for optimal growth when compared to 24 mM (or 1.5 g/L of 
NaNO3).  Another observation is that, although reduced nitrate enhances 
growth, the microcystin production seems to be disconnected and seems 
to follow a rate that is independent of growth.  
 As for the effect of cyanopeptides on the production rate of 
microcystin (Figure 5.13), a contradicting picture emerged as none of the 
peptides that had shown an inhibitory activity on the total de-novo 
microcystin (Figure 5.12) showed a significant inhibition on the production 
rate at day 10. However, exogenously added aeruginosin showed 
significant inhibition in the production rate while anabaenopeptin B 
showed an enhancing effect. The contradicting results observed may be 
explained by the fact that microcystin production is a complex 
biosynthetic process involving several enzyme complexes [176], and the 
suppression or upregulation of a few enzymes in the pathway may not 
translate into the quantities of the final product at a particular time point. 
It may also be that the reduced doubling time (table 5.1) exhibited by 
these peptides may have caused the intracellular MC’s to accumulate and 
ultimately give a high intracellular production rate. 
 The primary aim of this study was to evaluate the role of these 
cyanopeptides on M. aeruginosa PCC7806 and if possible extrapolate this 
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information into the general role of these metabolites in the ecosystem. 
Although microcystins have been studied for the past 30 years, conclusive 
evidence for their role is still being debated. It is clear the cyanopeptides 
are secondary metabolites i.e. these are not involved in the host’s 
primary metabolism and hence it should be expected that their 
absence/presence in the host organism may cause only subtle changes 
and it would be a challenge to detect/measure these changes.  
 Although several cyanopeptides have been isolated and 
characterised, only microcystins have been extensively studied. Hence, 
most literature available focuses on determining the role of microcystins 
in its host or the ecosystem. In an earlier study, it was reported that 
microcystins were produced to dissuade grazers such as daphnids [325, 
326], however, a contradicting conclusion that the daphnids showed no 
selectivity towards toxic and non-toxic strains and a recent study 
reporting that the microcystin synthetase genes evolved prior to the 
origin of metazoans [151] disprove this hypothesis.  
 One key observation of many of these cyanopeptides is that they 
are predominately intracellular molecules and hence intracellular functions 
such as iron chelation and signalling/gene regulation have been 
suggested. Microcystins have been thought of as iron chelators and it had 
been reported that at low concentrations of Fe (≤2.5 µM) the cell growth 
rate decreased, but their intracellular toxin content increased [160]. 
However, later studies contradicted this finding and reported that 
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microcystin content decreased with iron deplete conditions [329]. The 
authors also report that toxic strains of Microcystis maintain their levels of 
intracellular Fe2+ while non-toxic strains have low levels of Fe2+ [99]. The 
differences in findings may be due to differences in the strains and culture 
conditions, but mostly due to insensitive microcystin quantification 
methods. Moreover, microcystins have been found to be localised in the 
thylakoids and around phosphate bodies, which do not support the 
hypothesis of siderophores [270].  
 
 
5.4.3 The effect of cyanopeptides on the genes of microcystin 
biosynthesis 
 In 2000, the complete structure of the microcystin synthetase 
genes were published [176], which paved way for the investigation of the 
role of microcystins at the molecular level. Structurally, mcy (55 kb gene 
cluster for microcystin) is composed of 10 genes arranged in the form of 
two operons mcyABC and mcyD-J arranged in opposite directions [Figure 
5.14].  
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Figure 5.14: Structural organisation of microcystin genes showing the 
proposed sequence of microcystin assembly. ‘T’ indicates genes with a 
putative tailoring function. (Image: Kaebernick et al., FEMS Microbiology 
Ecology, 2001 [327]) 
 
 
 One early study, investigating the effect of exogenous microcystin 
on the gene expression of mcyB gene concluded that Microcystis cells are 
able to sense the lysis of surrounding cells and increase their intracellular 
microcystin production, thereby indicating that microcystin may function 
as an allelochemical (signalling molecules) [127].   Further, a study on 
the partial deletion of the putative transporter mcyH gene resulted in the 
complete absence of intracellular MC. The authors claim that MC’s may be 
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produced with an intention to export and hence may provide an 
extracellular role for microcystin [181]. However, it is generally accepted 
that MC’s are predominately intracellular molecules and the mutation of a 
transport gene should not affect their intracellular production.   
 A recently published study hypothesised that as MC’s are 
intracellular molecules, they may play a significant protective role, by 
binding to several essential proteins and protecting the cells against 
proteases and oxidative stress [266]. Another study, which exposed 
Microcystis to high light intensities of 250 µmol/m2/s found that wild type 
cells adapted faster to the increased light intensity and accumulated 
glycolate, with a view of decreasing their buoyancy. The authors claim 
that this may cause the cells to sink to lower water columns thereby 
avoiding high light intensities [281]. It has also been reported that 
microcystin deficiency upregulates a number of genes involved in 
secondary metabolism and could be complemented by the addition of 
exogenous MC. Further, they also report that exogenous microcystin is 
never imported by neighbouring cells but MC’s may pass on the signal 
through a network of sensors located on the cell surface [328] and hence 
MC’s may play an intra as well as extracellular role. Although the evidence 
presented indicates a multilevel role for microcystins, in the ecosystem, 
both microcystin-producing strains and non-MC producing wild type 
strains co-exist and dominate each other in water systems. Further, it has 
also not been explained why non-toxic mutant strains spontaneously 
generate from toxic strains [151].  
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 The results of the present study thus far indicate that the presence 
of exogenous peptides reduce cell numbers, which may explain the 
differences in intracellular microcystin quantified. In order to investigate 
the effect of exogenous peptides at the molecular level, it was decided to 
study the expression profile of some of the genes involved in microcystin. 
The study design was such that day 10 samples would be used for gene 
expression analysis as this would represent active cell growth period.  The 
mcyA gene, which encodes for N-methyltransferase and mcyE, which 
encodes a polyketide synthase module at the N-terminus and a peptide 
synthetase module at the C-terminus were chosen as they have been 
reported to be important for microcystin synthesis and insertional 
mutagenesis of these genes have reported to abolish microcystin 
production [330, 174]. Further, mcyA has been documented only in 
microcystin producing strains while mcyE is known to play an important 
role in the incorporation of Adda and D-Glutamic acid moieties in the 
microcystin biosynthesis [330, 331].  Total mRNA from the cells was 
extracted and purified as described in section 2.9. Following this, the 
mRNA specific for mcyA and mcyE and 16s rRNA was amplified by reverse 
transcription-PCR (RT-PCR) thus making DNA copies. This DNA was then 
separated on 1.2% agarose gel. The band intensities was quantified 
(using Gel-doc, UVITEC) and the relative band intensities of the mcyA and 
mcyE genes were determined in comparison to the band intensity of 16s 
rRNA. The relative band intensities, thus obtained, were reported as fold 
change in comparison to the control. The rationale behind the use of 16s 
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rRNA gene is that it is considered as a good housekeeping gene, meaning 
it is stably expressed [255]. Besides, several previous works involving the 
use of semi-quantitative RT-PCR have used the band density of this gene 
to comment on the efficiency of the RNA extraction procedure and as an 
internal control to normalize the band intensity of the gene in question 
[255, 332 - 333].  
 A visual observation of the 16s cDNA (from rRNA sequence) bands 
confirmed sufficient extraction of RNA and that comparable quantities of 
the sample has been loaded onto agarose gels. However, analysis of the 
band intensity using image analysis software (Gel-doc, UVITEC) showed 
that the average band intensity varied by ± 6.45%. In order to reduce 
errors in interpretation of results, the band intensities of mcyA and mcyE 
were normalized against their respective 16s rRNA bands. Between day 0 
and 10, the change in mcyA expression was 2 fold while that of mcyE was 
a 3 fold increase. This may be explained by the fact that the inoculum 
was obtained from a stationary phase culture while the day 10 sample 
would represent a mid-log culture.  
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 The mcyA gene expression profile revealed that except for the cells 
exposed to aeruginosin and microcystin-LR, all the other treatments 
showed some overexpression (Figure 5.15). Statistical analysis revealed 
that none of the expressions were significantly different from that of the 
control, but, it should also be noted that the semi-quantitative PCR used 
here is an insensitive technique. It may only be interpreted that the cells 
exposed to cyanopeptides (except aeruginosin) show some differences in 
the expression of the mcyA gene. It is interesting to note that, the cells 
exposed to aerucyclamide D showed the highest relative overexpression 
of mcyA, even when its exogenous concentration was only about 4 µg/ml 
and in spite of the insensitive quantification technique used. 
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 The expression of profile of mcyE gene revealed that many 
cyanopeptides, i.e. anabaenopeptin A & B, aeruginosamide, aeruginosin, 
cyanopeptolin A and microcystin-RR showed little or no difference in 
expression compared to the control (Figure 5.16). Only, the cells exposed 
to aerucyclamide D showed relatively high overexpression of mcyE. In 
fact, between mcyA and mcyE expression profiles, it was seen that only 
aerucyclamide D exposed cells consistently overexpressed these genes. 
 Overall, it could be stated that the presence of at least some of the 
cyanopeptides such as aerucyclamide D and microcystin-LF causes an 
overexpression of mcyA and mcyE genes, whereas only microcystin-LR 
inhibits the expression of its own biosynthetic genes. The presence of 
aeruginosin and to some extent cyanopeptolin A seemed to have no effect 
 - 247 - 
 
at all, although it should be noted that cyanopeptolins are known to 
degrade in the presence of M. aeruginosa PCC7806. The lack of statistical 
significance in Figure 5.15 (or 5.16) should not be construed as invalid 
results, as it is well known that semi-quantitative RT PCR produces highly 
variable results even when ample care has gone into sample handling and 
analysis procedures. Besides, quantification of bands using band intensity 
as a parameter is also highly variable. In such cases, qualitative 
interpretation of bands would be more accurate and at least give a 
relative indication of a positive or negative effect on gene expression 
levels (Figure 5.17). 
 
Figure 5.17: Agarose gel (1.2 %) bands of genes mcyA, mcyE and 16s 
rRNA of M. aeruginosa PCC7806 exposed to cyanopeptides for a period of 
10 days. 
  
 Comparing the gene expression to the net microcystin production 
(Figure 5.12), it was observed that the consistent overexpression of mcyA 
and mcyE does not translate into net microcystin production. It was also 
observed that exogenous microcystin-LR inhibits the expression of mcyA 
and mcyE which also does not translate into decreased production rate. 
The evidence presented here contradicts the findings of Schatz et al. 
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[127], where they report that the presence of exogenous microcystin 
induces the overexpression of mcyB (another gene in the microcystin 
biosynthesis operon) which translated into increased microcystin 
production. However, differences such as the strain of Microcystis used 
and microcystin quantification methods may explain the contradicting 
results. Moreover, they report that the gene mcyB is overexpressed 
whereas we report that gene mcyA/mcyE is underexpressed. Overall, 
from this study it could not be decisively concluded if exogenous 
cyanopeptides exhibit any significant effect on M. aeruginosa PCC7806, 
but it is obvious that the presence of at least some of the cyanopeptides 
causes a change in the expression profile of these genes.  
 The correlation between mcy gene expression levels and 
microcystin concentrations are controversial. One of earliest work on the 
effect of light on mcyB and mcyD genes concluded that total intracellular 
microcystin content and the expression of these genes are not correlated. 
They argued that the high light intensities studied may have induced the 
release of intracellular toxins and hence given lower values for 
intracellular toxin [255]. A study on iron availability and mcyD expression 
levels concluded that at day 10, although gene expression was only mildly 
enhanced, a significant increase in microcystin-LR was noticed [179].  
Later, a study on the effect of nitrate on mcyD expression concluded that 
even though the gene was underexpressed, the net microcystin-LR per 
cell was unchanged [332]. In another study using mcyE, the authors 
conclude that only mcyE gene copies correlated strongly with microcystin 
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concentration whereas McyE transcript levels did not correlate [331]. 
Overall, it may only be stated that microcystin biosynthesis is a complex 
process and it is difficult to establish a correlation between gene 
expression and microcystin concentrations. Moreover, as the gene 
products of most of the mcy genes is an enzyme, the overexpression or 
underexpression of a few genes may not translate into actual variations in 
microcystin concentrations. From this study, it is concluded that studying 
the expression of just two genes (although important for microcystin 
biosynthesis) is insufficient to determine the effect of cyanopeptides on M. 
aeruginosa PCC7806. In order to obtain a comprehensive view, it is 
recommended that all the genes involved in microcystin biosynthesis be 
monitored.  Moreover, the genes for cyanopeptolins and aerucyclamides 
have recently been identified [328] and when studied along with 
microcystin-LR genes, would give a broad picture on the effects of 
cyanopeptides on M. aeruginosa PCC7806. Further, monitoring the 
metabolic state of cells, in addition to monitoring growth of cells, by 
measuring chlorophyll-a genes or pheophytin (breakdown product of 
chlorophyll-a) may provide additional information on the intracellular 
activities of a cell when exposed to cyanopeptides. Finally, it is 
recommended that gene expressions are monitored using robust 
techniques such as qPCR as they have the advantage of reduced 
variability and contamination, online monitoring and do not require post 
reaction analyses. Further, some of these systems are capable of 
multiplexing and high-throughput analysis.  
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5.4.4 Effect of exogenous cyanopeptides on the release of 
intracellular metabolites 
 The presence of high concentrations of cyanopeptides may cause 
the cells to behave differently and leak their intracellular contents faster. 
The effect of cyanopeptides on the release of intracellular microcystin was 
also monitored. Analysis of the extracellular microcystin (m/z 992+1006) 
revealed that the total de-novo microcystin present in the extracellular 
was 0.32 ± 0.06 µg/ml which is about 30% of the intracellular 
synthesised (Figure 5.18). Further, the extracellular total microcystin data 
(m/z 992+1006) showed that none of the exogenously added peptides 
significantly affected the release of intracellular microcystin at day 10. 
This has also been corroborated with the findings reported in chap IV, 
Figure 4.13. While in the intracellular region, the ratio of microcystin-LR 
to demethyl-microcystin-LR was higher, in the extracellular region it 
seems that demethyl-microcystin-LR was higher than microcystin-LR. 
Taken together, it may be interpreted that while some exogenous 
peptides may cause inhibition in the release of intracellular microcystin, 
none of these peptides seemed to sustain this inhibition by day 10. 
Considering the age of the culture, the picture seen at day 10 may be 
considered to be the direct effect of exogenous peptides. The question of 
whether demethyl-microcystin-LR is more easily released from the 
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intracellular region compared to microcystin-LR remains to be further 
investigated. 
 
 
5.4.5 Effect of cyanopeptides on Cyanopeptolins 
 The organism M. aeruginosa PCC7806 produces several variants of 
cyanopeptolins namely A, B, C, D and 963A (Table 5.2) [163, 201]. The 
peak areas of the respective cyanopeptolins were obtained and the 
intracellular as well as the extracellular quantities were determined. 
Cyanopeptolin A (m/z 968 (de-novo)) was present in abundance and was 
quantifiable whereas de-novo cyanopeptolin B (m/z 939), C (m/z 951) 
and 963A (m/z 970) were present in negligible quantities and hence could 
not be quantified. De-novo cyanopeptolin D (m/z 966) was also present in 
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equal concentrations to cyanopeptolin A, but seemed to co-elute and in 
the absence of a suitable standard could not be quantified. Since 
chemically cyanopeptolin D is dissimilar to cyanopeptolin A in that its 
Nε,Nε-Dimethyl-L-lysine is replaced with L-arginine, quantification of one 
may not be related to the other (Figure 5.19). 
Table 5.2: Table of cyanopeptolins produced by M. aeruginosa PCC7806 
Name Formula 14N Mass 15N Mass 
Cyanopeptolin A C46H72N10O12 957 968 
Cyanopeptolin B C46H72N8O12 929 938 
Cyanopeptolin C C47H74N8O12 943 951 
Cyanopeptolin D C48H76N8O12 957 966 
Cyanopeptolin 963A C49H69N7O13 963 970 
 
  
 
 
 
- 253 - 
 
 
 
Figure 5.19: The ESI-MS chromatograms of the cyanopeptolins A, B, C, D and 963A showing their relative 
abundance and elution time. M. aeruginosa PCC7806 was grown for 10 days in BG11 (15N) and the cell 
pellet was extracted with 80% methanol and analysed in HPLC-MS/MS.  
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 At day 10, although differences were seen with many of the 
peptides, only the cultures that were exposed to aeruginosin (A’sin), 
microcystin-LR, and aerucyclamide D (Aeru D) showed sustained 
inhibition in their net quantities (Figure 5.20). Using the intracellular 
de-novo cyanopeptolin A content and the respective weeks cell 
number, the production rate i.e., the production per cell per day was 
determined (Figure 5.21).  
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 In terms of production rate, at day 10, the cultures that were 
exposed to aeruginosin showed significantly lower production rate 
compared to the control, whereas the cultures that were exposed to 
microcystin-LF, aerucyclamide A and anabaenopeptin B showed a 
significantly higher production rate. As stated previously, what seems 
to be enhanced peptide production may well be a direct effect of 
lowered cell growth rate, leading to the accumulation of more 
metabolite within the cells.  Within cyanobacteria, it is generally 
accepted that secondary metabolite production follows growth rate 
[297], but later studies also noted that higher growth rates resulted in 
reduced peptide production [277]. This study’s observations support 
the latter, at least in the case of microcystin and cyanopeptolin A 
production. Some previous work on cyanopeptolins have been 
published, however, the authors declare that due to absence of 
purified standards, their calculations would be inaccurate. Production 
details of cyanopeptolins have so far never been reported in literature 
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and hence to our knowledge, this is the first report where de-novo 
cyanopeptolin production has been deduced.  
 The effect of cyanopeptides on the release of intracellular 
cyanopeptolin A was studied and it revealed that none of the 
exogenously added peptides contributed to the significant release of 
intracellularly produced cyanopeptolin A (Figure 5.22). It has been 
previously reported that cyanopeptolins are unstable once outside the 
cell and hence this may have been a contributing factor here as well.  
 
 
5.4.6 Effect of cyanopeptides on Aerucyclamides 
 M. aeruginosa PCC7806 produces several aerucyclamides such 
as A (m/z 535), B (m/z 533), D (m/z 587) and C (m/z 517). 
Aerucyclamides are chemically different in that they contain sulphur 
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and unlike other secondary metabolites of PCC7806, are thought to be 
synthesised ribosomally (Table 5.3) [162, 90].  
 
Table 5.3: Table of aerucyclamides produced by M. aeruginosa 
PCC7806 
Name Formula 14N Mass 15N Mass 
Aerucyclamide A C24H34N6O4S2 534 540 
Aerucyclamide B C24H33N6O4S2  532 538 
Aerucyclamide C C24H33N6O5S 516 522 
Aerucyclamide D C26H31N6O4S3 586 592 
 
 Purified standards of aerucyclamide A and D were available and 
hence only these metabolites were quantified from the samples. The 
intracellular de-novo aerucyclamide A profile revealed that most of the 
treatments showed no significant effect in their intracellular quantities 
except exogenously added aerucyclamide A & D showed a significant 
inhibition in its intracellular content (Figure 5.23). In order to further 
investigate the effect of cyanopeptides, the production rate of 
aerucyclamide A was calculated (Figure 5.24). 
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 The production rate of aerucyclamide A, between day 1 to 10 
revealed that M. aeruginosa PCC7806, aerucyclamide A was produced 
at 3.01 ± 0.21 fg/cell/day. In terms of the effect of cyanopeptides on 
aerucyclamide A, at day 10, the treatments microcystin-LR, 
microcystin-RR, microcystin-LF, aeruginosamide, anabaenopeptin A & 
B, and aerucyclamide A showed significant increase in their production 
rate compared to the control. It seems that microcystins, 
anabaenopeptins and some aerucyclamides may have a positive effect 
on the production of aerucyclamides. This observation may well be 
considered pivotal, since aerucyclamides are ribosomal peptides 
(unlike microcystin and cyanopeptolins which are NRPS/PKS enabled) 
and may reflect cellular dynamics better than non-ribosomally 
synthesised peptides. In this view, it appears that cells exposed to 
certain cyanopeptides are metabolically more active than their 
unexposed counterparts, even though this activity does not translate 
to increased cell numbers (Table 5.1). It should also be pointed out 
here that, as M. aeruginosa PCC7806 produces many of the 
metabolites evaluated here, even in the control the cells are being 
exposed to some of their own cyanopeptides. In ecological scenarios, 
high exogenous cyanopeptides may be seen during bloom collapse. It 
also means that during bloom collapse, there are nutrients released 
which may be useful for the surviving few cells. In this scenario, the 
presence of exogenous cyanopeptides (by increasing the host’s 
metabolic activity) may favour the growth of the host cells adding a 
competitive advantage. In a recent transcriptomics aided study, it was 
reported that exogenous microcystin-LR, along with light served to 
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maintain PSI to PSII ratio and carbon metabolism providing an 
advantage to the host [328]. This study also supports this view and 
moreover adds that apart from certain microcystins, even 
aerucyclamides, aeruginosamide and few anabaenopeptins may also 
potentially serve as signalling molecules.  
 The effect of cyanopeptides on the release of intracellular 
aerucyclamide A (Figure 5.25) was studied and it was observed that 
none of the peptides had any significant effect on the release of 
intracellular aerucyclamide A.  
 
 The de-novo aerucyclamide D profile was also quantified and it 
revealed that the treatments that received microcystin-LF, 
aerucyclamide A and D showed significant reduction in aerucyclamide 
D synthesis (Figure 5.26). Further, the production rate of 
aerucyclamide D, when exposed to cyanopeptides was also calculated, 
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but it revealed that none of the peptides showed any significant 
difference when compared to the control at day 10 [310]. Since 
aerucyclamide D is also a ribosomally synthesised molecule, this was 
contradicting to the picture of aerucyclamide A production rate (Figure 
5.27) where the microcystins, anabaenopeptins, aeruginosamide and 
aerucyclamide A had shown significant increase when compared to 
control. However, the overall trend, i.e. the mean production in the 
treatments that received microcystins, aeruginosamide, 
anabaenopeptins and aeruginosamide A was higher than their control. 
This contradiction may be due to the low concentrations of 
aerucyclamide D produced (only 25% that of aerucyclamide A) by M. 
aeruginosa PCC7806.  
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 The analysis of the extracellular aerucyclamide D revealed that 
within the time periods investigated, only 10% of aerucyclamide D is 
present in the extracellular region compared to that of intracellular. 
Also, none of the exogenously added peptides had any significant 
effect on the release of de-novo intracellular aerucyclamide D (Figure 
5.28). 
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5.5 Discussion 
 Cyanobacteria produce numerous secondary metabolites, 
however, their function to the host or in the ecosystem is unknown. In 
this study, the effect of various cyanopeptides on the growth and 
secondary metabolite production of M. aeruginosa PCC7806 was 
investigated. A selection of purified peptides were dissolved in MilliQ, 
however due to differences in their solubility, were unable to achieve 
the intended 10 µg/ml concentration of each of the peptides. The 
peptides aerucyclamide D and aeruginosamide were least soluble in 
MilliQ, while aeruginosin and cyanopeptolin A were readily soluble. 
Only for aeruginosamide, an additional sonication step was added, 
however, solubility was still poor. It should be noted that even after 
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sonication, aeruginosamide would have been added to the culture and 
may have contributed to some of the activity seen. In terms of 
stability, all the peptides studied were stable for the 10 days duration, 
except cyanopeptolin A whose concentration appeared to decline with 
time. Cyanopeptolin A’s intracellular ex-novo concentration was also 
checked for the duration of the study and here again we noticed a 
decreasing trend.  
 When the cell numbers at day 10 were considered, it appeared 
that microcystin-LF and microcystin-RR, the two anabaenopeptins and 
aerucyclamides and aeruginosamide seemed to inhibit growth of M. 
aeruginosa PCC7806. However, when their corresponding doubling 
times were calculated, it revealed that only microcystin-LR, 
microcystin-LF, aerucyclamide A, aeruginosamide and anabaenopeptin 
B had significantly increased their doubling time (meaning slower 
growth rate). In ‘real world’ scenario, when cyanobacterial blooms 
collapse, the release of secondary metabolites by lysing cells, may 
signal surrounding cells to reduce cell division, yet prepare for re-
invasion. This may be a strategy for species survival and dominance.  
 The effect of cyanopeptides on de-novo microcystins (both 
demethyl-microcystin-LR and microcystin-LR) was evaluated. In this 
study, it was observed that M. aeruginosa PCC7806 produces 
demethyl-microcystin-LR and microcystin-LR in equal concentrations 
and the total de-novo microcystin concentration at day 10 was 1.09 ± 
0.09 µg/ml. Further, the daily production rate of de-novo microcystin 
was calculated and the impact of exogenous peptides was evaluated. It 
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revealed that during day 0 to 10, the organism was producing 
microcystin at the rate of 9.67 ± 0.90 fg/cell/day and only the 
peptides aeruginosin and anabaenopeptins B had a lasting significant 
enhancing effect on the production rate. It remains to be explored how 
these peptides induce the change and how this would affect an 
organism in the ecosystem. As M. aeruginosa PCC7806 produces 
cyanopeptolins as well as aeruginosamides, their production rates were 
also determined. It was calculated that the organism produces 
cyanopeptolin A at the rate of 4.16 ± 0.23 fg/cell/day (day 0 to 10) 
and that aeruginosin, microcystin-LF, aerucyclamide A and 
anabaenopeptin B had a significant effect on its production rate. From 
this study and previous studies, it was clear that cyanopeptolin A is an 
unstable molecule and hence the changes in production rate seen here 
may have also been the net result of cyanopeptolin biosynthesised vs 
degradation. 
 The view of the effect of cyanopeptides on M. aeruginosa 
PCC7806 was significantly changed when the production rate of 
aerucyclamides was determined. It was calculated that aerucyclamide 
A is produced at the rate of 3.01 ± 0.21 fg/cell/day (day 0 to 10) and 
that exogenous microcystin-LR, microcystin-LF, microcystin-RR, 
aeruginosamide, anabaenopeptin A & B and aerucyclamide A had an 
enhancing effect on the aerucyclamide A. As it is known that 
aerucyclamides are synthesised ribosomally and hence it is thought 
that they would reflect the intracellular dynamics more precisely 
compared to the non-ribosomally synthesised MC's or cyanopeptolins. 
In this view, it is inferred that many of the cyanopeptides confer a 
 - 266 - 
 
distinct advantage to the host (by upregulating their metabolism). 
However, it is also noted that such high concentrations of exogenous 
peptides may not occur unless there is massive bloom collapse. 
  An analysis on the effect of cyanopeptides on the production 
rates of secondary metabolites (of M. aeruginosa PCC7806) revealed 
that, between day 0 to 10 the metabolite aerucyclamide A appeared to 
be affected by most cyanopeptides, while microcystin-LR showed least 
difference. It is thought that this is due to the fact that aerucyclamide 
A is ribosomally synthesised and hence would reflect the intracellular 
metabolism closely compared to its NRPS/PKS counterparts. Hence, 
this leads to the conclusion that the cyanopeptides (microcystin-LR, 
microcystin-LF, microcystin-RR, aeruginosamide, aerucyclamide A, 
anabaenopeptin A & B) induce significant upregulation in the metabolic 
activities of M. aeruginosa PCC7806.  
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Table 5.4: A summary of the effect of cyanopeptides on the secondary 
metabolites of M. aeruginosa PCC7806 between day 0 to 10. 
 
▼ – significantly lower than control and ▲ significantly higher than 
control. (p≤0.05)  
 From the quantification of the production rate of aerucyclamide 
A, it appears that there is an upregulation, however, it is not known 
how this upregulation benefits the host. Further, it is also not known 
how this would affect the host in a competitive ecological scenario.  
 It is clear from this study, that in order to understand the role of 
cyanopeptides, further comprehensive studies are required. In this 
study, M. aeruginosa PCC7806, which produces several secondary 
metabolites (cyanopeptides), was used and its response to a selection 
of cyanopeptides was evaluated.  In which case, the control (where no 
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exogenous cyanopeptide was added) would also have been exposed to 
some of its own cyanopeptides causing auto-induction. For future 
studies, it is suggested that a naturally occurring non microcystin 
producing strain of M. aeruginosa be used (e.g. M. aeruginosa CYA43) 
as this would avoid auto-induction, at least from microcystins. Further, 
it is recommended that the growth of the organism is monitored by 
measuring the gene expression of chlorophyll-a, as this would directly 
reflect the health of a cell. It has been reported that the DI protein (of 
PSII) has a half-life between 2 to 3 hrs and is constantly [335] 
replaced. Finally, it is also suggested that gene expressions are 
quantified using automated qPCR or real time qPCR as these 
techniques are highly sensitive and require less post reaction analysis.  
 In many ways this study has contributed significantly to the 
work on M. aeruginosa PCC7806 (and to the larger context of 
cyanobacterial research). In terms of bioassays, it can be concluded 
that the growth of M. aeruginosa PCC7806 is optimal when grown in 
BG11 containing 0.75 g/L of sodium nitrate as compared to 1.5 g/L. It 
is also better to grow the inoculum in the same nitrate concentration 
and light intensity. It is also suggested that a single sample withdrawn 
at day 10 is sufficient where rapid results are required and this is 
consistent even when aged inoculums are used.  It was also seen that 
none of the exogenously added peptides significantly aided in the 
release of intracellular secondary metabolites of M. aeruginosa 
PCC7806. 
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 Cyanobacteria produce a multitude of diverse and interesting 
compounds of which some are harmful while others may have potential 
beneficial use. Of the many cyanobacteria that form blooms, M. 
aeruginosa is one of the most common in freshwater ecosystems. An 
interesting characteristic of some members of this genus is their ability 
to produce an array of cyanopeptides (secondary metabolites). Over 
the years of evolution, this genus has proved to be adaptable and open 
to accept foreign genes. It has been estimated that this species may 
have acquired up to 11% of its genes by horizontal gene transfer and 
that it may harbour about 13 secondary metabolite gene clusters. Of 
these clusters, the genes for microcystins (mcy), aeruginosins (aer), 
cyanopeptolins (mcn) and microviridin (mdn) seem to have been 
conserved within many of Microcystis species. It has been reported 
that the expression profile of these genes are similar in a typical 
day/night cycle and it is thought that the interaction between these 
genes may be one of the reasons for their joint conservation [217, 
336] down the years. It is also clear that the cells have to expend 
some energy into the production of these metabolites and in the case 
of M. aeruginosa PCC7806, which has 7 different secondary metabolite 
gene clusters, the energy expense would be considerable. Although 
genetic evidence suggests that these secondary metabolites may have 
some function to the producing organism, to date a clear evidence has 
not been reported.  
 The primary aim of this study was to answer the question, ‘Why 
do cyanobacteria produce secondary metabolites?’. With M. aeruginosa 
producing so many metabolites, it was essential to develop techniques 
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for quantifying de-novo production. By providing 15N as the sole source 
of nitrogen, de-novo production rates could be calculated. This enabled 
the monitoring of both the de-novo and the ex-novo metabolites 
produced. It was learnt that M. aeruginosa PCC7806 takes about 2 
days for complete biosynthesis of microcystin-LR, aerucyclamides and 
cyanopeptolins and that of all the metabolites produced by this 
organism, aerucyclamide A was the most abundant, followed by 
microcystin-LR. The fragmentation pattern revealed by the use of 
Waters® UPLC was reliable and adds to the robustness of this 
technique and it is suggested that this technique may be employed 
while studying other as yet uncharacterised metabolites. Interestingly, 
while microcystin-LR and cyanopeptolins showed fragmentation, 
aerucyclamides did not show any major fragments. 
 Cyanobacteria produce several secondary metabolites of which 
microcystins are the most studied, as they have caused several 
episodes of animal and human poisoning in the past. Although, 
microcystins have been studied for several decades and some 
researchers report tentative functions, a clear role has never been 
confirmed. When M. aeruginosa PCC7806 was exposed to high 
concentrations of microcystin-LR, an increase in the doubling time of 
the organism was seen. This increase caused the accumulation of more 
secondary metabolites intracellularly giving an impression of high 
production rate. Other than these changes, the presence of even high 
concentrations of microcystin-LR did not appear to affect the cells 
much. Low concentrations (0.1 µg/ml) of microcystin-LR seem to 
mildly benefit cell growth and metabolites production, yet the evidence 
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presented is insufficient to confirm a role for microcystin-LR. But 
interestingly, it was also learnt that the produced microcystin-LR or 
aerucyclamides are not recycled or degraded for the duration of (35 
days) the study. 
 As a role for microcystin-LR could not be confirmed, it was 
thought that, evaluating the effect of other cyanopeptides on M. 
aeruginosa PCC7806 may shed some light on their function. The effect 
of several cyanopeptides on M. aeruginosa PCC7806 was investigated. 
A selection of microcystins, aerucyclamides, cyanopeptolin, 
anabaenopeptins, aeruginosamide and aeruginosin were used. Of the 
selection, it appeared that at least, microcystin-LR, microcystin-LF and 
anabaenopeptins A & B induced some significant differences 
intracellularly. While microcystin-LR and microcystin-LF induced the 
cells to grow two-fold slower, anabaenopeptins seems to increase the 
production rate of the metabolite aerucyclamide A. Although the 
results do not clearly confirm a role for secondary metabolites, several 
key lessons were learnt i.e. monitoring the production of enzymatically 
synthesised (NRPS/PKS) metabolites would be misleading as this 
would be a poor indicator of intracellular status. However, ribosomally 
synthesised metabolites (aerucyclamides) are more suitable candidates 
as their production would be a direct reflections of the expression 
profile of their genes, which in turn would reflect the metabolic state of 
the cell.   
 This study has also highlighted several areas of improvement, 
which could be incorporated into future studies on cyanobacterial 
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allelopathy. In terms of cell enumeration, while haemocytometry is the 
standard technique, advanced techniques such as Multisizer or even 
flowcytometry have proved to be highly reliable techniques. The 
labeling of metabolites with 15N may be considered as a game changer, 
as this method enables the differentiation and accurate monitoring of 
ex-novo and de-novo metabolites. Further, the optimized rapid 
bioassay and molecular techniques such as gene expression studies 
coupled with sensitive qPCR techniques may be employed to study 
allelopathy in cyanobacteria.  
 Finally, although this study does not confirm a role for 
secondary metabolites, it makes no sense that cyanobacteria (at least 
some) stably maintain and express genes required for secondary 
metabolite biosynthesis. It is also intriguing to note that, within a 
cyanobacterial genus spontaneous mutants arise which lack the ability 
to produce secondary metabolites and that these mutants perform 
equally well in an ecosystem [337]. Marine ecosystems are often and 
always a mixed pool of many organisms, including bacteriophages. It 
would be very interesting to examine the role of bacteriophages (in 
this case cyanophages) in the transfer of NRPS/PKS genes to non-toxic 
strains of cyanobacteria. It is well documented that phages play a 
significant role in the horizontal gene transfer process and in the origin 
of new species [338, 339]. It is also known that lysogenic phages are 
stably maintained within cells conferring some advantage (or none at 
all) to the host and continue to be propagated infinitely. If it is 
hypothesised that the NRPS/PKS genes are part of a lysogenic phage 
genome and that sometime, due to natural processes are excised, 
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explains at least the development of spontaneous non-toxic mutants 
within in a toxic cyanobacterial population and vice-versa. The fact 
that cyanobacteria (compared to heterotrophic bacteria) are 
comparatively more difficult to transform, may suggests immunity 
conferred by lysogenic phages. However, further studies are required 
to evaluate this hypothesis. 
 
 
 
 
 
 
 
 
 
 
 
 - 275 - 
 
ROBERT GORDON UNIVERSITY 
 
 
 
 
 
 
 
 
 
Chapter VII 
 
References 
 
 
 
 
 
 
 
 
 
 
 - 276 - 
 
No References 
1 
Castenholz RW, Wilmotte A, Herdman M, Rippka R, Waterbury JB, 
Iteman I, et al. Phylum BX. Cyanobacteria. : Springer; 2001 
2 
Mur R, Skulberg OM, Utkilen H. Cyanobacteria In The 
Environment. 1999;  WHO 
3 
Stewart W. Nitrogen fixation by photosynthetic microorganisms. 
Annual Reviews in Microbiology. 1973; 27(1):283-316.  
4 
Schopf JW. The fossil record: tracing the roots of the 
cyanobacterial lineage. The ecology of cyanobacteria. : Springer; 
2000. p. 13-35.  
5 
Schopf J, Walter M. Origin and early evolution of cyanobacteria: 
the geological evidence [Algae]. Botanical Monographs (USA). 
1982; 
6 
Frangeul L, Quillardet P, Castets AM, Humbert JF, Matthijs HC, 
Cortez D, et al. Highly plastic genome of Microcystis aeruginosa 
PCC7806, a ubiquitous toxic freshwater cyanobacterium. BMC 
genomics. 2008; 9:274-2164-9-274. 
7 
Echlin, P. The blue-green algae. Scientific American. 1966; 
214:75–81. 
8 
Woese CR, Fox GE. Phylogenetic structure of the prokaryotic 
domain: the primary kingdoms. Proceedings of the National 
Academy of Sciences of the United States of America. 1977; 
74(11):5088-5090. 
9 
Chorus I. Cyanotoxin occurrence in freshwaters-a summary of 
survey results from different countries. Cyanotoxins Berlin 
Umweltbundesamt. 2001:75-82.  
10 
Christoffersen K. Ecological implications of cyanobacterial toxins in 
aquatic food webs. Phycologia. 1996; 35(6S):42-50.  
11 
Carmichael WW, Azevedo S, An JS, Molica R, Jochimsen EM, Lau 
S, et al. Human fatalities from cyanobacteria: chemical and 
biological evidence for cyanotoxins. Environmental health 
perspectives. 2001; 109(7):663.  
12 
Krienitz L, Ballot A, Kotut K, Wiegand C, Putz S, Metcalf JS, et al. 
Contribution of hot spring cyanobacteria to the mysterious deaths 
of Lesser Flamingos at Lake Bogoria, Kenya. FEMS microbiology 
ecology. 2003; 43(2):141-148. 
13 
Backer LC, Landsberg JH, Miller M, Keel K, Taylor TK. Canine 
cyanotoxin poisonings in the United States (1920s–2012): Review 
of suspected and confirmed cases from three data sources. Toxins. 
2013; 5(9):1597-1628.  
14 
World Health Organization. Guidelines for drinking-water quality: 
recommendations. : World Health Organization; 2004.  
15 
O’neil J, Davis TW, Burford MA, Gobler C. The rise of harmful 
cyanobacteria blooms: the potential roles of eutrophication and 
climate change. Harmful Algae. 2012; 14:313-334. 
16 
 Joehnk KD, Huisman J, Sharples J, Sommeijer B, Visser PM, 
Stroom JM. Summer heatwaves promote blooms of harmful 
cyanobacteria. Global Change Biology. 2008; 14(3):495-512. 
17 
Paerl HW, Huisman J. Climate change: a catalyst for global 
expansion of harmful cyanobacterial blooms. Environmental 
Microbiology Reports. 2009; 1(1):27-37. 
18 
Lawton LA, Codd G. Cyanobacterial (blue‐green algal) toxins and 
their significance in UK and European waters. Water and 
Environment Journal. 1991; 5(4):460-465. 
 - 277 - 
 
No References 
19 
 Agrawal MK, Bagchi D, Bagchi SN. Acute inhibition of protease 
and suppression of growth in zooplankter, Moina macrocopa, by 
Microcystis blooms collected in Central India. Hydrobiologia. 2001; 
464(1-3):37-44. 
20 
Harding WR, Rowe N, Wessels JC, Beattie KA, Codd GA. Death of a 
dog attributed to the cyanobacterial (blue-green algal) hepatotoxin 
nodularin in South Africa. Journal of the South African Veterinary 
Association. 1995; 66(4):256-259. 
21 
Singh S, Kate BN, Banerjee U. Bioactive compounds from 
cyanobacteria and microalgae: an overview. Critical reviews in 
biotechnology. 2005; 25(3):73-95.  
22 
MacKintosh C, Beattie KA, Klumpp S, Cohen P, Codd GA. 
Cyanobacterial microcystin-LR is a potent and specific inhibitor of 
protein phosphatases 1 and 2A from both mammals and higher 
plants. FEBS letters. 1990; 264(2):187-192.  
23 
Jones G, Blackburn S, Parker N. A toxic bloom of Nodularia 
spumigena Mertens in Orielton Lagoon, Tasmania. Oceanographic 
Literature Review. 1995; 6(42):479.  
24 
Heresztyn T, Nicholson B. Nodularin concentrations in Lakes 
Alexandrina and Albert, South Australia, during a bloom of the 
cyanobacterium (blue‐green alga) Nodularia spumigena and 
degradation of the toxin. Environmental Toxicology and Water 
Quality. 1997; 12(4):273-282.  
25 
Nehring S. Mortality of dogs associated with a mass development 
of Nodularia spumigena (Cyanophyceae) in a brackish lake at the 
German North Sea coast. Journal of Plankton Research. 1993; 
15(7):867-872.  
26 
Carmichael WW, Eschedor JT, Patterson GM, Moore RE. Toxicity 
and partial structure of a hepatotoxic peptide produced by the 
cyanobacterium Nodularia spumigen. L575 from New Zealand. 
Applied and Environmental Microbiology. 1988; 54(9):2257-2263.  
27 
Galat DL, Verdin JP, Sims LL. Large-scale patterns of Nodularia 
spumigena blooms in Pyramid Lake, Nevada, determined from 
Landsat imagery: 1972–1986. Hydrobiologia. 1990; 197(1):147-
164.  
28 
Baker P, Humpage A. Toxicity associated with commonly occurring 
cyanobacteria in surface waters of the Murray-Darling Basin, 
Australia. Marine and Freshwater Research. 1994; 45(5):773-786.  
29 
Ohta T, Sueoka E, Iida N, Komori A, Suganuma M, Nishiwaki R, et 
al. Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, 
is a new environmental carcinogen in male F344 rat liver. Cancer 
research. 1994; 54(24):6402-6406. 
30 
Van Buynder P, Oughtred T, Kirkby B, Phillips S, Eaglesham G, 
Thomas K, et al. Nodularin uptake by seafood during a 
cyanobacterial bloom. Environmental toxicology. 2001; 16(6):468-
471.  
31 
Mazur‐Marzec H, Meriluoto J, Pliński M, Szafranek J. 
Characterization of nodularin variants in Nodularia spumigena 
from the Baltic Sea using liquid chromatography/mass 
spectrometry/mass spectrometry. Rapid communications in mass 
spectrometry. 2006; 20(13):2023-2032.  
 - 278 - 
 
No References 
32 
Saito K, Konno A, Ishii H, Saito H, Nishida F, Abe T, et al. 
Nodularin-Har: a new nodularin from Nodularia. Journal of natural 
products. 2001; 64(1):139-141.  
33 
De Silva ED, Williams DE, Andersen RJ, Klix H, Holmes CF, Allen 
TM. Motuporin, a potent protein phosphatase inhibitor isolated 
from the Papua New Guinea sponge Theonella swinhoei Gray. 
Tetrahedron letters. 1992; 33(12):1561-1564.  
34 
Ohtani I, Moore RE, Runnegar MT. Cylindrospermopsin: a potent 
hepatotoxin from the blue-green alga Cylindrospermopsis 
raciborskii. Journal of the American Chemical Society. 1992; 
114(20):7941-7942.  
35 
Banker R, Carmeli S, Werman M, Teltsch B, Porat R, Sukenik A. 
Uracil moiety is required for toxicity of the cyanobacterial 
hepatotoxin cylindrospermopsin. Journal of Toxicology and 
Environmental Health Part A. 2001; 62(4):281-288.  
36 
Humpage AR, Fenech M, Thomas P, Falconer IR. Micronucleus 
induction and chromosome loss in transformed human white cells 
indicate clastogenic and aneugenic action of the cyanobacterial 
toxin, cylindrospermopsin. Mutation Research/Genetic Toxicology 
and Environmental Mutagenesis. 2000; 472(1):155-161. 
37 
Runnegar MT, Kong S, Zhong Y, Lu SC. Inhibition of reduced 
glutathione synthesis by cyanobacterial alkaloid 
cylindrospermopsin in cultured rat hepatocytes. Biochemical 
pharmacology. 1995; 49(2):219-225.  
38 
Runnegar MT, Kong S, Zhong Y, Ge J, Lu SC. The role of 
glutathione in the toxicity of a novel cyanobacterial alkaloid 
cylindrospermopsin in cultured rat hepatocytes. Biochemical and 
biophysical research communications. 1994; 201(1):235-241.  
39 
Kiss T, Vehovszky A, Hiripi L, Kovacs A, Vörös L. Membrane effects 
of toxins isolated from a cyanobacterium, Cylindrospermopsis 
raciborskii, on identified molluscan neurones. Comparative 
Biochemistry and Physiology Part C: Toxicology & Pharmacology. 
2002; 131(2):167-176.  
40 
Sivonen K, Himberg K, Luukkainen R, Niemelä S, Poon G, Codd G. 
Preliminary characterization of neurotoxic cyanobacteria blooms 
and strains from Finland. Toxicity Assessment. 1989; 4(3):339-
352. 
41 
Park H, Watanabe MF, Harada K, Nagai H, Suzuki M, Watanabe M, 
et al. Hepatotoxin (microcystin) and neurotoxin (anatoxin‐a) 
contained in natural blooms and strains of cyanobacteria from 
Japanese freshwaters. Natural toxins. 1993; 1(6):353-360.  
42 
Harada K, Kimura Y, Ogawa K, Suzuki M, Dahlem AM, Beasley VR, 
et al. A new procedure for the analysis and purification of naturally 
occurring anatoxin-a from the blue-green alga Anabaena flos-
aquae. Toxicon. 1989; 27(12):1289-1296.  
43 
Selwood AI, Holland PT, Wood SA, Smith KF, McNabb PS. 
Production of anatoxin-a and a novel biosynthetic precursor by the 
cyanobacterium Aphanizomenon issatschenkoi. Environmental 
science & technology. 2007; 41(2):506-510.  
 
 - 279 - 
 
No References 
44 
Namikoshi M, Murakami T, Watanabe MF, Oda T, Yamada J, 
Tsujimura S, et al. Simultaneous production of homoanatoxin-a, 
anatoxin-a, and a new non-toxic 4-hydroxyhomoanatoxin-a by the 
cyanobacterium Raphidiopsis mediterranea Skuja. Toxicon. 2003; 
42(5):533-538.  
45 
Carmichael W and Gorham P. Anatoxins from clones of Anabaena 
flos-aquae isolated from lakes of western Canada. Anatoxins from 
clones of Anabaena flos-aquae isolated from lakes of western 
Canada. Symposium: Experimental Use of Algal Culture in 
Limnology 26-28 October 1976, Sandefjord, Norway. 
Internationale Vereinigung fur Theoretische und Angewandte 
Limnologie, Mittelungen; 1978. 
46 
Edwards C, Beattie KA, Scrimgeour CM, Codd GA. Identification of 
anatoxin-a in benthic cyanobacteria (blue-green algae) and in 
associated dog poisonings at Loch Insh, Scotland. Toxicon. 1992; 
30(10):1165-1175.  
47 
Adeyemo OM, Sirén A. Cardio-respiratory changes and mortality in 
the conscious rat induced by (+) and (±)-anatoxin-a. Toxicon. 
1992; 30(8):899-905. 
48 
Mahmood N, Carmichael W. The pharmacology of anatoxin-a (s), a 
neurotoxin produced by the freshwater cyanobacterium Anabaena 
flos-aquae. Toxicon. 1986; 24.  
49 
Wonnacott S, Swanson K, Albuquerque E, Huby N, Thompson P, 
Gallagher T. Homoanatoxin: a potent analogue of anatoxin-a. 
Biochemical pharmacology. 1992; 43(3):419-423.  
50 
Molica RJ, Oliveira EJ, Carvalho PV, Costa AN, Cunha MC, Melo GL, 
et al. Occurrence of saxitoxins and an anatoxin-a (s)-like 
anticholinesterase in a Brazilian drinking water supply. Harmful 
Algae. 2005; 4(4):743-753.  
51 
Falconer IR. Algal toxins and human health. In The Handbook of 
Environmental Chemistry. Vol 5. Part C - Quality and treatment of 
Drinking Water II. Springer-Verlag, Berlin. 1998:53-82.  
52 
Matsunaga S, Moore RE, Niemczura WP, Carmichael WW. 
Anatoxin-a (s), a potent anticholinesterase from Anabaena flos-
aquae. Journal of the American Chemical Society. 1989; 
111(20):8021-8023.  
53 
Oshima Y, Hasegawa M, Yasumoto T, Hallegraeff G, Blackburn S. 
Dinoflagellate Gymnodinium catenatum as the source of paralytic 
shellfish toxins in Tasmanian shellfish. Toxicon. 1987; 
25(10):1105-1111.  
54 
Carmichael WW, Evans WR, Yin QQ, Bell P, Moczydlowski E. 
Evidence for paralytic shellfish poisons in the freshwater 
cyanobacterium Lyngbya wollei (Farlow ex Gomont) comb. nov. 
Applied and Environmental Microbiology. 1997; 63(8):3104-3110.  
55 
Humpage A, Rositano J, Bretag A, Brown R, Baker P, Nicholson B, 
et al. Paralytic shellfish poisons from Australian cyanobacterial 
blooms. Marine and Freshwater Research. 1994; 45(5):761-771.  
56 
Lagos N, Onodera H, Zagatto PA, Andrinolo D, Azevedo SM, 
Oshima Y. The first evidence of paralytic shellfish toxins in the 
freshwater cyanobacterium Cylindrospermopsis raciborskii, 
isolated from Brazil. Toxicon. 1999; 37(10):1359-1373.  
 - 280 - 
 
No References 
57 
Ballot A, Fastner J, Wiedner C. Paralytic shellfish poisoning toxin-
producing cyanobacterium Aphanizomenon gracile in northeast 
Germany. Applied and Environmental Microbiology. 2010; 
76(4):1173-1180.  
58 
Pearson L, Mihali T, Moffitt M, Kellmann R, Neilan B. On the 
chemistry, toxicology and genetics of the cyanobacterial toxins, 
microcystin, nodularin, saxitoxin and cylindrospermopsin. Marine 
Drugs. 2010; 8(5):1650-1680.  
59 
Yotsu-Yamashita M, Kim YH, Dudley SC, Choudhary G, Pfahnl A, 
Oshima Y, et al. The structure of zetekitoxin AB, a saxitoxin analog 
from the Panamanian golden frog Atelopus zeteki: a potent 
sodium-channel blocker. Proceedings of the National Academy of 
Sciences of the United States of America. 2004; 101(13):4346-
4351.  
60 
Kao C, Levinson S. Tetrodotoxin, saxitoxin, and the molecular 
biology of the sodium channel. New York Academy of Sciences; 
1986. 
61 
Su Z, Sheets M, Ishida H, Li F, Barry WH. Saxitoxin blocks L-type 
ICa. The Journal of pharmacology and experimental therapeutics. 
2004; 308(1):324-329.  
62 
Hall S, Strichartz G, Moczydlowski E, Ravindran A and Reichardt P. 
The saxitoxins: sources, chemistry, and pharmacology. The 
saxitoxins: sources, chemistry, and pharmacology. Marine toxins: 
Origin, structure, and molecular pharmacology (ACS symposium 
series); 1990. p. 29-65. 
63 
Komano A, Maruko H, Sekiguchi H, Seto Y. Detection of saxitoxin 
in counter terrorism using a commercial lateral flow immunoassay 
kit. Forensic Toxicology. 2011; 29(1):38-43.  
64 
Orjala J, Nagle DG, Hsu V, Gerwick WH. Antillatoxin: an 
exceptionally ichthyotoxic cyclic lipopeptide from the tropical 
cyanobacterium Lyngbya majuscula. Journal of the American 
Chemical Society. 1995; 117(31):8281-8282.  
65 
Nogle LM, Okino T, Gerwick WH. Antillatoxin B, a Neurotoxic 
Lipopeptide from the Marine Cyanobacterium Lyngbya majuscula. 
Journal of natural products. 2001; 64(7):983-985.  
66 
Li WI, Berman FW, Okino T, Yokokawa F, Shioiri T, Gerwick WH, et 
al. Antillatoxin is a marine cyanobacterial toxin that potently 
activates voltage-gated sodium channels. Proceedings of the 
National Academy of Sciences of the United States of America. 
2001; 98(13):7599-7604.  
67 
Burja AM, Banaigs B, Abou-Mansour E, Burgess JG, Wright PC. 
Marine cyanobacteria—a prolific source of natural products. 
Tetrahedron. 2001; 57(46):9347-9377.  
68 
Frenz JL, Kohl AC, Kerr RG. Marine natural products as therapeutic 
agents: Part 2. Expert Opinion on Therapeutic Patents. 2004; 
14(1):17-33. 
69 
Chen J, Forsyth CJ. Total synthesis of the marine cyanobacterial 
cyclodepsipeptide apratoxin A. Proceedings of the National 
Academy of Sciences of the United States of America. 2004; 
101(33):12067-12072.  
 
 
 - 281 - 
 
No References 
 
70 
Cetusic JR, Green FR, Graupner PR, Oliver MP. Total synthesis of 
hectochlorin. Organic letters. 2002; 4(8):1307-1310.  
71 
Williams PG, Luesch H, Yoshida WY, Moore RE, Paul VJ. Continuing 
studies on the cyanobacterium Lyngbya sp.: isolation and 
structure determination of 15-norlyngbyapeptin A and 
lyngbyabellin D. Journal of natural products. 2003; 66(5):595-
598.  
72 
Wipf P, Reeves JT, Balachandran R, Day BW. Synthesis and 
biological evaluation of structurally highly modified analogues of 
the antimitotic natural product curacin A. Journal of medicinal 
chemistry. 2002; 45(9):1901-1917.  
73 
Beck ZQ, Aldrich CC, Magarvey NA, Georg GI, Sherman DH. 
Chemoenzymatic synthesis of cryptophycin/arenastatin natural 
products. Biochemistry. 2005; 44(41):13457-13466.  
74 
Molinski TF, Dalisay DS, Lievens SL, Saludes JP. Drug development 
from marine natural products. Nature reviews Drug discovery. 
2009; 8(1):69-85.  
75 
Blunt JW, Copp BR, Hu WP, Munro MH, Northcote PT, Prinsep MR. 
Marine natural products. Natural product reports. 2007; 24(1):31-
86. 
76 
Montero A, Beierle JM, Olsen CA, Ghadiri MR. Design, synthesis, 
biological evaluation, and structural characterization of potent 
histone deacetylase inhibitors based on cyclic α/β-tetrapeptide 
architectures. Journal of the American Chemical Society. 2009; 
131(8):3033-3041.  
77 
Nagle DG, Zhou YD, Mora FD, Mohammed KA, Kim YP. Mechanism 
targeted discovery of antitumor marine natural products. Current 
medicinal chemistry. 2004; 11(13):1725-1756.  
78 
Schmidt EW, Nelson JT, Rasko DA, Sudek S, Eisen JA, Haygood 
MG, et al. Patellamide A and C biosynthesis by a microcin-like 
pathway in Prochloron didemni, the cyanobacterial symbiont of 
Lissoclinum patella. Proceedings of the National Academy of 
Sciences of the United States of America. 2005; 102(20):7315-
7320.  
79 
Williams PG, Yoshida WY, Moore RE, Paul VJ. Isolation and 
structure determination of obyanamide, a novel cytotoxic cyclic 
depsipeptide from the marine cyanobacterium Lyngbya 
confervoides. Journal of natural products. 2002; 65(1):29-31.  
80 
Edwards DJ, Marquez BL, Nogle LM, McPhail K, Goeger DE, Roberts 
MA, et al. Structure and biosynthesis of the jamaicamides, new 
mixed polyketide-peptide neurotoxins from the marine 
cyanobacterium Lyngbya majuscula. Chemistry & biology. 2004; 
11(6):817-833.  
81 
Han B, Gross H, Goeger DE, Mooberry SL, Gerwick WH. Aurilides B 
and C, Cancer Cell Toxins from a Papua New Guinea Collection of 
the Marine Cyanobacterium Lyngbya majuscula. Journal of natural 
products. 2006; 69(4):572-575. 
82 
Nogle LM, Marquez BL, Gerwick WH. Wewakazole, a Novel Cyclic 
Dodecapeptide from a Papua New Guinea Lyngbya majuscula. 
Organic letters. 2003; 5(1):3-6.  
83 
Nogle LM, Gerwick WH. Somocystinamide A, a novel cytotoxic 
disulfide dimer from a Fijian marine cyanobacterial mixed 
assemblage. Organic letters. 2002; 4(7):1095-1098.  
 - 282 - 
 
No References 
84 
Williams PG, Yoshida WY, Quon MK, Moore RE, Paul VJ. The 
structure of palau'amide, a potent cytotoxin from a species of the 
marine cyanobacterium Lyngbya. Journal of natural products. 
2003; 66(12):1545-1549.  
85 
Plaza A, Bewley CA. Largamides AH, unusual cyclic peptides from 
the marine cyanobacterium Oscillatoria sp. The Journal of organic 
chemistry. 2006; 71(18):6898-6907.  
86 
Edelman MJ, Gandara DR, Hausner P, Israel V, Thornton D, 
DeSanto J, et al. Phase 2 study of cryptophycin 52 (LY355703) in 
patients previously treated with platinum based chemotherapy for 
advanced non-small cell lung cancer. Lung Cancer. 2003; 
39(2):197-199.  
87 
Mori T, Barrientos LG, Han Z, Gronenborn AM, Turpin JA, Boyd MR. 
Functional homologs of cyanovirin-N amenable to mass production 
in prokaryotic and eukaryotic hosts. Protein expression and 
purification. 2002; 26(1):42-49.  
88 
Luke Simmons T, Engene N, Ureña LD, Romero LI, Ortega-Barría 
E, Gerwick L, et al. Viridamides A and B, lipodepsipeptides with 
antiprotozoal activity from the marine cyanobacterium Oscillatoria 
nigro-viridis. Journal of natural products. 2008; 71(9):1544-1550. 
89 
Barbaras D, Kaiser M, Brun R, Gademann K. Potent and selective 
antiplasmodial activity of the cyanobacterial alkaloid 
nostocarboline and its dimers. Bioorganic & medicinal chemistry 
letters. 2008; 18(15):4413-4415.  
90 
Portmann C, Blom JF, Kaiser M, Brun R, Ju ̈ttner F, Gademann K. 
Isolation of aerucyclamides C and D and structure revision of 
microcyclamide 7806A: heterocyclic ribosomal peptides from 
Microcystis aeruginosa PCC 7806 and their antiparasite evaluation. 
Journal of natural products. 2008; 71(11):1891-1896. 
91 
Paerl HW, Paul VJ. Climate change: links to global expansion of 
harmful cyanobacteria. Water research. 2012 Apr 1;46(5):1349-
63. 
92 
Kardinaal WEA, Visser PM. Dynamics of cyanobacterial toxins. 
Harmful Cyanobacteria Aquatic Ecology Series, Springer, 
Dordrecht, the Netherlands. 2005; :41-64. 
93 
Sivonen, K., and G. Jones. Cyanobacterial toxins, In I. Chorus and 
J. Bartram (eds.), Toxic cyanobacteria in water: a guide to their 
public health consequences, monitoring and management. 1999; 
p. 41–111.  
94 
Wiedner C, Visser PM, Fastner J, Metcalf JS, Codd GA, Mur LR. 
Effects of light on the microcystin content of Microcystis strain PCC 
7806. Applied and Environmental Microbiology. 2003; 69(3):1475-
1481. 
95 
Watanabe MF, Oishi S. Effects of environmental factors on toxicity 
of a cyanobacterium (Microcystis aeruginosa) under culture 
conditions. Applied and Environmental Microbiology. 1985; 
49(5):1342-1344. 
96 
Song L, Sano T, Li R, Watanabe MM, Liu Y, Kaya K. Microcystin 
production of Microcystis viridis (cyanobacteria) under different 
culture conditions. Phycological Research. 1998; 46(s2):19-23. 
97 
Long BM, Jones GJ, Orr PT. Cellular microcystin content in N-
limited Microcystis aeruginosa can be predicted from growth rate. 
Applied and Environmental Microbiology. 2001; 67(1):278-283.  
 - 283 - 
 
No References 
98 
Oh HM, Lee SJ, Jang MH, Yoon BD. Microcystin production by 
Microcystis aeruginosa in a phosphorus-limited chemostat. Applied 
and Environmental Microbiology. 2000; 66(1):176-179. 
99 
Utkilen H, Gjolme N. Iron-stimulated toxin production in 
Microcystis aeruginosa. Applied and Environmental Microbiology. 
1995; 61(2):797-800.  
100 
Orr PT, Jones GJ. Relationship between microcystin production and 
cell division rates in nitrogen‐limited Microcystis aeruginosa 
cultures. Limnology and Oceanography. 1998; 43(7):1604-1614.  
101 
Tonk L, Visser PM, Christiansen G, Dittmann E, Snelder EO, 
Wiedner C, et al. The microcystin composition of the 
cyanobacterium Planktothrix agardhii changes toward a more toxic 
variant with increasing light intensity. Applied and Environmental 
Microbiology. 2005; 71(9):5177-5181.  
102 
Sinetova MA, Červený J, Zavřel T, Nedbal L. On the dynamics and 
constraints of batch culture growth of the cyanobacterium 
Cyanothece sp. ATCC 51142. Journal of biotechnology. 2012 Nov 
30;162(1):148-55. 
103 
Jonasson S, Vintila S, Sivonen K, El-Shehawy R. Expression of the 
nodularin synthetase genes in the Baltic Sea bloom-former 
cyanobacterium Nodularia spumigena strain AV1. FEMS 
microbiology ecology. 2008; 65(1):31-39.  
104 
Saker ML, Neilan BA. Varied diazotrophies, morphologies, and 
toxicities of genetically similar isolates of Cylindrospermopsis 
raciborskii (nostocales, cyanophyceae) from Northern Australia. 
Applied and Environmental Microbiology. 2001; 67(4):1839-1845.  
105 
Pomati F, Moffitt MC, Cavaliere R, Neilan BA. Evidence for 
differences in the metabolism of saxitoxin and C1 2 toxins in the 
freshwater cyanobacterium Cylindrospermopsis raciborskii T3. 
Biochimica et Biophysica Acta (BBA)-General Subjects. 2004; 
1674(1):60-67.  
106 
Fastner J, Erhard M, von Döhren H. Determination of oligopeptide 
diversity within a natural population of Microcystis 
spp.(Cyanobacteria) by typing single colonies by matrix-assisted 
laser desorption ionization–time of flight mass spectrometry. 
Applied and Environmental Microbiology. 2001; 67(11):5069-
5076.  
107 
Janse I, Kardinaal WE, Meima M, Fastner J, Visser PM, Zwart G. 
Toxic and nontoxic microcystis colonies in natural populations can 
be differentiated on the basis of rRNA gene internal transcribed 
spacer diversity. Applied and Environmental Microbiology. 2004; 
70(7):3979-3987. 
108 
Foster JS, Singh AK, Rothschild LJ, Sherman LA. Growth-phase 
dependent differential gene expression in Synechocystis sp. strain 
PCC 6803 and regulation by a group 2 sigma factor. Archives of 
microbiology. 2007 Apr 1;187(4):265-79. 
109 
Mehta S, Gaur J. Use of algae for removing heavy metal ions from 
wastewater: progress and prospects. Critical reviews in 
biotechnology. 2005; 25(3):113-152.  
110 
Paul DGN, Valerie J. Production of secondary metabolites by 
filamentous tropical marine cyanobacteria: ecological functions of 
the compounds. Journal of Phycology. 1999; 35(6):1412-1421.  
 - 284 - 
 
No References 
111 
Legrand, C., Rengefors, K., Fistarol, G.O., and Graneli, E. 
Allelopathy in phytoplankton -biochemical, ecological and 
evolutionary aspects. Phycologia 2003; 42 (4):406–419. 
112 
Garcia‐Pichel F, Sherry ND, Castenholz RW. Evidence for an 
ultraviolet sunscreen role of the extracellular pigment scytonemin 
in the terrestrial cyanobacterium Chiorogloeopsis sp. 
Photochemistry and photobiology. 1992; 56(1):17-23.  
113 
Sharif DI, Gallon J, Smith CJ, Dudley E. Quorum sensing in 
Cyanobacteria: N-octanoyl-homoserine lactone release and 
response, by the epilithic colonial cyanobacterium Gloeothece 
PCC6909. The ISME journal. 2008; 2(12):1171-1182.  
114 
Paerl H. Nutrient and other environmental controls of harmful 
cyanobacterial blooms along the freshwater–marine continuum. 
Cyanobacterial harmful algal blooms: state of the science and 
research needs. : Springer; 2008. p. 217-237.  
115 
Keating KI. Allelopathic influence on blue-green bloom sequence in 
a eutrophic lake. Science (New York, N.Y.). 1977; 196(4292):885-
887. 
116 
Suikkanen S, Fistarol GO, Granéli E. Effects of cyanobacterial 
allelochemicals on a natural plankton community. Marine Ecology 
Progress Series. 2005; 287:1-9.  
117 
Volk R, Furkert FH. Antialgal, antibacterial and antifungal activity 
of two metabolites produced and excreted by cyanobacteria during 
growth. Microbiological research. 2006; 161(2):180-186. 
118 
Molísch,H. The effect of a plant on the other plants, Allelopathy. 
1937; Fischer, Jena. 
119 
Weir TL, Park S, Vivanco JM. Biochemical and physiological 
mechanisms mediated by allelochemicals. Current opinion in plant 
biology. 2004; 7(4):472-479.  
120 
Cutler HG. Biologically active natural products: potential use in 
agriculture. : American Chemical Society Washington, DC; 1988. 
121 
Scacchi A, Bortolo R, Cassani G, Pirali G, Nielsen E. Detection, 
characterization, and phytotoxic activity of the nucleoside 
antibiotics, blasticidin S and 5-hydroxylmethyl-blasticidin S. 
Journal of plant growth regulation. 1992; 11(1):39-46.  
122 
Mason CP, Edwards KR, Carlson RE, Pignatello J, Gleason FK, 
Wood JM. Isolation of chlorine-containing antibiotic from the 
freshwater cyanobacterium Scytonema hofmanni. Science (New 
York, N.Y.). 1982; 215(4531):400-402. 
123 
Pignatello JJ, Porwoll J, Carlson RE, Xavier A, Gleason FK, Wood 
JM. Structure of the antibiotic cyanobacterin, a chlorine-
containing. gamma.-lactone from the freshwater cyanobacterium 
Scytonema hofmanni. The Journal of organic chemistry. 1983; 
48(22):4035-4038.  
124 
Moore RE, Cheuk C, Patterson GM. Hapalindoles: new alkaloids 
from the blue-green alga Hapalosiphon fontinalis. Journal of the 
American Chemical Society. 1984; 106(21):6456-6457.  
125 
Leflaive J, Ten‐Hage L. Algal and cyanobacterial secondary 
metabolites in freshwaters: a comparison of allelopathic 
compounds and toxins. Freshwater Biology. 2007; 52(2):199-214. 
 - 285 - 
 
No References 
126 
Figueredo CC, Giani A, Bird DF. Does allelopathy contribute to 
cylindrospermopsis raciborskii (cyanobacteria) bloom occurrence 
and geographic expansion? 1. Journal of Phycology. 2007; 
43(2):256-265.  
127 
Schatz D, Keren Y, Vardi A, Sukenik A, Carmeli S, Börner T, et al. 
Towards clarification of the biological role of microcystins, a family 
of cyanobacterial toxins. Environmental microbiology. 2007; 
9(4):965-970.  
128 
Engelke CJ, Lawton LA, Jaspars M. Elevated microcystin and 
nodularin levels in cyanobacteria growing in spent medium of 
Planktothrix agardhii. Archiv für Hydrobiologie. 2003; 158(4):541-
550 
129 
Leao PN, Vasconcelos MTS, Vasconcelos VM. Role of marine 
cyanobacteria in trace metal bioavailability in seawater. Microbial 
ecology. 2007; 53(1):104-109.  
130 
Hulot FD, Huisman J. Allelopathic interactions between 
phytoplankton species: the roles of heterotrophic bacteria and 
mixing intensity. Limnology and Oceanography. 2004; 
49(4part2):1424-1434. 
131 
Ray S, Bagchi S. Nutrients and pH regulate algicide accumulation 
in cultures of the cyanobacterium Oscillatoria laetevirens. New 
Phytologist. 2001; 149(3):455-460.  
132 
Volk R. Studies on culture age versus exometabolite production in 
batch cultures of the cyanobacterium Nostoc insulare. Journal of 
Applied Phycology. 2007; 19(5):491-495.  
133 
Vardi A, Schatz D, Beeri K, Motro U, Sukenik A, Levine A, et al. 
Dinoflagellate-cyanobacterium communication may determine the 
composition of phytoplankton assemblage in a mesotrophic lake. 
Current Biology. 2002; 12(20):1767-1772.  
134 
De Figueiredo DR, Reboleira AS, Antunes SC, Abrantes N, Azeiteiro 
U, Goncalves F, et al. The effect of environmental parameters and 
cyanobacterial blooms on phytoplankton dynamics of a Portuguese 
temperate lake. Hydrobiologia. 2006; 568(1):145-157.  
135 
Kardinaal WE, Tonk L, Janse I, Hol S, Slot P, Huisman J, et al. 
Competition for light between toxic and nontoxic strains of the 
harmful cyanobacterium Microcystis. Applied and Environmental 
Microbiology. 2007; 73(9):2939-2946.  
136 
Gleason FK, Paulson JL. Site of action of the natural algicide, 
cyanobacterin, in the blue-green alga, Synechococcus sp. Archives 
of Microbiology. 1984; 138(3):273-277 
137 
Doan NT, Stewart PR, Smith GD. Inhibition of bacterial RNA 
polymerase by the cyanobacterial metabolites 12-epi-hapalindole 
E isonitrile and calothrixin A. FEMS microbiology letters. 2001; 
196(2):135-139. 
138 
Etchegaray A, Rabello E, Dieckmann R, Moon DH, Fiore MF, von 
Döhren H, et al. Algicide production by the filamentous 
cyanobacteriumFischerellasp. CENA 19. Journal of Applied 
Phycology. 2004; 16(3):237-243.  
139 
Gantar M, Berry JP, Thomas S, Wang M, Perez R, Rein KS. 
Allelopathic activity among Cyanobacteria and microalgae isolated 
from Florida freshwater habitats. FEMS microbiology ecology. 
2008; 64(1):55-64.  
 - 286 - 
 
No References 
140 
Pflugmacher S, Aulhorn M, Grimm B. Influence of a cyanobacterial 
crude extract containing microcystin‐LR on the physiology and 
antioxidative defence systems of different spinach variants. New 
Phytologist. 2007; 175(3):482-489.  
141 
Beresovsky D, Hadas O, Livne A, Sukenik A, Kaplan A, Carmeli S. 
Toxins and biologically active secondary metabolites of Microcystis 
sp. isolated from Lake Kinneret. Israel Journal of Chemistry. 2006; 
46(1):79-87.  
142 
Wiegand C, Peuthert A, Pflugmacher S, Carmeli S. Effects of 
microcin SF608 and microcystin‐LR, two cyanotobacterial 
compounds produced by Microcystis sp., on aquatic organisms. 
Environmental toxicology. 2002; 17(4):400-406. 
143 
Gleason FK, Case DE. Activity of the natural algicide, 
cyanobacterin, on angiosperms. Plant Physiology. 1986; 
80(4):834-837. 
144 
Gross EM, Wolk CP, Jüttner F. Fischerellin, A new allelochemical 
from the freshwater cyanobacterium fischerella muscicola. Journal 
of Phycology. 1991; 27(6):686-692. 
145 
Srivastava A, Jüttner F, Strasser RJ. Action of the allelochemical, 
fischerellin A, on photosystem II. Biochimica et Biophysica Acta 
(BBA)-Bioenergetics. 1998; 1364(3):326-336. 
146 
Rickards RW, Rothschild JM, Willis AC, de Chazal NM, Kirk J, Kirk 
K, et al. Calothrixins A and B, novel pentacyclic metabolites from 
Calothrix cyanobacteria with potent activity against malaria 
parasites and human cancer cells. Tetrahedron. 1999; 
55(47):13513-13520. 
147 
Chen X, Smith GD, Waring P. Human cancer cell (Jurkat) killing by 
the cyanobacterial metabolite calothrixin A. Journal of Applied 
Phycology. 2003; 15(4):269-277.  
148 
Doan NT, Rickards RW, Rothschild JM, Smith GD. Allelopathic 
actions of the alkaloid 12-epi-hapalindole E isonitrile and 
calothrixin A from cyanobacteria of the genera Fischerella and 
Calothrix. Journal of Applied Phycology. 2000; 12(3-5):409-416. 
149 
Babica P, Bláha L, Maršálek B. Exploring the natural role of 
microcystins—a review of effects on photoautotrophic organisms1. 
Journal of Phycology. 2006; 42(1):9-20.  
150 
Jüttner F, Lüthi H. Topology and enhanced toxicity of bound 
microcystins in Microcystis PCC 7806. Toxicon. 2008; 51(3):388-
397.  
151 
Rantala A, Fewer DP, Hisbergues M, Rouhiainen L, Vaitomaa J, 
Borner T, et al. Phylogenetic evidence for the early evolution of 
microcystin synthesis. Proceedings of the National Academy of 
Sciences of the United States of America. 2004; 101(2):568-573.  
152 
Humble AV, Gadd GM, Codd GA. Binding of copper and zinc to 
three cyanobacterial microcystins quantified by differential pulse 
polarography. Water research. 1997; 31(7):1679-1686.  
153 
Ihle T, Jähnichen S, Benndorf J. Wax and wane of microcystis 
(cyanophyceae) and microcystins in lake sediments: a case study 
in quitzdorf reservoir (Germany). Journal of Phycology. 2005; 
41(3):479-488.  
 - 287 - 
 
No References 
154 
Visser PM, Ibelings BW, Mur LR. Autunmal sedimentation of 
Microcystis spp. as result of an increase in carbohydrate ballast at 
reduced temperature. Journal of Plankton Research. 1995; 
17(5):919-933.  
155 
Moisander PH, Ochiai M, Lincoff A. Nutrient limitation of 
Microcystis aeruginosa in northern California Klamath River 
reservoirs. Harmful Algae. 2009; 8(6):889-897.  
156 
Downing T, Meyer C, Gehringer M, Van de Venter M. Microcystin 
content of Microcystis aeruginosa is modulated by nitrogen uptake 
rate relative to specific growth rate or carbon fixation rate. 
Environmental toxicology. 2005; 20(3):257-262. 
157 
Horst GP, Sarnelle O, White JD, Hamilton SK, Kaul RB, Bressie JD. 
Nitrogen availability increases the toxin quota of a harmful 
cyanobacterium, Microcystis aeruginosa. Water research. 2014; 
54:188-198.  
158 
Kromkamp J, van den Heuvel A, Mur LR. Phosphorus uptake and 
photosynthesis by phosphate-limited cultures of the 
cyanobacterium Microcystis aeruginosa. British Phycological 
Journal. 1989; 24(4):347-355. 
159 
Chen G, Yang Z, Ma Y, Ding C, et a. Effect of nitrogen and 
phosphorous on the production of microcystin under laboratory 
conditions. Journal of hygiene research. 2008; 37(2):147-50, 154. 
160 
Lukač M, Aegerter R. Influence of trace metals on growth and 
toxin production of Microcystis aeruginosa. Toxicon. 1993; 
31(3):293-305. 
161 
Jähnichen S, Ihle T, Petzoldt T, Benndorf J. Impact of inorganic 
carbon availability on microcystin production by Microcystis 
aeruginosa PCC 7806. Applied and Environmental Microbiology. 
2007; 73(21):6994-7002.  
162 
Portmann C, Blom JF, Gademann K, Ju ̈ttner F. Aerucyclamides A 
and B: isolation and synthesis of toxic ribosomal heterocyclic 
peptides from the cyanobacterium Microcystis aeruginosa PCC 
7806. Journal of natural products. 2008; 71(7):1193-1196.  
163 
Martin C, Oberer L, Ino T, König Wa, Busch M, Weckesser J. 
Cyanopeptolins, new depsipeptides from the cyanobacterium 
Microcystis sp. PCC 7806. The Journal of antibiotics. 1993; 
46(10):1550-1556. 
164 
Jakobi C, Oberer L, Quiquerez C, König WA, Weckesser J. 
Cyanopeptolin S, a sulfate-containing depsipeptide from a water 
bloom of Microcystis sp. FEMS microbiology letters. 1995; 129(2-
3):129-133. 
165 
Faltermann S, Zucchi S, Kohler E, Blom JF, Pernthaler J, Fent K. 
Molecular effects of the cyanobacterial toxin cyanopeptolin 
(CP1020) occurring in algal blooms: Global transcriptome analysis 
in zebrafish embryos. Aquatic Toxicology. 2014; 149:33-39.  
166 
Namikoshi M, Rinehart KL, Sakai R, Stotts RR, Dahlem AM, 
Beasley VR, et al. Identification of 12 hepatotoxins from a Homer 
Lake bloom of the cyanobacteria Microcystis aeruginosa, 
Microcystis viridis, and Microcystis wesenbergii: nine new 
microcystins. The Journal of organic chemistry. 1992; 57(3):866-
872.  
 - 288 - 
 
No References 
167 
Stotts RR, Namikoshi M, Haschek WM, Rinehart KL, Carmichael 
WW, Dahlem AM, et al. Structural modifications imparting reduced 
toxicity in microcystins from Microcystis spp. Toxicon. 1993; 
31(6):783-789.  
168 
Hermansky S, Stohs S, Eldeen Z, Roche V, Mereish K. Evaluation 
of potential chemoprotectants against microcystin‐LR 
hepatotoxicity in mice. Journal of Applied Toxicology. 1991; 
11(1):65-73.  
169 
Shenolikar S. Protein serine/threonine phosphatases-new avenues 
for cell regulation. Annual Review of Cell Biology. 1994; 10(1):55-
86.  
170 
Hooser SB, Beasley VR, Basgall EJ, Carmichael WW, Haschek WM. 
Microcystin-LR-induced ultrastructural changes in rats. Veterinary 
pathology. 1990; 27(1):9-15.  
171 
Hooser SB, Beasley VR, Waite LL, Kuhlenschmidt MS, Carmichael 
WW, Haschek WM. Actin filament alterations in rat hepatocytes 
induced in vivo and in vitro by microcystin-LR, a hepatotoxin from 
the blue-green alga, Microcystis aeruginosa. Veterinary pathology. 
1991; 28(4):259-266.  
172 
Nishiwaki-Matsushima R, Ohta T, Nishiwaki S, Suganuma M, 
Kohyama K, Ishikawa T, et al. Liver tumor promotion by the 
cyanobacterial cyclic peptide toxin microcystin-LR. Journal of 
cancer research and clinical oncology. 1992; 118(6):420-424.  
173 
Arment AR, Carmichael WW. Evidence that microcystin is a 
thio‐template product. Journal of Phycology. 1996; 32(4):591-
597. 
174 
Nishizawa T, Ueda A, Asayama M, Fujii K, Harada K, Ochi K, et al. 
Polyketide synthase gene coupled to the peptide synthetase 
module involved in the biosynthesis of the cyclic heptapeptide 
microcystin. Journal of Biochemistry. 2000; 127(5):779-789.  
175 
Dittmann E, Neilan BA, Erhard M, Von Döhren H, Börner T. 
Insertional mutagenesis of a peptide synthetase gene that is 
responsible for hepatotoxin production in the cyanobacterium 
Microcystis aeruginosa PCC 7806. Molecular microbiology. 1997; 
26(4):779-787.  
176 
Tillett D, Dittmann E, Erhard M, von Döhren H, Börner T, Neilan 
BA. Structural organization of microcystin biosynthesis in 
Microcystis aeruginosa PCC7806: an integrated peptide–polyketide 
synthetase system. Chemistry & biology. 2000; 7(10):753-764.  
177 
Utkilen H, Gjolme N. Toxin Production by Microcystis aeruginosa as 
a Function of Light in Continuous Cultures and Its Ecological 
Significance. Applied and Environmental Microbiology. 1992; 
58(4):1321-1325. 
178 
Kearns K, Hunter M. Toxin-producing Anabaena flos-aquae induces 
settling of Chlamydomonas reinhardtii, a competing motile alga. 
Microbial ecology. 2001; 42(1):80-86.  
179 
Sevilla E, Martin‐Luna B, Vela L, Bes MT, Fillat MF, Peleato ML. Iron 
availability affects mcyD expression and microcystin‐LR synthesis 
in Microcystis aeruginosa PCC7806. Environmental microbiology. 
2008; 10(10):2476-2483 
 - 289 - 
 
No References 
180 
Castejon M. Image of Microcystis aeruginosa PCC7806. 
[http://www.bioquz.es]. Available from: http://www.bioquz.es 
/bioquimica/ transcriptionalRegulationResearch.do ? 
enlaceSubmenu2 = Research & enlaceSubmenu = 
TranscriptionalRegulation&enlaceMenu=grupos. 
181 
Pearson LA, Hisbergues M, Borner T, Dittmann E, Neilan BA. 
Inactivation of an ABC transporter gene, mcyH, results in loss of 
microcystin production in the cyanobacterium Microcystis 
aeruginosa PCC 7806. Applied and Environmental Microbiology. 
2004; 70(11):6370-6378. 
182 
Ginn HP, Pearson LA, Neilan BA. NtcA from Microcystis aeruginosa 
PCC 7806 is autoregulatory and binds to the microcystin promoter. 
Applied and Environmental Microbiology. 2010; 76(13):4362-
4368. 
183 
Stanier RY, Kunisawa R, Mandel M, Cohen-Bazire G. Purification 
and properties of unicellular blue-green algae (order 
Chroococcales). Bacteriological Reviews. 1971; 35(2):171-205.  
184 
Sano T, Takagi H, Nagano K, Nishikawa M, Kaya K. Accurate LC-
MS analyses for microcystins using per-15N-labeled microcystins. 
Analytical and bioanalytical chemistry. 2011; 399(7):2511-2516. 
185 
Pestana, C. J. Monitoring and regulating cyanobacterial 
metabolites (microcystins and geosmin) in aquatic systems. 2012. 
PhD thesis. Available from Institutional repository of Robert 
Gordon University http://openair.rgu.ac.uk 
186 
Dai R, Liu H, Qu J, Zhao X, Hou Y. Effects of amino acids on 
microcystin production of the Microcystis aeruginosa. Journal of 
hazardous materials. 2009; 161(2):730-736. 
187 
Xing W, Huang W, Li D, Liu Y. Effects of iron on growth, pigment 
content, photosystem II efficiency, and siderophores production of 
Microcystis aeruginosa and Microcystis wesenbergii. Current 
microbiology. 2007; 55(2):94-98. 
188 
Tonk L. Impact of environmental factors on toxic and bioactive 
peptide production by harmful cyanobacteria. 2007. PhD Thesis. 
Available from Institutional repository of the University of 
Amsterdam (UvA) http://hdl.handle.net/11245/2.52677 
189 
Gouvêa SP, Boyer GL, Twiss MR. Influence of ultraviolet radiation, 
copper, and zinc on microcystin content in Microcystis aeruginosa 
(Cyanobacteria). Harmful Algae. 2008; 7(2):194-205. 
190 
Wang W, Shen H, Shi P, Chen J, Ni L, Xie P. Experimental evidence 
for the role of heterotrophic bacteria in the formation of 
Microcystis colonies. Journal of Applied Phycology. 2015; :1-13. 
191 
Hesse K, Dittmann E, Börner T. Consequences of impaired 
microcystin production for light-dependent growth and 
pigmentation of Microcystis aeruginosa PCC 7806. FEMS 
microbiology ecology. 2001; 37(1):39-43. 
192 
Brookes JD, Geary SM, Ganf GG, Burch MD. Use of FDA and flow 
cytometry to assess metabolic activity as an indicator of nutrient 
status in phytoplankton. Marine and Freshwater Research. 2000; 
51(8):817-823. 
193 
Hadjoudja S, Vignoles C, Deluchat V, Lenain JF, Le Jeune AH, 
Baudu M. Short term copper toxicity on Microcystis aeruginosa and 
Chlorella vulgaris using flow cytometry. Aquatic Toxicology. 2009 
Oct 4;94(4):255-64. 
 - 290 - 
 
No References 
194 
Lürling M. Daphnia growth on microcystin‐producing and 
microcystin‐free Microcystis aeruginosa in different mixtures with 
the green alga Scenedesmus obliquus. Limnology and 
Oceanography. 2003; 48(6):2214-2220. 
195 
Keshavanath P, Beveridge M, Baird D, Lawton L, Nimmo A, Codd 
G. The functional grazing response of a phytoplanktivorous fish 
Oreochromis mloticus to mixtures of toxic and non‐toxicstrains of 
the cyanobacterium Microcystis aeruginosa. Journal of fish biology. 
1994; 45(1):123-129 
196 
Wilson AE, Wilson WA, Hay ME. Intraspecific variation in growth 
and morphology of the bloom-forming cyanobacterium Microcystis 
aeruginosa. Applied and Environmental Microbiology. 2006; 
72(11):7386-7389. 
197 
Ramão A, Gimenez M, Laure HJ, Izumi C, Vida RC, Oba-Shinjo S, 
Marie SK, Rosa JC. Changes in the expression of proteins 
associated with aerobic glycolysis and cell migration are involved 
in tumorigenic ability of two glioma cell lines. Proteome sci. 2012 
Sep 3;10(1):53. 
198 
Parker CH, Stutts WL, DeGrasse SL. Development and Validation 
of a Liquid Chromatography-Tandem Mass Spectrometry Method 
for the Quantitation of Microcystins in Blue-Green Algal Dietary 
Supplements. Journal of agricultural and food chemistry. 2015 Dec 
2. 
199 
Edwards C, Lawton LA. Assessment of microcystin purity using 
charged aerosol detection. Journal of Chromatography A. 2010 
Aug 6;1217(32):5233-8. 
200 
Tan LT. Bioactive natural products from marine cyanobacteria for 
drug discovery. Phytochemistry. 2007; 68(7):954-979.  
201 
Bister B, Keller S, Baumann HI, Nicholson G, Weist S, Jung G, et 
al. Cyanopeptolin 963A, a chymotrypsin inhibitor of Microcystis 
PCC 7806. Journal of natural products. 2004; 67(10):1755-1757.  
202 
Dittmann E, Erhard M, Kaebernick M, Scheler C, Neilan BA, von 
Dohren H, et al. Altered expression of two light-dependent genes 
in a microcystin-lacking mutant of Microcystis aeruginosa PCC 
7806. Microbiology (Reading, England). 2001; 147(Pt 11):3113-
3119.  
203 
Pereira DA, Giani A. Cell density-dependent oligopeptide 
production in cyanobacterial strains. FEMS microbiology ecology. 
2014; 88(1):175-183.  
204 
Vézie C, Rapala J, Vaitomaa J, Seitsonen J, Sivonen K. Effect of 
nitrogen and phosphorus on growth of toxic and nontoxic 
Microcystis strains and on intracellular microcystin concentrations. 
Microbial ecology. 2002; 43(4):443-454.  
205 
Jacoby JM, Collier DC, Welch EB, Hardy FJ, Crayton M. 
Environmental factors associated with a toxic bloom of Microcystis 
aeruginosa. Canadian Journal of Fisheries and Aquatic Sciences. 
2000; 57(1):231-240.  
206 
Penn K, Wang J, Fernando SC, Thompson JR. Secondary 
metabolite gene expression and interplay of bacterial functions in 
a tropical freshwater cyanobacterial bloom. The ISME journal. 
2014; 8(9):1866-1878.  
207 
Börner T, Dittmann E. Molecular biology of cyanobacterial toxins. 
Harmful cyanobacteria. : Springer; 2005. p. 25-40. 
 - 291 - 
 
No References 
208 
Hesse K, Kohl J, Chorus I. Effects of light and nutrient supply on 
growth and microcystin concentration of different strains of 
Microcystis aeruginosa. Cyanotoxins: Occurrence, Effects, 
Controlling Factors. 2001 
209 
Ziemert N, Ishida K, Quillardet P, Bouchier C, Hertweck C, de 
Marsac NT, et al. Microcyclamide biosynthesis in two strains of 
Microcystis aeruginosa: from structure to genes and vice versa. 
Applied and Environmental Microbiology. 2008; 74(6):1791-1797.  
210 
Tooming-Klunderud A, Rohrlack T, Shalchian-Tabrizi K, Kristensen 
T, Jakobsen KS. Structural analysis of a non-ribosomal 
halogenated cyclic peptide and its putative operon from 
Microcystis: implications for evolution of cyanopeptolins. 
Microbiology (Reading, England). 2007; 153(Pt 5):1382-1393. 
211 
Fujii K, Sivonen K, Nakano T, Harada K. Structural elucidation of 
cyanobacterial peptides encoded by peptide synthetase gene in 
Anabaena species. Tetrahedron. 2002; 58(34):6863-6871.  
212 
Esquenazi E, Jones AC, Byrum T, Dorrestein PC, Gerwick WH. 
Temporal dynamics of natural product biosynthesis in marine 
cyanobacteria. Proceedings of the National Academy of Sciences of 
the United States of America. 2011; 108(13):5226-5231.  
213 
Vavilin D, Brune DC, Vermaas W. 15 N-labeling to determine 
chlorophyll synthesis and degradation in Synechocystis sp. PCC 
6803 strains lacking one or both photosystems. Biochimica et 
Biophysica Acta (BBA)-Bioenergetics. 2005; 1708(1):91-101.  
214 
Black K, Yilmaz M, Phlips EJ. Growth and toxin production by 
Microcystis aeruginosa PCC 7806 (Kutzing) Lemmerman at 
elevated salt concentrations. Journal of Environmental Protection. 
2011 Aug 10;2(06):669. 
215 
Moezelaar R, Stal L. A comparison of fermentation in the 
cyanobacterium Microcystis PCC7806 grown under a light/dark 
cycle and continuous light. European Journal of Phycology. 1997 
Nov 26;32(4):373-8. 
216 
Briand E, Bormans M, Quiblier C, Salençon MJ, Humbert JF. 
Evidence of the cost of the production of microcystins by 
Microcystis aeruginosa under differing light and nitrate 
environmental conditions. PLoS One. 2012 Jan 19;7(1):e29981. 
217 
Straub C, Quillardet P, Vergalli J, De Marsac NT, Humbert JF. A 
day in the life of Microcystis aeruginosa strain PCC 7806 as 
revealed by a transcriptomic analysis. PLoS One. 2011 Jan 
19;6(1):e16208. 
218 
Dervaux J, Mejean A, Brunet P. Irreversible collective migration of 
cyanobacteria in eutrophic conditions. PloS one. 2015 Mar 
23;10(3):e0120906. 
219 
Jiang Y, Ji B, Wong RN, Wong MH. Statistical study on the effects 
of environmental factors on the growth and microcystins 
production of bloom-forming cyanobacterium—Microcystis 
aeruginosa. Harmful algae. 2008 Feb 29;7(2):127-36. 
220 
El Semary NA. Investigating factors affecting growth and cellular 
mcyB transcripts of Microcystis aeruginosa PCC 7806 using real-
time PCR. Annals of microbiology. 2010 Jun 1;60(2):181-8. 
221 
Tonk L, Bosch K, Visser PM, Huisman J. Salt tolerance of the 
harmful cyanobacterium Microcystis aeruginosa. 2007.  
 - 292 - 
 
No References 
222 
Edwards C, Lawton LA, Beattie KA, Codd GA, Pleasance S, Dear 
GJ. Analysis of microcystins from cyanobacteria by liquid 
chromatography with mass spectrometry using 
atmospheric‐pressure ionization. Rapid communications in mass 
spectrometry. 1993; 7(8):714-721.  
223 
Banerjee S, Mazumdar S. Electrospray ionization mass 
spectrometry: a technique to access the information beyond the 
molecular weight of the analyte. International journal of analytical 
chemistry. 2012; 2012.  
224 
Yuan M, Namikoshi M, Otsuki A, Watanabe MF, Rinehart KL. 
Electrospray ionization mass spectrometric analysis of 
microcystins, cyclic heptapeptide hepatotoxins: modulation of 
charge states and [M H] to [M Na] ratio. Journal of the American 
Society for Mass Spectrometry. 1999; 10(11):1138-1151.  
225 
McLuckey SA. Principles of collisional activation in analytical mass 
spectrometry. Journal of the American Society for Mass 
Spectrometry. 1992; 3(6):599-614.  
226 
Diehnelt CW, Peterman SM, Budde WL. Liquid chromatography–
tandem mass spectrometry and accurate m/z measurements of 
cyclic peptide cyanobacteria toxins. TrAC Trends in Analytical 
Chemistry. 2005; 24(7):622-634.  
227 
Harada K, Imanishi S, Kato H, Mizuno M, Ito E, Tsuji K. Isolation 
of Adda from microcystin-LR by microbial degradation. Toxicon. 
2004; 44(1):107-109.  
228 
Benke P, Kumar MV, Pan D, Swarup S. A mass spectrometry-
based unique fragment approach for the identification of 
microcystins. Analyst. 2015; 140(4):1198-1206.  
229 
Pérez S, Aga DS. Recent advances in the sample preparation, 
liquid chromatography tandem mass spectrometric analysis and 
environmental fate of microcystins in water. TrAC Trends in 
Analytical Chemistry. 2005; 24(7):658-670.  
230 
Wu X, Yan Y, Wang P, Ni L, Gao J, Dai R. Effect of urea on growth 
and microcystins production of Microcystis aeruginosa. Bioresource 
technology. 2015; 181:72-77.  
231 
Yuan M, Namikoshi M, Otsuki A, Rinehart KL, Sivonen K, Watanabe 
MF. Low‐energy collisionally activated decomposition and 
structural characterization of cyclic heptapeptide microcystins by 
electrospray ionization mass spectrometry. Journal of mass 
spectrometry. 1999; 34(1):33-43.  
232 
Mayumi T, Kato H, Imanishi S, Kawasaki Y, Hasegawa M, Harada 
K. Structural characterization of microcystins by LC/MS/MS under 
ion trap conditions. Journal of Antibiotics. 2006; 59(11):710.  
233 
Kahn ML, Parra-Colmenares A, Ford CL, Kaser F, McCaskill D, 
Ketchum RE. A mass spectrometry method for measuring 15 N 
incorporation into pheophytin. Analytical Biochemistry. 2002; 
307(2):219-225. 
234 
Kardinaal, W.E.A., and P.M. Visser. Dynamics of cyanobacterial 
toxins, In J. Huisman, 
H.C.P. Matthijs, and P.M. Visser (eds.), Harmful cyanobacteria. 
Springer, Dordrecht, The 
Netherlands. 2005; p. 41-63. 
 - 293 - 
 
No References 
235 
Chaffin JD, Bridgeman TB, Heckathorn SA, Mishra S. Assessment 
of Microcystis growth rate potential and nutrient status across a 
trophic gradient in western Lake Erie. Journal of Great Lakes 
Research. 2011 Mar 31;37(1):92-100. 
236 
Li M, Nkrumah P, Xiao M. Biochemical composition of Microcystis 
aeruginosa related to specific growth rate: insight into the effects 
of abiotic factors. Inland Waters. 2014 Jun 8;4(4):357-62. 
237 
Yang Z, Geng L, Wang W, Zhang J. Combined effects of 
temperature, light intensity, and nitrogen concentration on the 
growth and polysaccharide content of Microcystis aeruginosa in 
batch culture. Biochemical Systematics and Ecology. 2012 Apr 
30;41:130-5. 
238 
Shen H, Song L. Comparative studies on physiological responses 
to phosphorus in two phenotypes of bloom-forming Microcystis. 
Hydrobiologia. 2007 Nov 1;592(1):475-86. 
239 
Cottingham KL, Ewing HA, Greer ML, Carey CC, Weathers KC. 
Cyanobacteria as biological drivers of lake nitrogen and 
phosphorus cycling. Ecosphere. 2015 Jan 1;6(1):1-9. 
240 
Davies OA, Abowei JF, Tawari CC. Phytoplankton community of 
Elechi creek, Niger Delta, Nigeria-a nutrient-polluted tropical 
creek. American Journal of Applied Sciences. 2009;6(6):1143-52. 
241 
Dunton PG, Walsby AE. The diameter and critical collapse pressure 
of gas vesicles in Microcystis are correlated with GvpCs of different 
length. FEMS microbiology letters. 2005 Jun 1;247(1):37-43. 
242 
Skulberg OM. Microalgae as a source of bioactive molecules–
experience from cyanophyte research. Journal of Applied 
Phycology. 2000; 12(3-5):341-348.  
243 
Paul VJ. Global warming and cyanobacterial harmful algal blooms. 
Cyanobacterial Harmful Algal Blooms: State of the Science and 
Research Needs. : Springer; 2008. p. 239-257.  
244 
Carmichael WW. Toxins of freshwater algae. In: A. T. Tu, editor. 
Handbook of natural toxins, Vol. 3: Marine toxins and venoms, Tu, 
A.T ed. New York: New York, NY, 1988. Vol 3 p. 121-147.  
245 
Chorus EI, Bartram J. Toxic cyanobacteria in water: a guide to 
their public health consequences, monitoring and management. 
1999. 
246 
Chorus I. Cyanotoxin occurrence in freshwaters-a summary of 
survey results from different countries. Cyanotoxins. Berlin. 
Umweltbundesamt. 2001; :75-82. 
247 
Mayer AM, Rodríguez AD, Berlinck RG, Hamann MT. Marine 
pharmacology in 2005–6: Marine compounds with anthelmintic, 
antibacterial, anticoagulant, antifungal, anti-inflammatory, 
antimalarial, antiprotozoal, antituberculosis, and antiviral 
activities; affecting the cardiovascular, immune and nervous 
systems, and other miscellaneous mechanisms of action. 
Biochimica et Biophysica Acta (BBA)-General Subjects. 2009; 
1790(5):283-308.  
248 
Dokulil M, Teubner K. Cyanobacterial dominance in eutrophic 
lakes. Causes-Consequences-Solutions. Lake Sci. 1998; 10:357-
370. 
249 
Hu Z, Liu Y, Li D, Dauta A. Growth and antioxidant system of the 
cyanobacterium Synechococcus elongatus in response to 
microcystin-RR. Hydrobiologia. 2005; 534(1-3):23-29.  
 - 294 - 
 
No References 
250 
Babica P, Hilscherová K, Bártová K, Bláha L, Maršálek B. Effects of 
dissolved microcystins on growth of planktonic photoautotrophs. 
Phycologia. 2007; 46(2):137-142.  
251 
Dokulil MT, Teubner K. Cyanobacterial dominance in lakes. 
Hydrobiologia. 2000; 438(1-3):1-12.  
252 
Botes DP, Wessels PL, Kruger H, Runnegar MT, Santikarn S, Smith 
RJ, et al. Structural studies on cyanoginosins-LR,-YR,-YA, and-YM, 
peptide toxins from Microcystis aeruginosa. Journal of the 
Chemical Society, Perkin Transactions 1. 1985; :2747-2748.  
253 
Dawson JF, Holmes CF. Molecular mechanisms underlying 
inhibition of protein phosphatases by marine toxins. Frontiers in 
bioscience: a journal and virtual library. 1999; 4:D646-58.  
254 
Xing Y, Xu Y, Chen Y, Jeffrey PD, Chao Y, Lin Z, et al. Structure of 
protein phosphatase 2A core enzyme bound to tumor-inducing 
toxins. Cell. 2006; 127(2):341-353.  
255 
Kaebernick M, Neilan BA, Borner T, Dittmann E. Light and the 
transcriptional response of the microcystin biosynthesis gene 
cluster. Applied and Environmental Microbiology. 2000; 
66(8):3387-3392. 
256 
Dziallas C, Pinnow S, Grossart HP. Quantification of toxic and 
toxin-producing cyanobacterial cells by RING-FISH in combination 
with flow cytometry. Limnology and Oceanography: Methods. 
2011 Feb 1;9(2):67-73. 
257 
Pezzullo JC. Analysis of variance from summary data. [homepage 
on the Internet]. 2015 [updated 17-April-2015; cited 2015 July]. 
Available from: http://statpages.org/anova1sm.html.  
258 
Briand E, Bormans M, Quiblier C, Salencon MJ, Humbert JF. 
Evidence of the cost of the production of microcystins by 
Microcystis aeruginosa under differing light and nitrate 
environmental conditions. PloS one. 2012; 7(1):e29981.  
259 
Wannemacher R. Chemical stability and laboratory safety of 
naturally occurring toxins. Fort Detrick, Frederick, MD: US Army 
Medical Research Institute of Infectious Disease. 1989. 
260 
Tsuji K, Watanuki T, Kondo F, Watanabe MF, Suzuki S, Nakazawa 
H, et al. Stability of microcystins from cyanobacteria—II. Effect of 
UV light on decomposition and isomerization. Toxicon. 1995; 
33(12):1619-1631.  
261 
Bortoli S, Oliveira-Silva D, Krüger T, Dörr FA, Colepicolo P, Volmer 
DA, et al. Growth and microcystin production of a Brazilian 
Microcystis aeruginosa strain (LTPNA 02) under different nutrient 
conditions. Revista Brasileira de Farmacognosia. 2014; 24(4):389-
398. 
262 
Dang TC, Fujii M, Rose AL, Bligh M, Waite TD. Characteristics of 
the freshwater cyanobacterium Microcystis aeruginosa grown in 
iron-limited continuous culture. Applied and Environmental 
Microbiology. 2012; 78(5):1574-1583.  
263 
Backer LC, Carmichael W, Kirkpatrick B, Williams C, Irvin M, Zhou 
Y, et al. Recreational exposure to low concentrations of 
microcystins during an algal bloom in a small lake. Marine Drugs. 
2008; 6(2):389-406.  
 - 295 - 
 
No References 
264 
Jones GJ, Orr PT. Release and degradation of microcystin following 
algicide treatment of a Microcystis aeruginosa bloom in a 
recreational lake, as determined by HPLC and protein phosphatase 
inhibition assay. Water research. 1994; 28(4):871-876.  
265 
Pestana CJ. Monitoring and regulating cyanobacterial metabolites 
(microcystins and geosmin) in aquatic systems. 2012. 
266 
Zilliges Y, Kehr J, Meissner S, Ishida K, Mikkat S, Hagemann M, et 
al. The cyanobacterial hepatotoxin microcystin binds to proteins 
and increases the fitness of Microcystis under oxidative stress 
conditions. PloS one. 2011; 6(3):e17615.  
267 
Tucker S, Pollard P. Identification of cyanophage Ma-LBP and 
infection of the cyanobacterium Microcystis aeruginosa from an 
Australian subtropical lake by the virus. Applied and Environmental 
Microbiology. 2005; 71(2):629-635.  
268 
Kurmayer R, Kutzenberger T. Application of real-time PCR for 
quantification of microcystin genotypes in a population of the toxic 
cyanobacterium Microcystis sp. Applied and Environmental 
Microbiology. 2003; 69(11):6723-6730.  
269 
Sangolkar LN, Maske SS, Muthal PL, Kashyap SM, Chakrabarti T. 
Isolation and characterization of microcystin producing Microcystis 
from a Central Indian water bloom. Harmful algae. 2009; 
8(5):674-684.  
270 
Young FM, Morrison LF, James J, Codd GA. Quantification and 
localization of microcystins in colonies of a laboratory strain of 
Microcystis (Cyanobacteria) using immunological methods. 
European Journal of Phycology. 2008; 43(2):217-225.  
271 
Meriluoto J, Karlsson K, Spoof L. High-throughput screening of ten 
microcystins and nodularins, cyanobacterial peptide hepatotoxins, 
by reversed-phase liquid chromatography-electrospray ionisation 
mass spectrometry. Chromatographia. 2004; 59(5-6):291-298.  
272 
Sedmak B, Eleršek T. Microcystins induce morphological and 
physiological changes in selected representative phytoplanktons. 
Microbial ecology. 2005; 50(2):298-305.  
273 
 Watanabe M, Oishi S. A highly toxic strain of blue-green alga 
Microcystis aeruginosa isolated from lake Suwa [Japan][toxicity 
expressed as death of mice]. Bulletin of the Japanese Society of 
Scientific Fisheries (Japan). 1983.  
274 
Ressom R. Health effects of toxic cyanobacteria (blue-green 
algae). : National Health and Medical Research Council; 1994. 
275 
 Martin C, Oberer L, Ino T, König Wa, Busch M, Weckesser J. 
Cyanopeptolins, new depsipeptides from the cyanobacterium 
Microcystis sp. PCC7806. The Journal of antibiotics. 1993; 
46(10):1550-1556. 
276 
Rounge TB, Rohrlack T, Tooming-Klunderud A, Kristensen T, 
Jakobsen KS. Comparison of cyanopeptolin genes in Planktothrix, 
Microcystis, and Anabaena strains: evidence for independent 
evolution within each genus. Applied and Environmental 
Microbiology. 2007; 73(22):7322-7330.  
277 
Tonk L, Welker M, Huisman J, Visser PM. Production of 
cyanopeptolins, anabaenopeptins, and microcystins by the harmful 
cyanobacteria Anabaena 90 and Microcystis PCC7806. Harmful 
Algae. 2009; 8(2):219-224.  
 - 296 - 
 
No References 
278 
Peña S, Scarone L, Medeiros A, Manta E, Comini M, Serra G. 
Synthesis of precursors and macrocycle analogs of aerucyclamides 
as anti-trypanosomal agents. Med Chem Comm. 2012; 
3(11):1443-1448.  
279 
Ríos V, Moreno I, Prieto A, Soria-Díaz M, Frías J, Cameán A. 
Comparison of Microcystis aeruginosa (PCC7820 and PCC7806) 
growth and intracellular microcystins content determined by liquid 
chromatography–mass spectrometry, enzyme-linked 
immunosorbent assay anti-Adda and phosphatase bioassay. 
Journal of water and health. 2014; 12(1):69-80.  
280 
Krüger T, Christian B, Luckas B. Development of an analytical 
method for the unambiguous structure elucidation of cyclic 
peptides with special appliance for hepatotoxic desmethylated 
microcystins. Toxicon. 2009; 54(3):302-312.  
281 
Meissner S, Steinhauser D, Dittmann E. Metabolomic analysis 
indicates a pivotal role of the hepatotoxin microcystin in high light 
adaptation of Microcystis. Environmental microbiology. 2014.  
282 
Luquet F, Millette M, LaCroix M. Growth inhibition of 
microorganisms by lactic acid bacteria. 2007. In USA Patent 
CA2672640A1. 
283 
Von Elert E, Oberer L, Merkel P, Huhn T, Blom JF. Cyanopeptolin 
954, a Chlorine-Containing Chymotrypsin Inhibitor of Microcystis 
aeruginosa NIVA Cya 43. Journal of natural products. 2005; 
68(9):1324-1327.  
284 
Neumann U, Campos V, Cantarero S, Urrutia H, Heinze R, 
Weckesser J, et al. Co-occurrence of non-toxic (cyanopeptolin) and 
toxic (microcystin) peptides in a bloom of Microcystis sp. from a 
Chilean lake. Systematic and applied microbiology. 2000; 
23(2):191-197.  
285 
Hrudey SE, Lambert TW, Kenefick SL (1994) Health risk 
assessment of microcystins in 
drinking water supplies. In: Toxic cyanobacteria — a global 
perspective, pp. 7-12. Adelaide, 
Australian Centre for Water Quality Research. 
286 
Harada K. Production of secondary metabolites by freshwater 
cyanobacteria. Chemical and Pharmaceutical bulletin. 2004; 
52(8):889-899. 
287 
Carmichael W. The toxins of cyanobacteria. Sci. Am. 1994, pp. 
78–86 
288 
Carmichael W. Cyanobacteria secondary metabolites—the 
cyanotoxins. Journal of applied bacteriology. 1992; 72(6):445-
459. 
289 
Carmichael, W. W. Toxins of freshwater algae. In Handbook of 
natural toxins, Vol. 3: Marine toxins and venoms, A. T. Tu (ed), 
Dekker M, New York, NY, 1988. pp. 121–147. 
290 
Shao J, Wu Z, Yu G, Peng X, Li R. Allelopathic mechanism of 
pyrogallol to Microcystis aeruginosa PCC7806 (Cyanobacteria): 
from views of gene expression and antioxidant system. 
Chemosphere. 2009; 75(7):924-928. 
291 
Gulledge B, Aggen J, Huang H, Nairn A, Chamberlin A. The 
microcystins and nodularins: cyclic polypeptide inhibitors of PP1 
and PP2A. Current medicinal chemistry. 2002; 9(22):1991-2003. 
 - 297 - 
 
No References 
292 
Hitzfeld BC, Hoger SJ, Dietrich DR. Cyanobacterial toxins: removal 
during drinking water treatment, and human risk assessment. 
Environmental health perspectives. 2000; 108 Suppl 1:113-122. 
293 
Niedermeyer TH, Daily A, Swiatecka-Hagenbruch M, Moscow JA. 
Selectivity and potency of microcystin congeners against OATP1B1 
and OATP1B3 expressing cancer cells. PloS one. 2014; 
9(3):e91476. 
294 
Fewer DP, Rouhiainen L, Jokela J, Wahlsten M, Laakso K, Wang H, 
et al. Recurrent adenylation domain replacement in the 
microcystin synthetase gene cluster. BMC evolutionary biology. 
2007; 7:183. 
295 
Dawson R. The toxicology of microcystins. Toxicon. 1998; 
36(7):953-962. 
296 
Vasconcelos V, Sivonen K, Evans W, Carmichael W, Namikoshi M. 
Hepatotoxic microcystin diversity in cyanobacterial blooms 
collected in Portuguese freshwaters. Water research. 1996; 
30(10):2377-2384. 
297 
Sivonen, K, & Jones, G. Cyanobacterial toxins. In I. Chorus, & J. 
Bartram (Eds.) Toxic cyanobacteria in water: A guide to their 
public health consequences, monitoring, and management. 
London: E & FN Spon, 1999: pp. 41–111 
298 
Trojanowicz M. Chromatographic and capillary electrophoretic 
determination of microcystins. Journal of separation science. 
2010; 33(3):359-371. 
299 
Ame MV, del Pilar Diaz M, Wunderlin DA. Occurrence of toxic 
cyanobacterial blooms in San Roque Reservoir (Córdoba, 
Argentina): A field and chemometric study. Environmental 
toxicology. 2003; 18(3):192-201. 
300 
Stoner RD, Adams WH, Slatkin DN, Siegelman HW. The effects of 
single L-amino acid substitutions on the lethal potencies of the 
microcystins. Toxicon. 1989; 27(7):825-828. 
301 
Watanabe MF, Oishi S, Harada K, Matsuura K, Kawai H, Suzuki M. 
Toxins contained in Microcystis species of cyanobacteria (blue-
green algae). Toxicon. 1988; 26(11):1017-1025. 
302 
Fischer A, Höger SJ, Stemmer K, Feurstein D, Knobeloch D, 
Nussler A, et al. The role of organic anion transporting 
polypeptides (OATPs/SLCOs) in the toxicity of different microcystin 
congeners in vitro: a comparison of primary human hepatocytes 
and OATP-transfected HEK293 cells. Toxicology and applied 
pharmacology. 2010; 245(1):9-20. 
303 
Sano T, Usui T, Ueda K, Osada H, Kaya K. Isolation of new protein 
phosphatase inhibitors from two cyanobacteria species, 
Planktothrix spp. Journal of natural products. 2001; 64(8):1052-
1055.  
304 
Harada K, Fujii K, Shimada T, Suzuki M, Sano H, Adachi K, et al. 
Two cyclic peptides, anabaenopeptins, a third group of bioactive 
compounds from the cyanobacterium Anabaena flos-aquae NRC 
525-17. Tetrahedron letters. 1995; 36(9):1511-1514. 
305 
Christiansen G, Philmus B, Hemscheidt T, Kurmayer R. Genetic 
variation of adenylation domains of the anabaenopeptin synthesis 
operon and evolution of substrate promiscuity. Journal of 
Bacteriology. 2011; 193(15):3822-3831. 
 - 298 - 
 
No References 
306 
Murakami M, Suzuki S, Itou Y, Kodani S, Ishida K. New 
anabaenopeptins, potent carboxypeptidase-A inhibitors from the 
cyanobacterium Aphanizomenon flos-aquae. Journal of natural 
products. 2000; 63(9):1280-1282. 
307 
Peña S, Scarone L, Manta E, Stewart L, Yardley V, Croft S, et al. 
Synthesis of a Microcystis aeruginosa predicted metabolite with 
antimalarial activity. Bioorganic & medicinal chemistry letters. 
2012; 22(15):4994-4997. 
308 
Fewer DP, Jokela J, Paukku E, Osterholm J, Wahlsten M, Permi P, 
et al. New structural variants of aeruginosin produced by the toxic 
bloom forming cyanobacterium Nodularia spumigena. PloS one. 
2013; 8(9):e73618.  
309 
Ishida K, Welker M, Christiansen G, Cadel-Six S, Bouchier C, 
Dittmann E, et al. Plasticity and evolution of aeruginosin 
biosynthesis in cyanobacteria. Applied and Environmental 
Microbiology. 2009; 75(7):2017-2026.  
310 
Lawton LA, Morris LA, Jaspars M. A Bioactive Modified Peptide, 
Aeruginosamide, Isolated from the Cyanobacterium Microcystis a 
eruginosa. The Journal of organic chemistry. 1999; 64(14):5329-
5332.  
311 
Leikoski N, Liu L, Jokela J, Wahlsten M, Gugger M, Calteau A, et al. 
Genome mining expands the chemical diversity of the cyanobactin 
family to include highly modified linear peptides. Chemistry & 
biology. 2013; 20(8):1033-1043. 
312 
Matern U, Oberer L, Erhard M, Herdman M, Weckesser J. 
Hofmannolin, a cyanopeptolin from Scytonema hofmanni PCC 
7110. Phytochemistry. 2003; 64(6):1061-1067.  
313 
Gademann K, Portmann C, Blom JF, Zeder M, Ju ̈ttner F. Multiple 
toxin production in the cyanobacterium Microcystis: isolation of 
the toxic protease inhibitor cyanopeptolin 1020. Journal of natural 
products. 2010; 73(5):980-984. 
314 
Harada K, Matsuura K, Suzuki M, Watanabe MF, Oishi S, Dahlem 
AM, et al. Isolation and characterization of the minor components 
associated with microcystins LR and RR in the cyanobacterium 
(blue-green algae). Toxicon. 1990; 28(1):55-64.  
315 
Spoof L, Vesterkvist P, Lindholm T, Meriluoto J. Screening for 
cyanobacterial hepatotoxins, microcystins and nodularin in 
environmental water samples by reversed-phase liquid 
chromatography–electrospray ionisation mass spectrometry. 
Journal of Chromatography A. 2003; 1020(1):105-119.  
316 
El Khalloufi F, Oufdou K, Lahrouni M, El Ghazali I, Saqrane S, 
Vasconcelos V, et al. Allelopatic effects of cyanobacteria extracts 
containing microcystins on Medicago sativa–Rhizobia symbiosis. 
Ecotoxicology and environmental safety. 2011; 74(3):431-438.  
317 
Mekebri A, Blondina G, Crane D. Method validation of microcystins 
in water and tissue by enhanced liquid chromatography tandem 
mass spectrometry. Journal of Chromatography A. 2009; 
1216(15):3147-3155. 
 - 299 - 
 
No References 
318 
Ueno Y, Nagata S, Tsutsumi T, Hasegawa A, Watanabe MF, Park 
HD, et al. Detection of microcystins, a blue-green algal 
hepatotoxin, in drinking water sampled in Haimen and Fusui, 
endemic areas of primary liver cancer in China, by highly sensitive 
immunoassay. Carcinogenesis. 1996; 17(6):1317-1321. 
319 
Jurczak T, Tarczynska M, Karlsson K, Meriluoto J. Characterization 
and diversity of cyano-bacterial hepatotoxins (microcystins) in 
blooms from polish freshwaters identified by liquid 
chromatography-electrospray ionisation mass spectrometry. 
Chromatographia. 2004; 59(9-10):571-578. 
320 
Lindholm T, Vesterkvist P, Spoof L, Lundberg-Niinistö C, Meriluoto 
J. Microcystin occurrence in lakes in Åland, SW Finland. 
Hydrobiologia. 2003; 505(1-3):129-138. 
321 
Ballot A, Krienitz L, Kotut K, Wiegand C, Metcalf JS, Codd GA, et 
al. Cyanobacteria and cyanobacterial toxins in three alkaline Rift 
Valley lakes of Kenya-Lakes Bogoria, Nakuru and Elmenteita. 
Journal of Plankton Research. 2004; 26(8):925-935. 
322 
Ballot A, Krienitz L, Kotut K, Wiegand C, Pflugmacher S. 
Cyanobacteria and cyanobacterial toxins in the alkaline crater 
lakes Sonachi and Simbi, Kenya. Harmful algae. 2005; 4(1):139-
150. 
323 
Kotak BG, Kenefick SL, Fritz DL, Rousseaux CG, Prepas EE, Hrudey 
SE. Occurrence and toxicological evaluation of cyanobacterial 
toxins in Alberta lakes and farm dugouts. Water research. 1993; 
27(3):495-506. 
324 
Falconer IR, Humpage AR. Health risk assessment of 
cyanobacterial (blue-green algal) toxins in drinking water. 
International Journal of Environmental Research and Public Health. 
2005; 2(1):43-50.  
325 
Rohrlack T, Dittmann E, Henning M, Borner T, Kohl JG. Role of 
microcystins in poisoning and food ingestion inhibition of Daphnia 
galeata caused by the cyanobacterium Microcystis aeruginosa. 
Applied and Environmental Microbiology. 1999; 65(2):737-739. 
326 
DeMott WR, Zhang Q, Carmichael WW. Effects of toxic 
cyanobacteria and purified toxins on the survival and feeding of a 
copepod and three species of Daphnia. Limnology and 
Oceanography. 1991; 36(7):1346-1357.  
327 
Kaebernick M, Neilan BA. Ecological and molecular investigations 
of cyanotoxin production. FEMS microbiology ecology. 2001; 
35(1):1-9.  
328 
Makower AK, Schuurmans JM, Groth D, Zilliges Y, Matthijs HC, 
Dittmann E. Transcriptomics-aided dissection of the intracellular 
and extracellular roles of microcystin in Microcystis aeruginosa 
PCC7806. Applied and Environmental Microbiology. 2015; 
81(2):544-554. 
329 
Pereira D, Pimentel J, Bird D, Giani A. Changes in oligopeptide 
production by toxic cyanobacterial strains under iron deficiency. 
Aquatic Microbial Ecology. 2015; 74(3):205-214. 
 
 - 300 - 
 
No References 
330 
Tillett D, Parker DL, Neilan BA. Detection of toxigenicity by a probe 
for the microcystin synthetase A gene (mcyA) of the 
cyanobacterial genus Microcystis: comparison of toxicities with 
16S rRNA and phycocyanin operon (Phycocyanin Intergenic 
Spacer) phylogenies. Applied and Environmental Microbiology. 
2001; 67(6):2810-2818. 
331 
Ngwa FF, Madramootoo CA, Jabaji S. Comparison of cyanobacterial 
microcystin synthetase (mcy) E gene transcript levels, mcy E gene 
copies, and biomass as indicators of microcystin risk under 
laboratory and field conditions. MicrobiologyOpen. 2014; 
3(4):411-425.  
332 
Sevilla E, Martin-Luna B, Vela L, Bes MT, Peleato ML, Fillat MF. 
microcystin-LR synthesis as response to nitrogen: transcriptional 
analysis of the mcyD gene in Microcystis aeruginosa PCC7806. 
Ecotoxicology. 2010; 19(7):1167-1173. 
333 
Mbukwa EA, Boussiba S, Wepener V, Leu S, Kaye Y, Msagati TA, et 
al. PCR amplification and DNA sequence of mcy A gene: The 
distribution profile of a toxigenic Microcystis aeruginosa in the 
Hartbeespoort Dam, South Africa. Journal of water and health. 
2013; 11(3):563-572.  
334 
Rasband, W.S., ImageJ, U. S. National Institutes of Health, 
Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2014.  
335 
Vavilin D, Vermaas W. Continuous chlorophyll degradation 
accompanied by chlorophyllide and phytol reutilization for 
chlorophyll synthesis in Synechocystis sp. PCC 6803. Biochimica et 
Biophysica Acta (BBA)-Bioenergetics. 2007; 1767(7):920-929. 
336 
Humbert, Jean-François, Valérie Barbe, Amel Latifi, Muriel Gugger, 
Alexandra Calteau, Thérèse Coursin, Aurélie Lajus et al. "A tribute 
to disorder in the genome of the bloom-forming freshwater 
cyanobacterium Microcystis aeruginosa." (2013): e70747. 
337 
Schatz D, Keren Y, Hadas O, Carmeli S, Sukenik A, Kaplan A. 
Ecological implications of the emergence of non‐toxic subcultures 
from toxic Microcystis strains. Environmental microbiology. 2005; 
7(6):798-805. 
338 
Canchaya C, Fournous G, Chibani-Chennoufi S, Dillmann M, 
Brüssow H. Phage as agents of lateral gene transfer. Current 
opinion in microbiology. 2003; 6(4):417-424. 
339 
de la Cruz F, Davies J. Horizontal gene transfer and the origin of 
species: lessons from bacteria. Trends in microbiology. 2000; 
8(3):128-133. 
 
 
